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ABSTRACT
Disorders of movement are recognized features of multiple sclerosis (MS). They
often involve the upper limbs, headland trunk and can prevent a person from carrying
out the simplest of daily activities such as holding a drink and feeding themselves.
This may have enormous psychological consequences, often leading to frustration,
embarrassment (particularly in social situations), withdrawal and increased
dependence on others.
Treatment of these disorders of movement, which are usually refractory to medical
therapy, has been by thalamotomy, a neuroablative technique. Results have been
variable and often unsatisfactory in the long term. Recently thalamic deep brain
stimulation (DBS) has been proposed after its successful use in the treatment of
Parkinsonian tremor. Relatively little information exists on the use of this treatment
in patients with MS. Studies carried out so far have been on very small cohorts and
have used non-validated outcome scales and short follow-up. There is little data on
the effect of the movement disorder on a person's disability, handicap and quality of
life (QOL); the perception of ability after surgery; and on the costs involved in
thalamic DBS.
The work presented here had 3 principal objectives: first to develop and validate a
scale for measuring movement disorders in MS (MDMS); secondly to evaluate the
effect of thalamic DBS on impairment, disability, handicap and aspects of quality of
life (QOL) relevant to these patients; and thirdly to estimate the costs associated with
thalamic DBS.
The Modified Fahn's Tremor Rating Scale (MFTRS) was developed and validated
for the purposes of this study. Results of the validity, reliability and responsiveness
of the MFTRS, as given in the published paper, showed that it can be used with
confidence in the clinical setting.
xiv
Thirty seven patients with MDMS were assessed before operation. Fifteen patients
underwent thalamic surgery. The target arm was assessed 1, 3, 6 and 12 months after
operation using the MFTRS, which measured severity of tremor, and the Jebsen Test
of Hand Function (JTHF) which measured performance of 7 subtests of upper limb
function. Information concerning the influence of the movement disorder on overall
disability, handicap and QOL was collected at or over 12 months and was compared
with that of the pre-operative assessment using various subjective rating scales and
questionnaires.
Results showed that thalamic DBS significantly reduced the severity of tremor
amplitude and significantly improved performance of the Jebsen subtests when the
DBS was on at each post-operative assessments (1, 3, 6, and 12 months) compared
with pre-operatively (all p values < 0.02). However, these symptomatic and changes
in function did not translate into significant improvements in patients' performance
in activities of daily living and thus there were no apparent economic benefits (ie.
savings in future care-costs). Also there was no change in patients' perceptions of
their handicap or in most aspects of QOL: the only significant change was that
patients perceived themselves to be less anxious 12 months after the operation
(p-0.03). The overall impact was therefore clinically limited.
This prospective study has illustrated the benefits and limitations of thalamic DBS in
patients with MDMS, and has highlighted the post-operative rehabilitation and
follow-up requirements and the resulting health economic implications associated
with its use. The validation of the MFTRS not only enabled the effect of thalamic





STEREOTACTIC NEUROSURGERY FOR MOVEMENT
DISORDERS IN PEOPLE WITH MULTIPLE
SCLEROSIS
1.1 Multiple Sclerosis (MS)
1.1.1 What is MS?
Multiple Sclerosis (MS) is primarily a disease of young adults (Ebers and Sadovnick
1997) of unknown aetiology. It is an acquired primary demyelinating disease of the
central nervous system (CNS) in which myelin is the target of an autoimmune
inflammatory process. Demyelination refers to the acquired damage, whatever the
cause, to apparently normal myelin (Whitaker and Mitchell 1997).
Primary demyelination implies that the myelin unit, comprising the oligodendrocyte
and CNS myelin sheath, is the pathogenic site of injury. In contrast, secondary
demyelination occurs when the axonal components are damaged so that the requisite
signal from the axolemma for myelin formation or maintenance is lost. Although the
axon is relatively spared in MS accounting for its designation as a primary
demyelinating disease, the axon can be affected, especially in later phases.
In 1993, a distinguished group of neurologists reached concensus on a classification
which has gained widespread acceptance for diagnosing MS in clinical practice,
epidemiology and treatment trials (Poser et al. 1983). The Poser criteria link natural
history and physical findings for the diagnosis of MS and define the age of onset
range as 10-59 years. The clinical manifestations of MS typically appear between 20
and 45 years of age (Riise 1997) with focal, multifocal, episodic and general
neurological signs and symptoms (Whitaker and Mitchell 1997).
MS has two clinical hallmarks which occur after the first episode of neurological
deficit. The first is the often sudden appearance of further neurological deficits,
called a relapse or exacerbation, followed by a more gradual disappearance of the
symptoms, or restoration of function, known as remission. By definition, a relapse
lasts at least 24 hours and cannot be attributed to any other cause, especially fever
(Lublin and Reingold 1996). The severity of the relapse is highly variable and relates
to the area and the volume of the CNS tissue damage. The gradual appearance of
neurological deficits, referred to as progression, may be associated with or
substituted for relapses and remissions, giving rise to different disease subtypes and
courses. It is the progressive deficit, which might also be viewed as the failure of
remission, that accounts for disability, handicap and decline in quality of life (QOL)
in MS.
The second hallmark of the disease is the dissemination of lesions anatomically
within the CNS. On the basis ofwhether one or both of these two clinical hallmarks
are present and whether one or more paraclinical abnormality can be demonstrated
by cranial or spinal magnetic resonance imaging (MRI), evoked potential or
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cerebrospinal fluid (CSF) testing, MS is diagnosed into definite MS and probable
MS, each with two subgroups, clinical and laboratory supported (Poser et al. 1983).
1.1.2 Incidence and prevalence of MS
To understand the epidemiology of MS it is necessary to define the terms incidence
and prevalence. The incidence rate is the most informative measure of disease
frequency and is simply the number of new cases within a period i.e. one year,
divided by the number of individuals at risk of developing the disease during the
same period. It is usually expressed as the number of cases per 100,000 population.
The annual incidence of cases with MS is 4 per 100,000 (Baum and Rothschild 198 i)
In MS the calculation of incidence is complicated by several factors. Although the
goal is to find the number of cases who develop the disease during each year, the
only figure that might be observed during a year is the number of cases who receive
a diagnosis. Only a few cases will receive a diagnosis during the same year as they
first experienced symptoms of the disease. The rest will be observed during the
following years. The diagnosis ofMS is often uncertain in the early stages and there
is an acknowledged time lag from clinical onset ofMS to diagnosis which averages 4
years (Ebers and Sadovnick 1997).
The generation of reliable incidence data on MS is therefore related to a number of
difficulties and therefore most studies investigating the frequency ofMS have aimed
only at ascertaining all patients who have the disease at the particular date of the
study. This gives the prevalence rate, which is defined as the number of cases in a
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population who, at some fixed point in time, have the disease relative to the total
population at the time of the study. The prevalence rate is easier to obtain since it can
be calculated directly, based on present information. However, it is not a very good
measure of the risk of developing the disease in the population under study as it is
subject to factors such as survival and migration, which can bias the results.
There is considerable variation in the prevalence ofMS around the world (Compston
and Sadovnick 1992). Cross-cultural epidemiological studies have found a
significant correlation between prevalence rates and geographical latitude, with the
higher prevalence rates occurring further away from the equator (Silberberg 1977).
Multiple sclerosis has a prevalence of approximately 100 per 100,000 population in
most parts of the United Kingdom (UK), northern Europe, northern United States of
America (USA) and Canada (Compston and Sadovnick 1992). In the UK,
epidemiological studies have shown prevalence rates of between 99 per 100,000
(Roberts et al. 1991) and 178 per 100,000 (Swingler and Compston 1988), putting
this country firmly in the high prevalence category. MS affects approximately 1.1
million people worldwide (Dean 1994) and women are more susceptible than men by
a factor which is at least 1.5:1 (Kurtzke 1991).
1.1.3 Clinical subtypes of MS
The multiplicity of neurological deficits, the relative mix of relapses and remissions
with or without overall progression and the severity of the disease leads to a marked
clinical heterogeneity of the population of individuals accurately diagnosed with MS
(Matthews 1988). MS has generally been described in terms of a series of disease
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states - relapsing-remitting (RR), relapsing-progressive (RP), secondary-progressive
(SP) and primary-progressive (PP), the definitions of which have been subject to
considerable controversy. In an effort to standardize the terminology used for MS
subtypes, an international survey (Lublin and Reingold 1996) led to the following
classification which is depicted graphically to show the evolution of MS-related
impairment over time:
Figure 1-1: Four different courses ofMS
These are the relapsing-remitting (RR), primary-progressive (PP), secondary-

















a) Relapsing-remitting (Figurel-la); clearly defined disease relapses with full
recovery or with sequelae and residual deficit upon recovery. Periods between
disease relapses are characterized by a lack of disease progression.
b) Primary-progressive (Figure1-lb); disease progression from onset with
occasional plateaus and temporary minor improvements.
c) Secondary-progressive (Figurel-lc); initial RR disease course followed by
progression with or without occasional relapses, minor remissions and plateaus.
d) Progressive-relapsing (Figure 1-d); progressive disease from onset, with clear
acute relapses, with or without full recovery, with periods between relapses
characterized by continuing progression.
In addition to this classification and the possible combinations of relapses,
remissions and progression, the same survey addressed the accepted usage of the
terms used to denote clinical severity. Benign MS is defined as disease which allows
a patient to remain fully functional in all neurologic symptoms 15 years after onset of
the disease. Malignant MS is characterized by rapid, progressive course, leading to
significant disability in multiple neurologic systems or death in a relatively short
time after disease onset.
The clinical course is highly variable (Silberberg 1977): about 20% of people with
MS experience a benign course and are only mildly affected throughout their lives; at
the other extreme, about 10% of patients present with a primary progressive
(malignant) form of the disease (Shannon 1999) . This latter group of patients tends
to be older at onset than the others (Graham 1999) , deteriorate rapidly and can have
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a shortened life span (McDonald and Thompson 1997) . The RR state is encountered
in approximately 70% of MS patients, the RP variety in 15% and the PP variety in
15% (Weinshenker 1997). Of those with RR disease, roughly 50% will have
converted to a SP form of MS within 10 years (Runmarker and Andersen
1993;Weinshenker et al. 19969) . Furthermore the pathologic changes in MS may be
asymptomatic.
1.1.4 Clinical symptoms of MS
MS not only has a variable clinical course but also has a variable presentation
between patients. Highly diverse signs and symptoms arise from CNS damage and
the consequences of slowed or blocked conduction in axons (Matthews 1988) . In
spite of the fact that demyelination may occur essentially anywhere within the CNS,
the majority of patients have their initial symptoms in a relatively limited
distribution. The Gottingen study of 812 cases of MS (Bauer 1978) identified the
most common symptoms at presentation and during the course of the disease as listed
in the table below:
Table 1. 1: Multiple sclerosis-symptoms at presentation and during the course of
the disease











Loss of vision, strength or sensation are the typical initial manifestations of MS as
can be seen from Table 1-1, and ataxia occurs more commonly during the course of
the disease. For those patients who present initially with cerebellar signs
'the early appearance of cerebellar ataxia indicates poor prognosis and
cerebellar signs are frequently persistent without significant remission'
(Matthews 1988).
It is also uncommon for a patient to develop an isolated cerebellar syndrome. More
commonly, cerebellar signs occur with a multiplicity of other findings which usually
include sensory disturbance, weakness and, possibly, brain stem signs (Matthews
1988).
The results of the Gottingen study (Bauer 1978) confirmed the well known
information that most frequently observed symptoms arise from damage to major
white matter tracts and present as unilateral or bilateral visual loss (optic tracts),
hemiparesis (pyramidal tracts), ataxia (cerebellar connections) and intemuclear
ophthalamoplegia (internuclear brainstem connections) (McAlpine et al. 1955).
This study addressed the specific problem of movement disorders due to multiple
sclerosis (MDMS) and not other symptoms of MS and therefore these will not be
considered further.
1.1.5 A framework for measuring the effect of tremor on impairment, disability
and handicap
1.1.5 (i) The International Classification of Impairment, Disability and Handicap
In 1980 the World Health Organization published the first version of the
International Classification of Impairments, Disabilities and Handicaps (ICIDH
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1980) as a classification of disablement and functioning which systematically
grouped the 'consequences of disease' into 3 'dimensions' the definitions for which
are: losses or abnormalities of bodily function and structure (formerly impairments),
limitations of a person's activity (formerly called disability), and restrictions in
participation in society (formerly called handicap). Although the terminology in the
ICIDH-2 (1997) has been changed the new terms are not yet widely known or
accepted and therefore for the purpose of this thesis they are still referred to by the
former terms of impairment, disability and handicap.
The overall disablement phenomena were visualised as follows in the 1980 version
of the ICIDH:
Figure 1-2: Relationship between impairment, disability and handicap as depicted
in ICIDH 1980:
Disease or ► Impairments ►Disabilities ► Handicaps
disorder , A
The original text suggests a degree of linearity by presenting each dimension
graphically leading to the next as shown in Figure 4-1. There is no doubt that the
representation of the model above was over-simplified as it implied a unidirectional
flow from impairment, to disability, to handicap. However, the relationship between
dimensions is clearly more complex in that alteration at a structural level may not
lead to disability (i.e. functional consequences of an impairment do not necessarily
arise). Further, extensive handicap may occur with apparently minimal disability.
Another criticism of the 1980 ICIDH model was that it did not adequately reflect the
role of the social and physical environment in disablement but perpetuated a solely
medical view of disability. Authors such as French and Swain acknowledged that
disabled people have rejected the notion that their difficulties arise from individual
impairment but believe instead that disability is socially created by the many
physical and social barriers which exist within society (French and Swain 1997)
It is now recognized that the impact of ill health is not solely dependent on the
impairments, disabilities and handicaps which result from it but on other contextual
factors also. The ICIDH-2 (1997) has recently been designed which includes a list of
contextual (environmental and personal) factors, which all have an impact on ill
health. Environmental factors can be further sub-divided into social and physical
factors and include social attitudes, laws, policies, architectural characteristics, legal
and social structures, as well as climate, terrain and so forth; and personal factors
include sex, age, other health conditions, coping styles, social background,
education, profession, past and current experience, overall behaviour pattern,
character style and other factors that determine how disablement is experienced by
the individual.
In order to avoid misinterpretations that that were induced by the ICIDH 1980
diagram a current understanding may be presented as in Figure 1-3.
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a) Environmental (social, physical)
b) Personal
The diagram shows that disablement and functioning are outcomes of interactions
between health conditions and contextual factors. The interaction is complex, bi¬
directional and dynamic. The model does not place a causal linkage between the
three dimensions of disablement and functioning; rather they occur within each of
the three dimensions of impairment, disability (now called activity) and handicap
(now called participation) and by means of contextual factors.
The subjective satisfaction with life is called 'quality of life' (QOL). There is a lot of
debate about whether or not QOL is an entirely different entity from handicap, or is
merely the same entity viewed from a different perspective. The two terms can be
differentiated by considering handicap as the objective or externally assessed social
consequences of a health condition, whereas QOL life measures the patient's
subjective impression of their state of affairs. An important aspect of the present
study was to establish the patients' perceptions of the outcome of the intervention as
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there is a dearth of information in this area. However research into QOL is less well
developed than that concerning impairment or disability and many difficulties remain
in its measurement (Fallowfield 1990; Rothwell 1998) . Many researchers believe
that the term 'quality of life' refers to an illusion that cannot be defined and therefore
cannot be measured (Wade 1992) . Wade argues that a solution to this problem is to
be explicit about the aspects of QOL that are important and relevant to the research
in question and to measure them individually.
1.1.6 The impact of MS on impairment, disability, handicap and quality of life
The most obvious manifestation ofMS is neurological impairment and as discussed
above a wide range of impairments can occur in MS.
'The attraction of thinking about disease in terms of impairments is that it
is often these impairments that are the targets of treatment; they are the
means by which severity is usually measured, and they help in monitoring
the patients' progress. The very success of the biological approach to
disease has tended to blinker clinicians to other possible views.' (Ebrahim
1991)
However, there is now an awareness that treating the biological consequences of
disease is not enough and that impairment has a major impact on disability and
handicap. Many patients with MS have a normal life span and have to live with some
degree of disability over a prolonged period which can dramatically affect the level
of handicap and the quality of life experienced by afflicted patients and their
families.
For patients with chronic, incurable diseases such as MS, the main objective of an
intervention may be to lessen the impact of disease, to enable the sufferer to realise
his potential within the limitations imposed by the disease and to reduce the
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disadvantage experienced as a result of ill-health. The framework suggested by the
ICIDH-2 (1997) allows evaluation of the achievement of such an objective.
MDMS often affect the upper limbs and can interfere with or prevent a person from
carrying out the simplest of daily tasks (Matthews 1988) such as blowing one's
nose, holding a drink, or feeding oneself. Even mild upper limb tremor can also
affect a variety of other activities such as balance and walking, home making or
driving and therefore can result in increasing dependence on others. This has
enormous psychological consequences, often leading to frustration, anger,
embarrassment and withdrawal, especially since the MDMS are extremely difficult
to treat.
Several other factors make MS a disease with important psychological and social
implications which can cause restriction in social participation. First its unpredictable
nature makes it difficult for patients to gain a sense of control over their illness.
Second MS typically affects young adults (Ebers and Sadovnick 1997) , thereby
limiting their most productive years (Bourdette et al. 1993) . Thirdly as no cure is
available patients must rely on treatments which only alleviate symptoms and slow
disease progression (Jacobs et al. 1994; Johnson et al. 1995) . Also the disease
although limiting to the patient may not be readily apparent to others. This
contributes to a sense of isolation experienced by many people with MS (Murray
1995).
Handicap is defined in the ICIDH as the disadvantage for any given individual,
resulting from impairment or disability, that limits or prevents fulfilment of a role
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that is normal (depending on age, sex, social and cultural factors). People have many
different roles such as being a partner, a parent, a friend, a wage earner and many
more. Thus the level of handicap is defined by the social environment of the
individual and how their own specific environment interacts with their impairment or
their disability. A given set of impairments and disabilities will not lead to the same
handicaps in every patient. In this way, handicap emphasises the uniqueness of each
person, and the need for a unique response.
Many authors have proposed that not only disabilities and the influence of
disabilities on the life of the patient (handicap) but also the subjective satisfaction
with life as judged by the patient should be used to reflect the impact of diseases on
the lives of individuals (Fallowfield 1990) . As already mentioned the subjective
satisfaction with life is called 'quality of life' (QOL). It is an important area of
research as in the management of chronic diseases such as multiple sclerosis for
which cure is not possible but death is a remote outcome, the key goal of health care
is often to reduce handicap and optimise a patient's quality of life.
In this study, palliative thalamic DBS was carried out in the hope not only of
reducing the severe movement disorder of an upper limb (impairment) in an attempt
to improve functional use of the limb but also to enable the person to participate in
simple activities of daily living at a personal level (disability) and also at the level of
society, thereby reducing the level of handicap. The study also aimed to address the
patient's perception of the outcome as there is a dearth of information in this area.
Multiple measures of outcome were therefore used within the framework of the
ICIDH-2, which will be discussed in detail in Chapter 4.
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1.2 Movement Disorders in Multiple Sclerosis (MDMS)
The tremor of multiple sclerosis is often a component of a complex disorder of
movement referred to as ataxia. Ataxia and tremor occur commonly and the
movement disorder often includes dysmetric and other ataxic features (Hallet et al.
1985) which are due to the involvement of the cerebellar pathways. Serial dysmetria
has been described as 'successive inaccurate movements producing the appearance
of irregular tremor' (Sabra and Hallet 1984) and 'the result of the voluntary
sequential correction ofmovement errors' (Hallet 1986).
Cerebellar and/or brain stem involvement or both is seen in 82 % of cases ofMS at
some time during the course of their illness (Bauer 1978) as was shown in the
Gottingen study involving 812 patients with MS. In a three year follow-up study of
multiple sclerosis, cerebellar deficits resulting in difficulties with functional activities
were found to occur in 33% of 259 patients and to be predictive of a worse outcome
(Weinshenker et al. 1996; Weinshenker 1997) . Similar proportions of patients with
MS were reported to have moderate tremor (Haddow et al. 1997) or ataxic symptoms
(Alusi et al. 1999a) in other studies. A recent study of tremor in 100 patients with
MS randomly selected from the Central Middlesex Hospital MS Unit register showed
that tremor occurs in about half the MS population and is disabling in about one sixth
(Alusi et al. 1999b). Tremor therefore occurs more commonly than previous
estimates suggest.
There may be several reasons for this under-estimation of tremor in MS. Firstly, the
incidence and prevalence ofMDMS are difficult to estimate since it is often difficult
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to distinguish intention tremor from the motor dysfunction due to serial dysmetria. In
addition, the relapsing and remitting nature of the disease process in the early stages
of MS results in transient neurological signs that make it difficult to assess the full
extent of the problem.
1.2.1 Types ofMDMS
There is considerable controversy surrounding the precise definition and
identification of the different components of the disorders of movement which are
commonly seen in patients with MS and which are produced by cerebellar disease.
Until very recently there have been no detailed prospective studies of MDMS
determining the incidence of the various types ofMDs. However Alusi et al (Alusi et
al. 1999b) recently studied 100 patients with MDMS and showed that tremor affected
the upper limbs in 55%, the lower limbs in 11%, the head (titubation) in 7% and the
body (truncal ataxia) in 5%. However, it was not clear from data provided what
percentage of patients had tremor affecting both the upper limbs and trunk which
seemed surprising as the majority of patients referred for assessment of their MD
(movement disorder) in the present study commonly presented with titubation of the
head and truncal ataxia.
Most textbooks still rely on Gordon Holmes's descriptions (Holmes 1917), which
highlighted that in cerebellar disorders there are, in addition to tremor,
decomposition of voluntary movement, asynergia (failure of smooth co-ordination of
the movement's component parts), dysmetria, and dysdiadochokinesia (inability to
perform rapidly alternating movements) all occurring together. Clinical descriptions
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do not distinguish between these different components (tremor, dysmetria and other
ataxic features) but merely describe the whole disorder loosely under the term,
ataxia.
It is very difficult to differentiate tremor, dysmetria and ataxia in clinical practice
(Alusi et al. 1999a). However according to the International Tremor Foundation
'Tremor Investigating Group' (TRIG)
'as long as the dominant feature of the movement disorder is rhythmicity,
it should be labelled as tremor' (Deuschl et al. 1998).
In MS, tremor can affect the upper limbs, head and axial muscles (Compston 1986)
and is
'present when the limb is at rest (it may subside if one can get the limb
into complete repose), increases with the maintenance of posture and is
markedly exaggerated by an attempted movement.' (Weiner and Lang
1989)
However, the disorders of movement observed during a voluntary movement of a
limb of a patient with MS can not always be described as rhythmical but appear
irregular, not patterned, uncoordinated and flailing. The name of this tremor
syndrome has long been a matter of debate. The traditional terms, 'rubral' and
'midbrain' tremor have been used in the past but are now considered misleading
because more and more lesions outside these classic locations are described with the
same or similar phenomenology (Nakamura et al. 1993). Holmes (Holmes 1917)
gave one of the first concise descriptions of 'rubral' tremor in 1917 and emphasised
that patients who had this type of tremor exhibited tremor at rest. Holmes' tremor has
been introduced (Deuschl et al. 1998) as a substitute for the misnomer 'rubral'
tremor to avoid names that include topographic descriptions. It is important to note
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however that patients with MS do not have tremor at rest and therefore do not have
true Holmes' tremor (Alusi et al. 1999b).
To overcome this confusion with nomenclature for the purposes of this study, it was
therefore decided to refer to these dyskinetic movements in which tremor played a
prominent but not a unique role, under the umbrella term of movement disorders.
However it was apparent that not only were there difficulties in attempting to
distinguish between tremor and associated ataxic components of a MDMS but there
were also difficulties in classifying and grading the different types of tremor. Several
studies have reported difficulties with scoring tremor (Bain et al. 1993; Bain et al.
1994; Bain 1999) . Bain describes a recent study (Bain et al 1993) in which he and
three other neurologists with experience in the field of assessing disorders of
movement rated 20 patients for upper limb tremor. They agreed on the definitions for
rating different types of tremor between themselves beforehand. Despite this, there
was poor agreement among the assessors concerning which of the patients had
kinetic or intention tremor and even less agreement on the severity of these two
components of tremor.
A working consensus for the classification and definition of tremor based on the
assumption that different components of tremor can be separated by clinical
observation has recently been reached (Deuschl et al. 1998) . This classification was
based on that of the Tremor Investigation Group (TRIG) (Findley and Roller 1995)
which was devised and adopted for this study in 1995. It favours the classification of
tremor into rest and action varieties. Action tremor is any tremor that is produced by
voluntary contraction of muscle: it includes postural, isometric and kinetic tremor.
The last of these includes intention tremor, the notion ofwhich
'brings us to the murky waters of the concept "ataxia"' (Hallet 1986)
1.2.1 (i) Rest tremor
In MS true rest tremor (tremor which is present in a body part that is not voluntarily
activated and that is completely supported against gravity) is not seen (Alusi et al.
1999b).
1.2.1 (ii) Action tremors
Postural tremor
Postural tremor is present while voluntarily maintaining a position against gravity
and can be present in the head, trunk and limbs. If postural tremor is severe it may be
present on lying and may inaccurately be called rest tremor, because the patient is
unable to relax completely. This type of tremor is referred to as titubation when it
affects the head and trunk and it can be particularly striking when a patient is
standing. A large amplitude 'wing beating' postural tremor that increases
progressively on maintained posture has been well described (Hallet et al. 1985;
Sabra and Hallet 1984) , thus the postural component must be evaluated with the
arms extended and arms flexed (Nguyen and Degos 1993).
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Alusi et al recently reported that different types of postural tremor were encountered
in their study of 100 patients with MDMS. These were a) distal, some of which
resembled essential tremor; b) proximal high amplitude; c) combined proximal and
distal; d) dystonia-associated. However the operational definitions for assessing these
different types of postural tremor were not provided in the report of the preliminary
findings from this study.
Kinetic tremor
Kinetic tremors occur during any voluntary movement. Intention tremor is seen when
tremor amplitude increases during visually guided movements towards a target. This
type of tremor is commonly seen in patients with MS and has a tendency to worsen
with increasing precision requirements and is influenced by hypotonia (Sabra and
Hallet 1984). Cerebellar tremor is often used synonymously with intention tremor
although various other clinical expressions of intention tremor have been described
recently. These include 'hyperkinetic tremor' (Findley and Gresty 1981) which
combines proximal postural and kinetic components (Alusi et al. 1999b), also called
'severe postural cerebellar tremor' by several authors (Hallet 1986; Nguyen and
Degos 1993; Sabra and Hallet 1984) . These terms are not yet commonly used in
clinical practice and although the description of hyperkinetic tremor better describes
the flailing movement that is seen throughout a voluntary movement performed by a
person with MDMS it is not clear how one goes about assessing such a movement.
There is no doubt that this type of uncontrolled movement disorder combining
postural and kinetic components is common in patients with MS as was shown in
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Alusi et als study in which the commonest components were 'hyperkinetic' and
distal postural tremor.
There has been a great deal of confusion in the past regarding the use of the term
'intention tremor' as it has been used in reference to tremors on contemplating,
initiating, performing or completing a movement and is therefore very ambiguous.
Indeed Gilman believes that
'Ataxic or intention tremors are the oscillations of the extremity which
occur during movements. In current terminology, both of these types
should be labelled "kinetic tremors". The term "intention tremor" should
be avoided because of the frequent misinterpretation of its meaning.'
(Gilman 1981)
The classification adopted for this study continued to use the term 'intention tremor'
because it is common practice amongst clinicians. However, intention tremor was
combined with kinetic tremors (kinetic/intention), because there are practical
difficulties with trying to assess the component parts of a movement and it is
therefore better to avoid this difficulty and to make an overall assessment of the
kinetic movement of the limb as it moves towards a target. It must be stressed that
when assessing kinetic/intention tremor in this study the goal directed movement was
observed from start to finish rather than limiting the assessment to the end of the
movement as has been done in other studies (Alusi et al. 1999b).
1.2.1 (iii) Goal-related tremor
Goal related tremor is the appearance of kinetic tremor during the performance of
highly skilled, goal-specific movements. Kinetic tremor in MS persists or worsens
with goal-directed movement and it is associated with dysmetria (Hallet 1986).
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Analysing a goal directed movement is complex. There are several problems that can
induce an oscillation in the terminal component of a goal directed movement, namely
true intention tremor, serial dysmetria, low frequency sway movements resulting
from proximal postural instability and postural tremor that has been inhibited by
motion.
1.2.2 Pathophysiology ofMDMS
The pathological basis for the MDMS is unclear (Bain 1999) . In MS the disease
process affecting the cerebellum and its connections is usually too diffuse to allow
accurate localization of the lesions which underlie the tremor. The source of tremor
is most likely to be demyelination along the pathway from the dentate nucleus of the
cerebellum to the ventro-intermediate nucleus in the thalamus (VIM), rather than
demyelination in the cerebellum itself (Holmes 1904). A facilitatory loop exists
whereby sensory information is relayed from the contralateral sensory-motor cortex
via the pons to the cerebellum. The output then projects via the thalamus to the motor
cortex. Movement disorders are a result of disinhibition of this loop (Goldman and
Kelly 1995).
There have been no post mortem studies linking the tremor ofmultiple sclerosis to a
discrete lesion but clinical-pathological correlation has demonstrated that the lesion
responsible for intention tremor in MS is almost certainly in the superior cerebellar
peduncle and that lesions of the red nucleus are not relevant (Hallet 1998). These
lesions in the superior cerebellar peduncle may lead to secondary changes in the
function of the VIM which may act as a pacemaker and drive the tremor
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(Narabayashi 1992). Narabayashi's study of the recordings from the VIM nucleus of
the contralateral thalamus have shown abnormal neuronal activity leading to the
possible identification of tremor-generating cells (Narabayashi 1992). It is believed
that a destructive lesion (thalamotomy) or stimulation (DBS) of cells in the V.I.M.
nucleus will suppress tremor either by interrupting the aberrant pathway or by
destroying tremor generating cells or via both mechanisms. Recently other areas of
the ventral nuclear group in the thalamus such as the ventral oralis posterior (VOP)
have also been suggested to be important in the genesis of tremor (Lenz et al. 1994).
Although the studies by Narabayashi and Lenz were carried out in patients with
Parkinson's disease, their results could be relevant to patients with MDMS.
1.3 The Management ofMDMS
Tremor is an involuntary rhythmic oscillatory movement of a body part and is one of
the most disabling and distressing symptoms experienced by people with multiple
sclerosis (Tranchant et al. 1995). There are few clinical syndromes therapeutically
more frustrating for the neurologist than patients with MDMS who present with a
combination of proximal upper limb tremor, titubation of the head and violent
shaking of the trunk on attempting a change in posture or a simple goal-related
activity (Matthews 1988).
Although there are a number of methods of treatment documented, few result in any
significant benefit.
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1.3.1 Physiotherapy and Occupational Therapy
Rehabilitation is aimed primarily at improving the ability to perform functional tasks
through reduction of and compensation for tremor. Direct treatment of tremor
involves techniques such as joint approximation and compression, viscous damping
and bracing of the limb, facilitation and re-education of posture and movement and
weights (Barlow and Schwab 1971; Chase et al. 1965; Hasler 1981; Howison et al.
1978; Morgan et al. 1999; Sutherland 1982) . The use of weights has not found
widespread support because relatively high loads are required for control of tremor
and this can exacerbate fatigue and weakness. In addition, compensator}' approaches
are also used by therapists (Ayres 1963; Rood 1962; Voss 1972) . These include the
provision of aids and equipment such as weighted utensils or the 'Neater Eater' a
damped eating device manufactured by Michaelis Engineering, (Buxton, UK),
alterations to the patient's postural support, for example using a chair with a winged
headrest for postural head tremor, adapting the patient's environment and advising
on different ways of carrying out activities. Although these methods of treatment are
documented there has been little evidence until recently to suggest that they result in
any significant benefit. Jones's study (Jones et al. 1996) recently demonstrated that
adopting a multi-disciplinary approach to the above strategies could have a beneficial
impact on disability and handicap in patients with MS.
1.3.2 Drug management
No established pharmacological therapy exists for cerebellar tremor. No single
pharmacological pathway exists as multiple neurotransmitter systems are involved
(Wasielewski et al. 1998). Current options for medical treatment have been described
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as 'disappointing' (Poser et al. 1983), 'of no benefit' (Nguyen et al. 1996),
'ineffective' (Wasielewski et al. 1998) and 'of limited success' (Rice et al. 1997).
Unfortunately for this group of patients the benefit of the medication is usually
outweighed by the side effects and the general opinion is that no drug can produce a
worthwhile improvement. The medications listed in table 1-2 have been tested on
small numbers of patients with MDMS but with variable success.
Four of the 15 patients who underwent surgery in the present study had been tried on
different medications for tremor. The medications most commonly prescribed were
primodone, propranolol, and ondansetron. None of the patients were taking any
medication to control their movement disorders at the time of operation.
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on intention tremor or functional improvement
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2 clonazepam 9-15 mg Abolished intention tremor
(Clifford
1983)
8 tetrahydrocannabinol 5-15 mg Beneficial effect in 2 patients
(Rice et al.
1997)
16 ondansetron 8 mg Significant benefit on spiral copying and 9





Irving Cooper first described thalamotomy in patients with MDMS more than three
decades ago. Thalamotomy is a neurodestructive procedure where brain tissue is
ablated either by thermocoagulation, cooling or chemical means. Haddow and
coauthors (Haddow et al. 1997) reviewed 14 articles published between 1960 and
1992, describing thalamotomy for tremor in patients with MS. The total number of
patients amounted to 234. The results from this review suggests that in selected
patients with MS 65-90% of patients showed immediate symptomatic benefit from
thalamotomy and 70% were reported to still be improved at one year (Goldman and
Kelly 1992; Hitchcock et al. 1987; Speelman and Van Manen 1984). However
functional improvement of the relevant arm is estimated to occur in only 25 - 47% of
patients (Goldman and Kelly 1992; Haddow et al. 1997; Hitchcock et al. 1987;
Speelman and Van Manen 1984).
The benefit in functional ability due to the resolution of the tremor after thalamotomy
at 12 months was disappointing and only addressed in a small number of papers
(Goldman and Kelly 1992; Hauptvogel et al. 1975; Hitchcock et al. 1987; Speelman
and Van Manen 1984; Whittle and Haddow 1995) . Only one series on 11 patients
provided detailed post-operative data on the functional results of thalamotomy
(Speelman and Van Manen 1984).
Despite the relief of tremor afforded by thalamotomy in the short term, the authors of
Haddow's review concluded that they had several reservations about the use of this
procedure in patients with MS. These included moderation of benefit due to the
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remaining ataxia, immediate post-operative side-effects and a possible negative
influence on the rate of progression of the disease process.
The morbidity was high with percentages between 18% to 57% of patients
experiencing permanent adverse effects (Goldman and Kelly 1992; Speelman and
Van Manen 1984) . The most often reported complications of thalamotomy are
worsening of gait, hemiparesis and dysarthria. In addition, epilepsy, sensory
disturbances, dysphagia, transient bladder disturbances, depression, confusion,
lethargy and somnolence have also been, albeit rarely, described (Barnett et al. 1992;
Haddow et al. 1997; Shazadi et al. 1996; Speelman and Van Manen 1984) . The side
effects associated with thalamotomy for MDMS are more severe than those observed
in Parkinsonian or essential tremors (Benabid et al. 1996). In his series of 11 patients,
Speelman (Speelman and Van Manen 1984) reported permanent hemiparesis in four
cases, and one died of aspiration pneumonia 3 weeks after surgery Barnett et al
(Barnett et al. 1992) recently observed permanent hemiparesis in two of six patients.
So far, one patient has been reported with a relapse of the MS, probably in relation to
the surgery (Goldman and Kelly 1992). The site of the thalamotomy has to be
selected according to the somatotrophic distribution inside the VIM nucleus and the
size of the lesion has to be larger when the tremor involves the proximal muscles
(Hirai et al. 1983).
There are inadequate data on the post-operative course of individual patients and the
length of follow-up in many of the series reported in the literature. Long term follow
up after thalamotomy was reported at 18 months (Speelman and Van Manen 1984),
two years (Goldman and Kelly 1992; Hitchcock et al. 1987), and three years (Arsalo
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et al. 1973). However, little useful information can be derived from the last study by
Arsalo et al which has the longest follow up of MS patients after thalamotomy as
there were major methodological weaknesses in the study. No validated scales were
used, tremor type was not specified, tremor severity was not objectively quantified
and there was no measurement of the ability to perform tasks of function using the
upper limb.
Long term outcome after thalamotomy is an important issue since it is likely that the
profiles of MS patients chosen for either thalamotomy or thalamic DBS would be
similar. The longer term outcome of MS patients who had been treated with
thalamotomy in the Department of Clinical Neurosciences (DCN) between 1989 -
1994 was evaluated for effect on tremor resolution and disability, with a minimum of
three year follow-up (Hooper and Whittle 1998).
All 10 patients had a form of cerebellar tremor which had been distinguished
clinically into either a 'rubral' tremor characterized by severe postural tremor
affecting the head, trunk and upper limbs, with a superimposed kinetic/intention
component that was present during volitional limb movements; or an isolated
kinetic/intention tremor. All patients were severely disabled and had no functional
use of their affected upper limbs. After computerised tomography (CT) image-guided
ventrolateral thalamotomy, brachial tremor was reduced in 9 of 10 patients
immediately after the operation (Whittle and Haddow 1995). None of the patients
with severe 'rubral' tremor had complete abolition of their movement disorder, and
although it was reduced in most patients they remained disabled. This was often
partly due to the unmasking or persistence of cerebellar disease. At one year follow-
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up only three patients, who had the best preoperative Barthel scores, were
functionally improved (cases 4, 5 and 10). At final review, a median of 56 months
after operation, only six patients remained alive, and one (patient 10) remained
improved in their ability to carry out activities of daily living (Appendix 1).
This review of the patients who underwent thalamotomy for MDMS had some
important implications. First, the results strongly suggested that in many patients the
onset of severe disorders of movement was followed by a progressive functional
decline, and even death, due to the MS. Secondly, although stereotactic surgery may
have some temporary functional benefits, except in the occasional case the surgery is
unlikely to have a major longstanding beneficial impact, predominantly because of
additional CNS damage due to the MS. Thirdly, adequate evaluation of thalamic
DBS in MS patients with movement disorders will require long term follow up not
only in view of the poor long term outcome of these patients who have undergone
thalamotomy in the past but also because there are important clinical, management
and health economic implications associated with its use (Geny et al. 1996; Whittle
et al. 1998).
1.3.3 (ii) Thalamic deep brain stimulation
Thalamic deep brain stimulation involves stereotactic surgery to implant an electrode
in the ventrolateral nuclear complex of the thalamus and implantation of a pulse
generator and connecting lead to generate electrical impulses which are delivered to
the electrode. The technique of thalamic deep brain stimulation (DBS) was first
described in 1980 by Brice and McLellan (Brice and McLellan 1980) for movement
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disorders which were due to multiple sclerosis. Since that time there have been
substantial technical advances in DBS hardware and brain imaging. Thalamic DBS,
which is a less destructive surgical method than thalamotomy, is an established
treatment for Parkinson's disease (Benabid et al. 1996). One of the cogent reasons
for the limitation of thalamotomy is the reluctance to cause additional permanent
lesion of the CNS. Chronic DBS offers the advantage of being non-destructive,
reversible and adjustable if necessary. Another advantage is that with bilateral DBS
procedures, there are significantly fewer complications than with bilateral
thalamotomy (Benabid et al. 1991).
Components of the Thalamic Stimulation system
Figure l-4:Thalamic stimulation system components
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The Medtronic thalamic stimulation system (Figure 1-4) consists of three implanted
components: a stimulation lead (DBS electrode), an extension wire and an
implantable pulse generator (IPG).
The stimulation lead consists of four insulated wires connected to four electrical
contacts, or electrodes. The stimulation lead is implanted in the ventrolateral
thalamus and it is connected to an extension wire that connects distally to the IPG.
The IPG is commonly implanted in the chest wall in the subclavicular region. The
IPG is a small sealed metal container with a 3.7-volt battery and the electronics for
the thalamic stimulation system.
The IPG is programmed percutaneously using a computer to set the appropriate
intensity, pulse duration and rate of stimulation. The computer programs the IPG
through a programming head placed on the skin over the IPG. The goal is to
maximize suppression of the tremor with minimal or no side effects. Patients require
their own unique parameters of stimulation to suppress tremor. In Geny's series of 13
patients with MS treated with thalamic stimulation they showed that the possibility
of modifying the electrical variables and the site of stimulation after surgery was
crucial for obtaining optimum results on tremor (Geny et al. 1996).
A secondary goal of programming is to prolong battery life. Optimal programming of
the thalamic system of stimulation is used to achieve these goals.
Relatively little information exists on the value of this treatment in MDMS, although
one study suggested good results in 69% of patients (Geny et al. 1996). There have
now been 7 papers on a total of 48 patients which have described the relative merits
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of thalamic DBS (Benabid et al. 1996; Brice and McLellan 1980; Geny et al. 1996;
Nguyen and Degos 1993; Schuurman et al. 2000; Siegfried 1993; Taha et al. 1999)
and the associated problems encountered with the procedure (Whittle et al. 1998).
Schuurman's study (Schuurman et al. 2000) of 68 patients (45 with Parkinson's
disease, 13 with essential tremor and 10 with MS) randomly assigned to undergo
thalamotomy or thalamic DBS recently claimed that 'there was a significant
difference in the incidence of adverse effects' between the two groups with DBS
being safer. However this claim should be regarded with some caution as one patient
with Parkinson's disease in the thalamic stimulation group died during the operation
after an intracerebral haemorrhage. Also, 16 of the 34 patients in the thalamotomy
group had persisting complications at six months post-operatively. This rate is higher
than the rate in most published series for permanent complications after thalamotomy
in Parkinson's disease, essential tremor (Jankovic et al. 1995) and MS (Haddow et al.
1997); however it was a prospective study.
Even though thalamic DBS is more flexible than thalamotomy in allowing the
stimulation parameters to be adjusted, if systemic functional decline due to the MS
parallels that previously described (Geny et al. 1996) and seen in the thalamotomy
cohort reviewed as part of this study (Hooper and Whittle 1998) thalamic DBS will
only have temporary beneficial effects.
There are disadvantages associated with thalamic DBS and these include higher
costs, limits imposed by the hardware, the need for replacement of the batteries and
the natural resistance to the implantation of a foreign body. With regard to the
important question of long term tolerance, two studies have reported equipment"
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related complications (Benabid et al. 1996; Schuurman et al. 2000). Three patients in
Benabid et al's study had late scalp infections necessitating removal of the DBS
electrodes and in one patient in Schuurman et al's study the pulse generator site
became infected and had to be replaced after antibiotic therapy.
It is agreed that there is a need for further prospective studies of thalamic DBS
(Krauss and Mundinger 1996; Speelman et al. 1998; Whittle et al. 1998) to
determine not only the long term efficacy of this novel treatment and its potential
advantages compared with stereotactic thalamotomy but also to avoid inappropriate
application and unnecessary morbidity. The considerable cost implications of
thalamic DBS also merit consideration to prevent wastage of funds.
1.4 The Effectiveness of Stereotactic Surgery for MDMS
1.4.1 Measurement ofmovement disorders in MS
Previous studies evaluating the effect of stereotactic thalamic surgery for MDMS
were largely observational studies. When measurement of the movement disorder
was undertaken it was performed using tremor rating scales which had not been
validated for the purposes of the studies. No laboratory based measures have been
used to measure the outcome after surgery in patients with MDMS.
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1.4.1 (i) Observational studies
Haddow's review of the literature on thalamotomy (Haddow et al. 1997) highlights
some of the weaknesses associated with the design of past studies involving patients
with MDMS.
The diagnosis of MS was made purely on general clinical examination and signs in
all but two of the studies: one study (Speelman and Van Manen 1984) used criteria
defined by McDonald and Halliday (McDonald and Halliday 1977) and the other
study (Hauptvogel et al. 1975) used Poser's criteria (Poser et al. 1983) to confirm a
specific diagnosis ofMS.
Prior research has been based on small numbers of patients with MDMS who were
incidentally sampled for the studies. This introduced an element of bias to the studies
as there was no form of randomisation performed. The results which were reported
were concerned with comparatively small samples of patients with MS who were
grouped along with many patients having surgery for other neurological conditions
such as Parkinson's disease and essential tremor. The majority of studies were
therefore not designed to address specific problems occurring in the MS subgroup
and development of valid and sensitive scales to assess the outcome of surgical
treatments in this cohort was not a priority.
Few of the studies that have addressed thalamotomy for MDMS have had rigorous
evaluations of the patient cohorts preoperatively and postoperatively: postoperative
follow up was poorly defined and only 3 articles had rigid long term follow-up times
(Hitchcock et al. 1987; Speelman and Van Manen 1984; Van Manen 1974). The
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operative procedures varied: the targets for lesioning were variable. Usually the
ventrolateral nuclear complex (VL) was targeted (Goldman and Kelly 1992;
Speelman and Van Manen 1984; Whittle and Haddow 1995) without any more
specific details being provided; sometimes in isolated studies a specific area of this
nucleus was nominated. Methods of physiological target localisation were varied and
included exploratory brain stimulation with clinical monitoring in the conscious
patient (Arsalo et al. 1973; Whittle and Haddow 1995) and microelectrode
recordings (Goldman and Kelly 1992). The method of creating the lesion varied and
was most commonly by thermocoagulation (Goldman and Kelly 1992; WTiittle and
Haddow 1995). It was also not clear whether confounding variables such as drugs
prescribed for tremor which may have had an effect were controlled for in past
studies. This issue of confounding variables was not discussed in any of the studies
and was therefore probably not given any consideration.
As a consequence it is difficult to draw any meaningful conclusions from past studies
as statistical testing was probably invalid due to the limitations and weaknesses
discussed. The claim that 70% of MS patients still had reduced tremor 12 months
after surgery (Haddow et al. 1997) must therefore be regarded with a great deal of
caution.
1.4.1 (ii) Subjective rating scales
'The quality and utility of much of the literature concerning the surgical
treatment of tremor in patients with MS is suboptimal' (Haddow et al.
1997).
The most common method of assessing the response of tremor to thalamotomy and
other different therapies for MDMS in the past has been the re-evaluation scoring of
tremor and disability scales (Goldman and Kelly 1992; Hitchcock et al. 1987;
Speelman and Van Manen 1984; Whittle and Haddow 1995). However, this has been
done in a variable way using a wide range of poorly defined, ad hoc scales, which
have often not been thoroughly evaluated for reliability, validity and sensitivity.
Hitchcock's study (Hitchcock et al. 1987) of 47 patients who underwent
thalamotomy for movement disorders, between 1979 and 1984, included 30 patients
with MS and used what they described as "a simple grading of symptomatic
improvement in terms of'cured', 'improved' or 'unchanged'. Arsalo's study (Arsalo
et al. 1973) involving 26 patients treated with thalamotomy for intention tremor used
a measurement scale which was equally crude: a 'good' outcome meant no
remaining tremor in the hand for which thalamotomy had been performed when the
patient was discharged from hospital, a 'fair' outcome meant thai some tremor could
still be seen; and a poor outcome meant that the effect of thalamotomy on tremor was
minimal.
There are major problems with the use of these scales as they are highly subjective
requiring the examiner to make a personal judgement as to what they regarded
'improved' and 'minimal' to mean. There were no operational definitions given for
using the scales, and the authors did not define what was being measured or
differentiate between the different types of tremor. These scales were consequently
not shown to be valid or reliable and the results and conclusions of these studies must
be regarded with caution.
Speelman's study (Speelman and Van Manen 1984) was the only study of
thalamotomy for MDMS which provided detailed pre and post-operative data, and
presented results in such a way that it was possible to relate changes in disability
scores and functional status scores to specific patients. Speelman designed a scale for
this study to rate the severity of tremor in the 11 patients with MS after thalamotomy.
It was an ordinal 0-3 point scale where 0 = no intention tremor, +1 = slight
intention tremor: minimal impairment of arm, +2 = moderate intention tremor: ability
to keep the hand within 15cm of an intended object, +3 = severe intention tremor:
inability to keep the hand within a distance of 15cm of the intended object. It was
claimed to be measuring the severity of intention tremor but instead was assessing
the patient's ability to voluntarily maintain a position against gravity which
according to the recent classification of tremor (Deuschl et al. 1998) based on the
work of the Tremor Invesigation Group is the definition of postural tremor. Another
major weakness of Speelman's study was that no attempt was made by the author to
establish the psychometric properties of the scale.
Fahn gave a detailed account of his scale in a book called 'Parkinson's Disease and
Movement Disorders' (Fahn et al. 1988). Since then it has been widely used in its
published form in studies assessing tremor severity in Parkinson's disease, essential
tremor (Hariz et al. 1998; Hubble et al. 1996; Schuurman et al. 2000) and cerebellar
outflow lesions (Krauss et al. 1994). It has also been used in a modified form by
Benabid et al (Benabid et al. 1991; Benabid et al. 1996). Despite the continued use
internationally of Fahn's Tremor-Rating Scale there has been no validatory work
carried out to assess the reliability, validity or sensitivity of the use of the Fahn's
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Tremor Rating Scale (FTRS) in any group of patients. It has been described by
Goldman and Kelly (Goldman and Kelly 1992) as an 'established scale' presumably
because of its widespread use and not because it has been shown to be
psychometrically sound. They used the FTRS to explore the symptomatic impact of
thalamotomy for tremor in 14 patients with movement disorders, five of whom had
intention tremor due to MS.
Fahn's scale differed from other scales in that it was the first tremor rating scale to be
used that measured the different components of tremor (rest, postural,
action/intention) and also the severity of tremor in different areas of the body (head,
trunk, upper limbs and lower limbs). It was a five level (0-4 point) scale which
quantified tremor according to the magnitude of the tremor amplitude and was rated
as 0 = none, 1 = slight (amplitude <0.5cm), 2 = moderate (amplitude 0.5 - 1cm), 3 =
marked (amplitude 1 - 2cm) or 4 = severe (amplitude >2cm).
No special tools were required other than a pencil, paper and two cups to hold water.
In addition a task-specific quantification involving handwriting, drawing and
volumetric tasks, functional disability were also included. The scale also provided
definitions to allow subjective global assessments of tremor, including subjective
comparisons by the patient for evaluating the effectiveness of treatment and
variations in severity of tremor over time.
The disability scale in FTRS has been used independently in different studies to
assess and quantify disability. Krauss et al (Krauss et al. 1994) used it when
reporting the long term results of stereotactic surgery in 35 patients with severe upper
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limb tremor due to traumatic brain injury. They showed that functional disability was
reduced from a mean value of 57% of maximum disability to 37% over the longer
term (p < 0.001). Goldman and Kelly (Goldman and Kelly 1992) also used the
disability scale in a slightly modified form (omitting assessment of speech) to
evaluate disability in nine patients (three patients after infarction, three patients after
trauma and three patients with MS) who had undergone thalamotomy for disorders of
movement of the upper limb. They calculated the mean disability scores and
separated out the disability scores by aetiology. The only subgroup to attain a
statistically significant (p = 0.02) postoperative reduction in disability score was the
post-infarction patient group; however, the MS patients and trauma patients tended
towards improved disability.
Comparing changes in mean disability scores as was performed in the above two
studies is hazardous as Fahn's Functional Scale is an ordinal scale which means that
a difference of one point is clearly not equivalent throughout the scale. It provides a
rank ordering of the patient's ability to perform the functional tasks specified in the
scale and therefore comparing mean scores is potentially misleading and should be
avoided.
Some of the more recent studies evaluating thalamic DBS have made some attempt
to use scales that are more objective and quantify the severity of tremor, as can be
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Benabid et al claimed that it was FTRS which was being used in their studies
(Benabid et al. 1991; Benabid et al. 1993; Benabid et al. 1996) and referred to
Fahn's published methods. However the scale that was used to assess the severity of
tremor was not the scale proposed by Fahn as it was not based on the assessment of
the amplitude of tremor. It was a 5 point scale but it used different operational
definitions to quantify the tremor (4 = complete disappearance of tremor in all
circumstances; 3 = reappearance of a slight tremor in rare circumstances, for instance
under stress; 2 = moderate benefit; 1 = slight benefit without real improvement in
daily life; 0 = no benefit at all or worsening of tremor). No mention of this change to
Fahn's scale was made in the paper.
Geny's et aV s study (Geny et al. 1996) evaluated the effect of thalamic DBS on 13
patients with MS. The authors devised a scale that was similar to FTRS in that it
quantified tremor according to the magnitude of the tremor amplitude. The scale was
designed specifically for patients with MDMS and defined the tremor amplitude
from 0 - 10cm: 0 = no tremor; 1 = maximal amplitude <lcm; 2 = amplitude 1 - 5cm;
2 = amplitude 5 - 10cm; 3 = amplitude >10cm.
Fahn's scale was designed predominately for use with Parkinson's, essential tremor
(ET) and cerebellar outflow patients and the tremor amplitude ranged from 0 - 2cm.
Geny's scale which was designed specifically for patients with MDMS defined the
tremor amplitude from 0 - 10cm. Geny et al also used a modified form of
Speelman's functional scale to which an intermediate state was added that
corresponded to the capability of easily catching an object. Although the scales were
devised for the study they were not validated before being used. They have
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subsequently been used in a recent comparative study of thalamotomy and
thalamic DBS in Parkinson's, essential tremor and MS patients (Schuurman et al.
2000). Schuurman et al in their study used what was referred to as the 'Modified
Tremor Scale' and quoted Speelman's article as the source of the reference for the
scale. However the tremor rating scale used in Schuurman's study is a 0 - 4 point
scale rather than a 0 - 3 point scale originally described by Speelman. We can only
assume that Schuurman et al therefore modified the scale for the study although no
reference of this alteration to Speelman's tremor scale is given in the paper. Nguyen
(Nguyen and Degos 1993) also used Speelman's Functional Scale in his study
evaluating the effect of thalamic DBS on proximal upper limb tremor in 4 patients
with MS. Despite the continued use of these scales in patients with MDMS no
attempt has been made to validate their use on this group of patients.
Design of rating scales for tremor is in a process of evolution but, at present, no
validated scale is available for assessing movement disorders in multiple sclerosis
(Haddow et al. 1997). This is in contrast to both essential tremor and Parkinsonian
tremor for which there are subjective scales such as the Webster Rating Scale
(Webster 1968) and the Unified Parkinson's Disease Rating Scale (version 3.0)
(Fahn and Elton 1987) for measuring movement disorders. Presumably these
diseases have been the focus for the development of tremor rating scales in the past
because treatments exist that reduce impairment such as tremor and bradykinesia.
Unfortunately most of these scales tend to mix impairment with disability, using the
disability to rate the severity of the impairment, and have poor operational
definitions. This is illustrated in the Unified Parkinson's Disease Rating Scale where
a score of 3 indicates marked tremor, which interferes with many activities, and a
score of 4 indicates severe tremor, which interferes with most activities. Both the
Webster Rating Scale and the Unified Parkinson's disease Rating Scale have been
widely used but there have not been any formal studies of reliability performed on
either scale. As Elbe and Koller remark in their book on tremor
'Rating scales are imprecise and subjective. Most have evolved ad hoc
from epidemiological and therapeutic studies, and none have received
universal acceptance or validation.' (Elbe and Koller 1990)
The lack of a validated tremor rating scale presented a major problem for this present
study as in order to critically evaluate the effect of thalamic DBS on MDMS
measurement scales were required that had known validity, reliability and
responsiveness.
Handicap and disability are important to patients and those who treat them and look
after them, yet these areas have been neglected in previous clinical trials. Instead the
focus has often been on measuring the amplitude of the tremor and its severity and
too much emphasis has been placed on professionals' opinion of the outcome of
treatment rather than that of the patient. This may reflect the bias of the professionals
as well as difficulty in the satisfactory assessment of outcome using currently
available scales of function, disability and handicap. Schuurman et al's recent study
(Schuurman et al. 2000) which was a randomised comparison of DBS and
thalamotomy which included 5 patients with MDMS in each group is one of the few
studies that has focused on this issue, using functional status as a primary outcome
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rather than symptoms of the disease. Furthermore, in no prospective study of
patients with MDMS has the influence of tremor on overall disability, handicap and
quality of life or the patient's perception of changed ability been measured.
1.4.2 Cost-benefit analysis
There are health economic implications associated with thalamic DBS. These arise
from assessment, purchase (£7,602 per set) and implanting of the thalamic DBS;
follow-up; comprehensive post-operative rehabilitation requirements in that patients
need intensive physiotherapy and occupational therapy to relearn use of the target
upper limb; and staff costs for support. Patients also need to be monitored for any
adverse side effects relating to the stimulation and at some stage the IPG battery will
need to be replaced. The cost involved with the purchase of the equipment alone is
an obstacle for the use of thalamic stimulation as a regular treatment in some
economically deprived countries. No study has addressed the cost-benefit of thalamic
DBS although it had been stated recently that this was required (Speelman et al.
1998; Whittle et al. 1998) .
1.5 Challenges in the Measurement and Treatment of
MDMS
1.5.1 Validation and use of tremor rating scale and upper limb function test
One of the most important aspects at the beginning of the study was to devise and
validate a series of tests to enable prospective and objective documentation of the
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clinical and disability status of patients with disorders of movement who were
referred for (potential) therapy using thalamic DBS.
Fahn's Tremor Rating Scale (FTRS) and the Jebsen Test of Hand Function (JTHF)
were chosen for use in this study over other existing tremor rating scales and hand
function tests because they appeared potentially capable of quantifying tremor
severity and quantifying deficit in performance of hand function. It was necessary to
make some minor modifications and omissions to the original FTRS and then to
evaluate the psychometric properties of the amended scale (Modified FTRS) to
enable it to be used in patients with disorders ofmovement due to MS.
The first aim of the study was to assess the applicability of the modified version of
FTRS (MFTRS) in the measurement of the disorder ofmovement for reliability and
validity. The JTHF had already been extensively evaluated with regard to reliability
and validity in neurological patients presenting with intention tremor.
1.5.2 Evaluation of thalamic DBS
After reviewing the past studies it was evident that there was a lack of objective
evidence supporting the use of thalamic DBS in MS. The second aim of this study
was therefore to determine whether thalamic DBS (i) decreased tremor and (ii)
improved hand function in the target upper limb in patients with MDMS.
The issue of sample size presented a major problem in the proposed study as the size
of the sample was determined by the number of patients with MDMS who were
easily accessible and willing to be considered for inclusion in the study. The ideal
solution to overcome the problem of incidental sampling and of a sample population
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that may not be representative of the population would have been a large, multi-
centred randomised controlled trial. However this would not only have been
enormously costly but it would also have been very difficult to organise and
therefore was not practical. The study sample was intended to include a
representative sample of patients with MDMS thus including patients with
movement disorders which ranged in severity from mild to severe. This study was
therefore a pragmatic study intended to provide a preliminary evaluation of the
relative merits of thalamic DBS in MDMS.
The proposed study involved extensive clinical, functional and video assessments of
patients before surgery and at 1, 3, 6 and 12 months after surgery which were
performed by the researcher, independent of the operating surgeon, with the
stimulator on and off. The assessment procedure involved the patient and his family
in the decision process and emphasized the importance of clear realistic goals to be
agreed. The two main primary outcome measures used for assessing tremor severity
and upper limb performance were to be the modified Fahn's tremor rating scale and
the Jebsen test of hand function.
In addition, the effect of thalamic DBS on overall cognitive function, disability,
handicap, quality of life and the patients' perception of the outcome of the treatment
were also to be evaluated. Specific scales of cognitive function (neuropsychological
test), disability (self-care section of the FIM and BI), handicap (LHS, Handicap
Questionnaire) and QOL (FSS, HAD, subjective global assessment of tremor-related
disability in the MFTRS, patients' opinion of outcome questionnaire) were used for
this purpose.
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1.5.3 Health economic measurement of the 'cost-benefit' of thalamic DBS
The third aim of the study was to provide an estimate of the costs involved in the
patients in whom thalamic DBS were implanted for MDMS and to establish whether
it resulted in any economic benefit (savings in future care costs) in this cohort of
patients. If it were possible to demonstrate that as a result of thalamic DBS there was
a reduction in resource use in the longer term then the overall/additional cost of the
intervention might be offset.
1.6 Summary of the Study Objectives
The purpose of the work presented here was to study the effectiveness of thalamic
DBS in MS. However in order to do this a series of clinical tests had to be devised
and validated at the beginning of the study. The main aims were therefore to:
(i) determine whether current scales devised for rating tremor in patients with
Parkinson's disease and essential tremor were appropriate for evaluating
MDMS.
(li) devise and validate standardized tests for use with MDMS which could be
adopted by other centres performing such surgery so that results could be
reported consistently and comparisons made.
("hi) provide a preliminary evaluation of the relative merits of thalamic DBS and
thalamotomy in the management of patients with tremor due to MS with an
emphasis on examining outcome in terms of not only quantitative change in
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tremor, but on changes in disability, handicap, quality of life and patient
perception of effectiveness.
(iv) address the cost implications of thalamic DBS
1.7 Hypothesis
The hypotheses under investigation were:
1. That there would be a difference between the pre and post operative scores and
scores when the DBS was on versus off in the target upper limb of tremor
severity (MFTRS) and performance of functional tasks (number of subtests of the
JTHF passed) in patients with MS as a result of thalamic DBS.
2. That there would be a change in the ability to perform self-care activities of daily
living (FIM), overall disability (EDSS), handicap (LHS and handicap
questionnaire), fatigue (FSS) and mood (HAD) in patients with MS as a result of
thalamic DBS.
3. That there would be a change in tremor-related disability post-operatively as
perceived by the patient and examiner as a result of thalamic DBS (global
subjective assessment in MFTR).
4 That the patients' subjective opinion of the outcome of the operation would be
positive.
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5. That there would be a change in the patients' functional ability in relation to
activities of daily living (self-care assessment of FIM and BI) and therefore a
change in the home-care resources used post-operatively by patients with MS as
a result of thalamic DBS.
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CHAPTER 2
MEASUREMENT OF IMPAIRMENT, DISABILITY,
HANDICAP AND ASPECTS OF QUALITY OF LIFE
ASSOCIATED WITH MOVEMENT DISORDERS IN
MULTIPLE SCLEROSIS
2.1 Introduction
Measurement is a key process both in research and clinical practice and is 'the use of
a standard to quantify an observation' (Wade 1992). If the measurement procedure is
poor, then the validity of the findings, and hence the usefulness of the study, will be
severely limited (Polgar and Thomas 1991).
As discussed in the previous chapter many of the past studies evaluating stereotactic
surgery for movement disorders due to MS did not use measures with proven
reliability or validity. The lack of a validated scale for measuring movement
disorders due to MS presented a major problem for the present study. It was therefore
first essential to consider whether current scales devised for rating movement
disorders in other situations might be appropriate for evaluating movement disorders
in patients with MS. It was also clear that if a suitable tremor rating scale existed,
studies of reliability and validity would be required.
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2.2 Basic Requirements ofMeasuring Instruments
2.2.1 Reliability, validity and sensitivity
'The adequacy of any measure is determined by its reliability and validity'
(Polgar and Thomas 1991)
Reliability refers to the reproducibility of scores obtained from a measure. A
measuring instrument or test should have reliability in that the instrument should
give the same result consistently when used repeatedly or by different examiners.
These aspects of reliability reflect the stability or dependability of the measurement
process. Therefore when assessing reliability one is assessing a process as well as an
instrument (Seaby and Torrance 1992).
Scoring systems containing clear operational definitions generally improve reliability
compared to vague, intuitive or judgmental approaches to assessment.
Standardized procedures similarly contribute to reliable and valid measurement and
may be defined as using specified test administration and scoring procedures under
the same environmental conditions, with consistent directions (Johnston 1992).
According to Johanson (Johnston 1992) inter-examiner reliability is a prominent
issue with rating scales because if trained individuals cannot agree, the assessment
procedure is of doubtful objectivity and utility. The extent of agreement is therefore a
function not only of the inherent qualities of the assessment scale but also of features
of the setting and the characteristics of the examiners.
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Many of the procedures know to reduce unreliability were used in this study. An
existing scale (Fahn's Tremor Rating Scale) was carefully developed and modified
for use with patients with MS (Modified Fahn's Tremor Rating Scale). The Modified
Fahn's Tremor Rating Scale had explicit operational definitions: defined criteria;
standardized decisions and definitions; and instructions and guidelines for examiners
to establish the rules for rating severity of the movement disorder.
However reliability is a necessary but not a sufficient condition for good or valid
measurement (Kerlinger 1986) . A test should also have validity in that it measures
what it sets out to measure. Any valid test will by definition be reliable but it is
frequently ignored. This might be due to the fact that validity is more difficult to
assess than reliability and frequently involves extensive analysis of the degree of
agreement between different measures.
Ebrahim (Ebrahim 1991) argues that medical thinking about validity is preoccupied
with criterion or 'gold standard' validity which may be appropriate for measuring
biological impairments but is not in the case of measuring disability, handicap and
quality of life, where no 'gold standards' exist. Consequently experts in the field of
measurement have developed a logical scheme for categorising types of validity.
There are five primary types of validity: face, predictive, content, construct and
criterion validity (Rothstein 1993).
The truly ideal scale, which probably does not exist, should in addition to having the
properties of reliability and validity, be sensitive to detecting change. Many scales
are insensitive to detecting change particularly at the higher levels of recovery
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(ceiling effect) or the lower levels of recovery (floor effect). The scale should be
able to detect clinically important change over time, be easily used and widely
applicable. There is a profusion of tremor rating scales and disability scales, which
go nowhere towards meeting this ideal.
2.2.2 Features of ordinal scales ofmeasurement
There are certain rules which need to be adhered to when using ordinal scales such as
rating scales if they are to be used soundly.
An ordinal scale, which rates severity of tremor on a 5 point 0-4 scale where 0 = no
tremor and 4 = severe tremor, provides a rank order of a patient's severity of tremor.
With ordinal scales, statements about ranks can be made eg. if patient A scores 4 on
the tremor rating scale and patient B scores 2, it can be said that patient A has more
severe tremor than patient B. We cannot however, make statements about the relative
size of these differences (ie. claim that Patient A's tremor is twice as severe as
patient B's tremor), because the difference between each pair of ordinal positions on
the scale is not necessarily the same. Such a scale is non-linear and therefore
provides a non-quantifiable measure of severity of tremor (Oyster et al. 1987) which
is not well suited to parametric statistical analysis. As noted above explicit
operational definitions concerning each rank order on the scale help to ensure
reliability.
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2.3 Measurement ofMDMS- Methods for Assessing
Impairment
2.3.1 Kurtzke's Functional Systems (FS) and the Expanded Disability Status
Scale (EDSS)
In 1955, Kurtzke proposed a scale for rating neurological impairment in MS.
Between 1955 and 1983 the initial version was improved several times by Kurtzke.
The 1983 version currently used is based on a two-phase procedure. First, eight
neurological functions (pyramidal, cerebellar, brainstem, sensory, bladder and bowel,
visual, cerebral and other) are assessed by standard neurological examination, where
all save the last are graded from zero (normal) to maximal impairment (grade 5 or 6).
The last category 'other functions' is dichotomous, with 0 = no other dysfunctions
present and 1 = any other dysfunctions present. Secondly the overall disability is
measured on the Expanded Disability Status Scale (EDSS). The EDSS is based on
the eight measures of impairment given in the first phase and on an assessment of
walking disability and self-care ability.
The EDSS (Kurtzke 1981) is a global rating of neurological impairment consisting of
20 statements that describe decremental reductions in function. The global rating
score ranges from 0 to 10, with no impairment (score 0) progressing through signs
and symptoms, problems with mobility, upper limb and bulbar functions, and
resulting in death due to MS (score of 10).
In practise the lower EDSS grades (0 - 3.5) are defined primarily by variations in
grades in the functional systems, while in the upper range of the scale the EDSS
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depends primarily on the patient's ability to carry out activities of daily living. In
the mid-range the EDSS relies on a not very precise assessment ofwalking ability (4
- 7): for example, the difference between grades 5 and 5.5 is essentially the ability to
walk some 100 metres but not 200 metres. Almost all patients with EDSS scores
higher than 5 have walking difficulties and those with score over 6.5 are confined to
a wheelchair.
Table 2. 1: Expanded disability status scale
FUNCTIONAL SYSTEMS SUBSCALE
RANGE





Bladder and Bowel 0-6
Cerebral 0 1
Other dysfunctions 0 or 1
Overall EDSS Score 0-10
Weabiesses and limitations of the EDSS
In light of the classification already discussed the title is inappropriate because the
functional systems concentrate on impairments but include reference to disability and
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handicap by including components related to the patient's ability to work and
carry out activities of daily living.
As a measure of impairment in MS the EDSS has a number of problems. In several
of the functional systems there is lack of precision in the definition of the different
grades of impairment. Consider for example, the cerebellar status score: 0 = normal;
1 = abnormal signs without disability; 2 = mild ataxia; 3 = moderate truncal or limb
ataxia; 4 = severe ataxia in all limbs; 5 = inability to perform co-ordinated
movements due to ataxia. Terms such as "mild", "moderate" and "severe" are not
defined or quantified. The scale does not allow for a patient who may have unilateral
tremor. It is difficult to use with precision and the reliability of the EDSS scores is
therefore questionable.
The process of combining the score in the functional systems with extra data based
on the patient's mobility can also be complex, especially in the middle ranges of the
EDSS in patients with higher scores in functional systems that do not seriously affect
the ability to walk. In the middle and upper ranges there is also a relative lack of
sensitivity to potentially important clinical changes that do not affect mobility.
In relation to both its reliability and its responsiveness, the EDSS has been subject to
considerable criticism (Noseworthy et al. 1990; Whitaker et al. 1995; Willoughby
and Paty 1998). Studies of the reliability of the EDSS have shown considerable inter-
examiner variability especially as regards the cerebellar, cerebral and sensory
systems. One other area of discontent is the significance of change in the EDSS
score. Kurtzke defined patient improvement or deterioration as a change of one point
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(Kurtzke 1981; Kurtzke 1983), but Amato et al (Amato et al. 1988) and
Noseworthy et al (Noseworthy et al. 1990) suggest that so small a change may be
clinically insignificant or may be due to examiner inconsistency. They argue the need
for a 2 point difference (1.0 point on the EDSS and 2 points on the FS).
In the EDSS, the functional systems do not provide a separate assessment of
impairment in the upper limbs and are therefore more sensitive to detecting change in
the lower limbs. This insensitivity to upper extremity functional status and its change
creates a major problem in studies such as this one where the upper limbs were a
principal focus of investigation. This weakness of the scale may also enhance the
widespread belief that the upper extremities are relatively spared in MS.
The sub-scale for measuring mental state is very crude and was not adequate for use
in this study as it was important to ascertain the neuropsychological status of the
patients with reliable and valid measures to ensure that the procedure did not result in
any deterioration in mental functioning.
Justification for using the Kurtke's FS and the EDSS
'The Kurtzke Scale has little to recommend it, and clinical assessment of
clinical impairment should be combined with general measurements of
disability.' (Wade 1992)
Kurtzke's Functional Systems which concentrate on measuring impairments in MS
have been used for many years in studies of patients with MS and continue to be
used despite their methodological weaknesses. Although the FS and the EDSS were
recently criticized by Willoughby (Willoughby and Paty 1998), MS researchers still
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generally regard these scales as the preferred measure of outcome in clinical trials
of experimental MS therapies (Noseworthy et al. 1989). However there is widespread
feeling that it is time to develop a more reliable replacement particularly for the
measure of impairment as defined by the World Health Organisation (WHO) but to
date no such scale has been proposed.
Kurtzke's FS and the EDSS were included in this study as they were quick and
simple to score once a neurological assessment had been carried out. They are still
used by the neurologists in the department as part of the assessment of patients with
MS. However separate scales which had been validated on patients with MS were
also used to measure impairments which were particularly relevant to this study:
namely tremor and cognitive dysfunction.
2.3.2 Quantitative laboratory based measurements
There is a plethora of sophisticated tools with which to measure human motor
performance, owing to the proliferation of microcomputers and advances in
biotechnology. Involuntary abnormal movements, especially tremor, are particularly
amenable to measurement using techniques such as electromyography,
accelerometry, computerized maze co-ordination and visually guided manual
tracking tests and kinematic studies (Liu et al. 1999).
A large investment of time and money is often required when using sophisticated
laboratory-based procedures and all have associated difficulties in measuring
complex movement disorders.
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EMG can only provide a surrogate marker of limb movement. Signals derived
from accelerometry of intention tremor are inaccurate because the finger-nose test
provides a non-stationary signal consisting of at most 10 tremor cycles and both the
tremor and intended limb movement frequencies overlap. Other disadvantages
associated with accelerometry are that accelerometers can only measure activity at
one site and record tremor in one spatial dimension (unless complex, expensive
triaxial accelerometry is used). In order to assess movement disorders in MS the
behaviour of the whole limb in all three planes ofmovement needs to be appreciated.
Despite these problems, accelerometry has become a standard technique for
assessing tremor in clinical trials as it provides a quantitative measurement of upper
limb tremor. Bain and Findley have shown, however, that accelerometry is not a
valid method of assessing the functional significance of postural tremor upon patients
(Bain et al. 1993). Tracking tests can be useful for quantifying tremor which involves
a single joint but are unsuitable for the assessment of tremors that appear in free limb
movements which involve multiple joints (Beppu et al. 1984; Liu et al. 1997) and
are therefore of limited use. Kinematic studies can circumvent this difficulty but
analysis of the derived signal is complex and limits their widespread use (Findley et
al. 1981; Hewer et al. 1972).
In the present study the question being addressed was whether thalamic DBS
operation would result in suppression of tremor which would consequently improve
the resultant upper limb disability and function. It was decided that simple
observation and measurement of the patients' motor behaviour was probably the best
form of measurement for this study as it was likely that the majority of patients
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referred to the study would be severely disabled and confined to wheelchairs,
dependent on carers and hospital transport for attending follow-up assessments.
Sophisticated and lengthy laboratory-based measurement was therefore not
appropriate or practical.
2.3.3 Subjective tremor-rating scales
A preliminary evaluation of different tremor rating scales, tests of hand function,
disability and quality-of-life scales was undertaken at Liberton Hospital in
Edinburgh. There were a number of patients under the age of 65 with movement
disorders due to MS, who were either in the unit for a short period of respite care or
for an in-patient admission for rehabilitation. The researcher carried out a
preliminary evaluation of different subjective rating scales and tests of upper limb
function so as to examine the strengths and weaknesses of the tests and establish the
applicability in a cohort of patients with movement disorders due to MS. This proved
to be invaluable in enabling selection of the most practical and appropriate tests and
modification if necessary for the purposes of this study. The modifications and
omissions made to the published methods are described in detail in this chapter.
The tremor-rating scales that have been used in previous studies and the problems
associated with their use for evaluating treatments for MDMS have already been
discussed in Chapter 1. Tremor and ataxia are common problems in patients with MS
and specific scales have been developed focusing on this patient group (Geny et al.
1996; Speelman and Van Manen 1984) but neither of these scales have been
validated. The only tremor-rating scale which appears to have had any formal
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assessment of its psychometric properties is Bain and Findley's Tremor-Rating
Scale (Bain et al. 1993) and validation was not carried out on patients with MDMS.
2.3.3 (i) Bain and Findley's Tremor-Rating Scale
Bain and Findley's scale (Bain and Findley 1993) scores tremor magnitude
separately for different parts of the body and also for different tremor components. It
is a combination of a descriptive scale (no tremor, mild, moderate, severe, extremely
severe) and a numerical analogue scale (0 - 10). It was chosen after experimentation
with several other designs because it proved to be reliable and user-friendly. It is
slightly unusual in having more steps than most tremor-rating scales which the
authors claim 'tends to improve its precision and reliability'. The scale relies on the
examiners having some experience of movement disorders and utilises a cognitive
process whereby an observer ascribes a number to a phenomenon to indicate its
degree ofmembership of a set. The scale relates magnitude of the tremor to different
anatomical sites (the limbs and head excluding the trunk) and assesses different
components of tremor for each of these body parts. The various components of
tremor were: rest, postural, kinetic, and intention. The authors avoided the inclusion
ofmeasurements of disability and handicap within the scale.
The psychometric properties of the scale were assessed in a study (Bain et al 1993)
involving 20 patients with movement disorders due to essential tremor and eight
patients with postural limb tremor associated with dystonia. The scores obtained with
the scale were compared with the results of upper limb accelerometry, an activity of
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daily living self-questionnaire and estimates of tremor induced impairment in
writing and drawing specimens.
The inter and intra examiner reliability of the scale was assessed using vidoetape of
the patients seen in the assessment clinic and the same four raters. Two video
assessments sessions were carried out, the first, one month and the second two
months after the initial assessment in the clinic. The rating scale proved to have good
inter and intra-examiner reliability for assessing the postural components of head and
upper limb tremor and fair to moderate for lower limb tremor. However 'the
examiners had great difficulty applying the terms kinetic and intention tremor to real
life observations in spite of having previously agreed on these definitions'. For
instance the Kappa values for the inter-examiner reliability of right upper limb
kinetic and intention tremor components were 0.02 - 0.65 (slight - substantial) and -
0.03 - 0.54 (poor - moderate) respectively. Consequently, during the second video
assessment 'intention' tremor was not scored, and by confining attention to recording
the severity of the kinetic tremor seen midway through a movement, greater inter-
examiner agreement was obtained; for example 0.44 - 0.66 (moderate - substantial)
for the right upper limb.
The validity of the scale was assessed by measuring the correlation between the
mean scores for the different components of tremor in each body part and the results
of upper limb accelerometry, activities of daily living self-questionnaire and
estimates of tremor induced impairments in writing and drawing specimens which
are techniques commonly used in clinical trials evaluating treatment such as drugs on
severity of tremor. The results showed that the examiners' scores for the right upper
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limb postural component in each patient correlated well with the results obtained
from the disability self questionnaire (r = 0.64), and acceleration in the right arm (r =
0.67), as well as handwriting (r = 0.76) and spirography (r = 0.81). In contrast the
frequency and acceleration values from right upper limb accelerometry were poorly
correlated with disability (r = 0.04), spirography (r = 0.41) and handwriting (r =
0.34). The rating scale therefore produced a reliable method of assessing postural
tremor severity, particularly in the upper limbs and head and was a more valid index
of tremor induced disability than standard postural accelerometry.
There were limitations of Bain and Findley's Tremor-Rating Scale in relation to
using it in the present study. The scale related magnitude of tremor to different body
parts but it did not include evaluation of the trunk. Many patients with MS present
with truncal ataxia/tremor, the severity of which needs to be assessed. The scale
provided a broader gradation system than any other scale but it was found not to be
'user friendly'. It was difficult to make a judgement as not only did the examiner
have to decide whether each component of tremor at a given anatomical site was
mild, moderate, severe or extremely severe but a numerical score also had to be
ascribed to the tremor. The authors also separated kinetic tremor from intention
tremor, something which is difficult to do in clinical practice and this was reflected
by the fact that the examiners had great difficulty in applying the terms 'intention'
and 'kinetic' to real life observations despite having previously agreed on these
definitions. The inter-examiner reliability was poor for upper limb kinetic and
intention components and this reflected the practical difficulties of defining the
boundaries between the kinetic and intention tremor. In addition, the reliability study
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had been carried out on patients with essential tremor and 'dystonic tremor', the
aetiology of which was nor disclosed but was almost certainly not MS.
2.3.3 (ii) Fahn's Tremor-Rating Scale - methods as published
Fahn et al gave a detailed account of his scale in a book called 'Parkinson's Disaease
and Movement Disorders in 1988 (Fahn et al. 1988) (see Appendices 2 and 3 for the
published FTRS form and definitions of the tremor scale) and, as already discussed,
despite the continued international use of this scale there has been no validatory work
earned out to assess the reliability, validity or sensitivity of the use of the FTRS in
any group of patients. The scale is divided into three parts:
Part A quantifies the tremor at rest, with the patient holding a posture, and with
performing action and intention manoeuvres for nine parts of the body (the face,
tongue, voice, head, trunk upper limbs and lower limbs). Although the arms are the
part of the body most commonly affected by tremor of all types, other parts of the
body may also develop tremor. The face, tongue and voice are included as in
Parkinson's Disease, tremor usually occurs in the distal muscles but can also involve
the lips, chin and tongue. Essential tremor besides appearing in the arms can also
appear in the neck and vocal cords. Tremor resulting from a lesion in the superior
cerebellar peduncle, referred to as a 'cerebellar outflow lesion' by Fahn et al,
commonly seen in patients with MS or patients with head injuries, tends to affect the
upper limbs, trunk and head.
Severity of tremor in each of the nine body parts is rated in the scale by its
amplitude, and is rated as none, slight (amplitude <0.5cm), moderate (amplitude 0.5
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- 1cm), marked (amplitude 1 - 2cm) or severe (amplitude >2cm). Whether the
tremor is intermittent or always present (a characteristic of rest tremor in Parkinson's
disease) is not a factor in the severity score.
Tremor severity is rated for the nine body parts for three situations: rest, maintaining
a posture and performing an activity. Rest tremor is assessed with the body parts
supported against gravity. This may be achieved in a supported sitting position but in
some patients it may be necessary for the patient to lie supine. Tremor of the body
part when maintaining a posture is considered a postural tremor. Fahn et al assumed
a level of sitting ability in patients being assessed with the scale, as the trunk was
assessed in sitting (presumably unsupported) or standing. Postural tremor of the arms
is observed by having the patient stretch his arms out in front of his body with his
elbows extended and then flexed. The authors did not distinguish between these two
positions when scoring the postural tremor in the arms but scored them together even
though he assessed these two positions separately. Action and intention tremor
included goal related tremor and was scored by observing the patient perform the
finger nose test and the functional tasks in Parts B and C. No attempt was made to try
to distinguish between action, intention and goal related tremors. They were grouped
together and scored as one.
Part B of Fahn's Tremor Rating scale includes subjective rating of tasks performed
with each hand. These included drawing of Archimedes' spirals (spirography which
was incorrectly referred to as 'spirometry' by Fahn et al), line drawings and pouring
water from one cup to another (volumetric test). Handwriting was also evaluated
using only the dominant hand. The quantification of spirography and the line
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drawing was based on the crossing of the lines in the figure on the assessment
form, 0 = normal; 1 = slightly tremulous; 2 = moderately tremulous or crosses lines
frequently; 3 = accomplishes task with great difficulty, many errors; and 4 - unable
to complete drawing. There was less space between the lines in the smaller of the
two spirals making the task more difficult. Pouring water from one cup to another
was also quantified. Cup size and amount ofwater used in the test were specified to
ensure consistency between assessments. The amount ofwater spilled is the basis for
the severity grading: 0 = normal function; 1 = more careful than a person without
tremor, but no water is spilled; 2 = spills a small amount ofwater (up to 10% of total
amount); 3 = spills a considerable amount of water (10 - 50%); 4 = unable to pour
water without spilling most of the water (>50%).
Part C assesses functional disability. Its items evaluate the severity of tremor with
speaking, eating (feeding), bringing liquids to the mouth, hygienic care, dressing and
working including homemaking and domestic tasks. These scores, with the exception
of speaking, are provided by patients, who are asked to evaluate their ability to carry
out these tasks (for definitions see Appendix 2). The speaking score encompasses
both voice tremor and 'dystonic adductor dysphonia' as the authors believe that some
patients may have both disorders and it is difficult to distinguish between them.
The sub-total scores, i.e. sums of each separate part (A, B and C) are calculated and
totalled to give an overall score of all three parts. The maximum possible scores are
80 for Part A, 36 for Part B, and 28 for Part C, making the maximum possible total
score 144.
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In addition to the quantification of tremor through Parts A, B and C, the scoring
form allows for an assessment of overall severity by both the examiner and the
patient. This subjective global severity is based on tremor related disability, which is
calculated according to the percent of impairment in carrying out all activities of
daily living and the cosmetic effect of tremor, which can be psychologically
damaging.
2.4 Measurement ofMDMS - Methods for Assessing
Overall Disability and Specific Upper Limb Disability
2.4,1 Functional Independence Measure and Bathel Index
The Functional Independence Measure (FIM) was devised by a national group of
clinical, research and administrative experts in rehabilitation in the United States of
America as an instrument for general use in rehabilitation practice (Granger et al.
1986). It was originally developed to measure 18 core areas of function at four levels
of dependence, and as such to be a 'minimum data set'. It has since been expanded
so that the 18 core areas of function are assessed using a scale that has seven levels
of ability. For each item, a score of 1 indicates complete dependence on others to
achieve the activity, and a score of 7 represents complete independence (see
Appendix 15).
It has been validated in this seven level score format (Hamilton et al. 1994) and it has
been shown to have validity in patients with MS (Granger et al. 1990). Granger el
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al's study (Granger et al. 1990) demonstrated the FIM's sensitivity to differences
in patient functional status: the FIM, when compared to a battery of other functional
status instruments, was most closely associated with the extent of care required by
the MS patients in the study.
The Barthel Index (BI) (Mahoney and Barthel 1965) is the most commonly used
tool for recording disability and physical recovery. It is a measure of 10 activities of
daily living involving bathing, stairs, dressing, mobility, transfers, feeding, toilet use,
grooming, bladder and bowel function. The BI scores are often summed to give a
total score which ranges from 0 to 20 in 1-point increments. It has been shown to be
a robust, reliable and valid instrument for measuring disability. Its reliability has
been studied in several different settings, including a rehabilitation setting (Collin et
al. 1998). It has intra-examiner reliability and inter-examiner reliability and is
reliable whether the patient is observed performing the tasks or asked about their
ability to perform the tasks. The validity of the BI is well established. The score
correlates with clinical impression; with motor loss after stroke; and with scores on
other ADL indices. Its main use has been with stroke patients.
Justification for using the FIM and the BI
The FIM and the BI were both used in this study. The self care section of the FIM
was chosen specifically to assess the patient's ability to perform functional self care
tasks with the target upper limb. The FIM was chosen for this purpose as it has seven
levels of ranking thus achieving a more sensitive definition of dependence than the
BI which has only two or three and is insensitive to small differences (Wade 1992)"
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One of the main criticisms of the BI is its insensitivity to show change particularly
at each end of the scale. It has definite floor and more importantly ceiling effects
(Skilbeck et al. 1983; Wade 1992) however the majority of patients with MDMS
were moderately to severely disabled so the fact that there were few challenging
tasks at the higher end of the scale was not anticipated to be a problem.
The FIM also scores some activities of daily living (eating, drinking, grooming,
dressing, toileting) individually. The FIM therefore permitted a more precise
description of the levels of dependency produced by the patient's movement disorder
and according to Granger it is the most useful tool in predicting the burden of care in
MS (Granger et al. 1990). FIM training videos were available and were used to teach
the researcher to use the scale to evaluate self-care activities for daily living.
The FIM scale also covered areas of communication, social integration and cognition
which the BI did not, but the researcher did not score these areas. There were time
constraints imposed upon the researcher at the initial assessment owing to the time
required to carry out the extensive battery of tests assessing severity of tremor and
function of the target upper limb. A trained neuropsychologist carried out an
assessment to establish the cognitive dysfunction at the initial assessment using a
valid and reliable neuropsychological test battery.
The absence of scoring for fatigability, vision and sexual function are notable
omissions in both the FIM and the BI and both scales therefore lack specificity for
MS. It was therefore necessary to include a separate scale for fatigue as disorders of
movement can influence levels of fatigue in MS.
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The major focus of this study was to find out whether tremor causing functional
disability of the upper limb, head and trunk could be reduced by thalamic DBS.
Specific tremor-rating scales and tests of upper limb performance (JTHF) and
function (Self-care section of FIM) went part of the way to serving this purpose.
However, it was also important to include an overall measure of patient disability
because there can be major interactions between tremor and the neurological deficits
found in multiple sclerosis. It was essential to classify the group of patients in the
study by identifying their general level of functional disability before and twelve
months after the implant of the thalamic DBS. It was anticipated that the surgical
procedure might eliminate tremor but it was also important to establish that in doing
so it did not also adversely affect aspects of other function.
The BI was used for this purpose as the scoring was simple and only took a few
minutes. The FIM took 20 minutes to complete and was also designed to be
completed by a multi-disciplinary team and therefore would have been used out of
context in this study. Both the FIM and the BI are ordinal scales with a rudimentary
scoring system which should not be summed to give an index score although this is
commonly performed in studies. Valuable information is lost by summing the
different items.
Quantitative tests of neurological function (QENF) pioneered over a period of two
decades by Tourellotte and Syndulko (Touttellotte and syndulko 1989; Syndulko et
al. 1993) were also considered. The basis for these tests is the timing of a series of
measurements of co-ordination that challenge the neural systems most often affected
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in MS. However they have not made major inroads into the routine evaluation of
MS.
The advantages of these tests were reported to be that motor function in the arms and
legs could be scored separately and that the tests were reliable on repeated testing if
carried out by a trained member of staff. The tests have been extensively evaluated in
a two year follow up study involving 55 patients with MS. Unfortunately, although
some of the more simple behavioural challenges seemed appropriate for our patients,
eg. the simulated activities of daily living, the majority of the components were
totally unsuitable: finger tapping and foot tapping are often used as tests for
dysdiadochokinesia but they are of questionable clinical significance; the Perdue peg
board proved too taxing for our patient group; standing in balance on two legs with
eyes open then closed, standing in balance on one leg with eyes open then closed and
tandem gait were primarily concerned with co-ordination associated with equilibrium
and were presumably developed for quantifying sensory ataxia rather than motor
ataxia.
2.4.2 Sitting, Standing and Walking Tests
2.4.2 (i) One minute sitting balance
A test to determine the extent of trunk control when in a vertical position did not
exist. Full control of independent sitting balance requires patients to be able to
maintain an upright posture using normal postural adjustment mechanisms during or
after being displaced by an external force. A subject may maintain a sitting posture
that is biomechanically stable by collapsing into flexion at the thoracic and /or
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lumbar spine. Alternatively, an upright posture may be obtained by cross-bracing
with hands on thighs. This is a sitting posture which is commonly adopted by MS
patients with truncal ataxia, in an attempt to gain some truncal stability when they are
forced to sit unsupported. It is important to realize that this posture can be maintained
in the absence of joint control at the trunk and hips but that it is not a functional
position as patients are unable to free their arms. It was therefore important to adopt
a standardized definition of independent 'normal' sitting balance for the purpose of
this study.
Previous studies of sitting balance reported in the literature have weak definitions of
'sitting'. A classic example is provided by Beals (Beals 1966) in a study evaluating
prognostic indicators for walking in children aged 9 months with cerebral palsy.
Beals defined sitting as 'sits alone for 5-10 minutes'. This gives no indication of
trunk posture or hand support and thus no valid indication of control status. A
biomechanically valid test of independent sitting balance was defined in a study by
Butler (Butler 1998) as: 'sitting on a bed with head erect, eyes looking forwards,
trunk erect and not slumped with minimal flattening of the lumbar spine, thighs to
remain in contact with the bed and no hand or arm support on bed, thigh or body and
independent sitting balance maintained for 60 seconds. ' It was used for the purposes
of this study and was scored as a pass or fail.
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2.4.2 (ii) 10 second standing balance
The patient was observed attempting unsupported standing in balance for more than
10 seconds. Physical help was permissible in making the transition from sitting to
standing, but not during the timing period.
2.4.2 (iii) Ten metre walk
The patient was observed walking a measured distance of 10 metres. The patient
commenced the walk from a standing start, from a predetermined spot and was
instructed to walk to a point at the end of the walkway. Timing was started at the
beginning of the first step and finished as the patient crossed the mark indicating the
end of the walkway. The examiner walked next to the patient on the tremorous or
more tremorous side. If appropriate, a walking aid was used but verbal cueing was
avoided. Verbal instruction was standardized to 7 would like you to walk to the far
end of this room at a speed that is comfortable for you, and I will time how long it
takes
Justification for these methods
Many of the patients referred for thalamic DBS had truncal ataxia and truncal
instability. This initially proved to be problematic to measure objectively as there
were no specific tests for truncal ataxia. However the concept of using appropriate
tests of neurological performance where the behaviour in response to specific
challenges was objectively evaluated, presented a useful way of assessing the control
of the trunk in these patients. The patients' performance of three simple tests of
sitting, standing and walking were compared to an initial 'baseline' score for each
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activity, to determine any change over time. The protocols adopted for these tests
(Appendix 16) were based on the standardized measures of simple functional
movement used to measure the mobility outcome after stroke (Smith and Baer 1999).
These tests had face validity and the 10 metre walk has been shown to be reliable
(Wade 1992). It was anticipated that if there was a dramatic change in the severity of
truncal ataxia as a result of the surgical procedure this might impact on the patients'
ability to perform the tests successfully. Each test was scored simply as a pass or fail
and the time taken for the patient to perform the test was recorded.
2.4.3 Objective Tests ofUpper Limb Function
2.4.3 (i) Tests to measure focal upper limb function
'The measurement of arm function initially seems difficult because the
arm and hand have so many uses from gesture through balance, gross
strength related function and on to fine manual dexterity' (Wade 1992).
The ability of a patient to use his hands and arms effectively in everyday activities is
dependent upon not only co-ordination but anatomical integrity, mobility, muscle
strength and sensation. It is also influenced by age, sex, mental state and by disease
processes not only affecting the hands and upper limbs but other areas also.
One approach to testing arm disability is to measure (in detail) the patient's
performance of one single skill. Normative values are available for these tests which
are useful in the diagnostic process if the patient is suspected of a movement disorder
affecting the upper limbs. These tests also give a better impression of the course of a
disease affecting movement rather than relying solely on clinical judgement and are
therefore helpful in following patients' progress in clinical trials.
75
Four tests are discussed: Nail and peg/box and block tests; tapping tests and the
spiral test.
Nail andpeg and the box and block tests
These are timed tests where the patient is required to pick up either nails (Verkerk et
al. 1990) or wooden dowels (Goodkin et al. 1988) and place them accurately into
holes on a wooden board. The box and block test (Mathiowetz et al. 1985) involves
picking up blocks of wood and transferring them from one part of a box to another
and has been used in studying deterioration in MS (Goodkin et al. 1988) . In the nail
test, described as a test to assess co-ordination, the subject has to move 32 nails from
one side of a board with 64 holes, to the other. The total score is the number of nails
moved in 30 seconds. The authors reported that the test was highly reproducible in
healthy subjects. However owing to small patient numbers the reliability in patients
was questionable.
The nine hole peg test is a standardized, reliable, valid and rapidly administered test
of upper extremity function which is used frequently for Parkinson's disease or
ataxia (of any cause) (Wade 1992), particularly in out-patient clinics. Age-related
data are available for neurologically normal subjects (Mathiowetz et al. 1985). The
test has been used in clinical studies (Goodkin et al. 1988) and has along with the
box and block test been shown to be more sensitive in detecting changes in upper
extremity function in patients with MS than the EDSS. The test scores the ability to
manipulate pegs. The patient is required to pick up nine wooden dowels and place
them into a wooden base with nine holes in any order until all the holes are filled!
76
They then have to remove the pegs one at a time and return them to the container.
An observer times from start to end. The test is a measure of finger dexterity but can
also be used to measure the disabling effects of sensory loss and ataxia, two
impairments which according to Wade (Wade 1992) are difficult to measure in
isolation.
Tapping tests
Various tapping tests have been developed in an attempt to quantify cerebellar
dysfunction. They are based on a decreased capability to make quick alternating
movements (dysdiadochokinesia). In the so-called finger tapping test the patient is
instructed to tap successively the key of a computer with the index finger for 15
seconds (Schimoyama et al. 1990). The study yielded information as to what extent
age, handedness and sex may affect motor function in normal subjects. Tapping
frequency distinguished the normal control group from abnormal groups (ie. patients
with pathology) but it could not distinguish one abnormal group from another.
Notermans et al (Notermans et al. 1994) described a tapping test for the upper limbs
where a device is used consisting of two push buttons placed at a fixed distance apart
and connected to a computer. The patient is asked to push the left and right buttons
alternately with the index finger as fast as possible for 15 seconds. The test is simple
but it seems to be unreliable (Heller et al. 1987) probably because it is greatly
affected by motivation and therefore is not recommended (Wade 1992). The
reliability and validity of these tests has not been reported in detail.
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Spiral tests
The spiral test is described along with the nail test by Verkerk et al (Verkerk et al.
1990). These tests are used in the Department of Neurology of the Academic
Hospital in Groningen to measure co-ordination of the hands. A sheet of paper (size
A4) is used on which two spirals are printed; the distance between the lines is 1cm
(Appendix 7). The subjects must draw as quickly as possible a line from the starting
position (the arrow) to the central point, without touching the spirals. The total score
is the time in seconds needed to perform the test, with 3 seconds added for each time
a line is touched and with 5 seconds added for each time a line is crossed.
Limitations ofthefocal tests ofupper limb function
Although these tests are frequently used to assess tremor related disability in the
upper limbs of patients with movement disorders it was apparent after experimenting
with using the tests with patients with MDMS that they were not suitable for this
patient cohort for the following reasons. A major problem with MS patients with
advanced disability is associated disuse atrophy. Many of the patients were unable to
manipulate small objects such as a pen or wooden dowels because of poor finger
function which could result from a variety of factors such as impaired proprioception
in the hand, altered muscle tone and muscle weakness. Also, in many cases the
movement disorder was so severe that the violent uncontrolled moments of the upper
limb did not allow the patient to pick up or place one peg or to rest a pen on a piece
of paper on a table let alone attempt to draw a spiral with it. If drawing a spiral was
possible, the spirals encorporated in Fahn's TRS were preferred as they were easier
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to complete than the one described by Verkerk et al (Verkerk et al. 1990): they
required the patient to complete only three circles of a spiral as opposed to six which
tended to cause fatigue. These tests may also be affected by other factors such as lack
of motivation, visual disturbance or sensory problems which are common in MS
(Bauer 1978).
It was often frustrating, demoralizing and tiring for patients to be asked to perform
many of these tests because the tests required the patients to possess a background
level of postural control in the upper limb which many of the patients did not have.
Also some researchers question the clinical relevance of some of these measures of
focal upper limb function. Therefore these tests were considered to be inappropriate.
2,4.3 (ii) Test Batteries to measure upper limb function
There are many different methods of measuring arm and hand function and, from
studies performed, there does not appear to be one preferred method (Blair 1999).
There are many tests which contain a greater or lesser number of individual items
that measure the general ability of a patient to perform upper limb tasks which
depend upon well-preserved use of the arm. These tests use common activities to
simulate movements which may be used in ADL. None has been specifically
developed for use with patients with multiple sclerosis.
Tests which assess the hand by means of functional tasks are concerned only with the
subject's ability and speed of performance, whilst the 'quality' of movement and
performance are not rated. This is an advantage when using such tests to document
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clinical change in response to treatment as difficulties in measuring the 'quality' of
movement, based on an unclear norm, do not arise.
Jebsen Test ofHand Function
Jebsen (Jebsen et al. 1969) devised a series of seven standardized and objectively
measured subtests to provide an objective measurement of hand function which was
based on performance in a normal population. It was designed for both clinical and
research use. The tasks making up the test were chosen as those representing hand
function commonly used in ADL. The time of performance is recorded for each sub¬
test. Tasks used may be grouped into those requiring fine manipulation and those
requiring gross handling. The subtests requiring the use of fine manipulation include:
writing, turning cards over, picking up small objects and placing them in a can, a
simulated feeding task and stacking draughts. Those using gross movements are
placing large empty tins and large weighted tins onto a set target. The test takes
approximately 20 minutes.
In the original article, Jebsen et al reported British norms which were developed on a
sample of 360 normal subjects. Mean times and standard deviations for normal
subjects were presented in two large groups (ages 20-59 and 60-94) for each test
item. The JTHF has also been standardized on an American population (Agnew and
Maas 1982a; Agnew and Maas 1982b) for use with patients with rheumatoid disease.
To evaluate the reliability of test results in a given individual, 26 patients with stable
hand disabilities were tested on two occasions. The sample population consisted
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largely of neurological patients although none of them were patients with MS. The
results of the reliability study reported in the original paper by Jebsen showed that
fair to excellent reliability was found for each subtest. Validity of the JTHF was not
evaluated by the authors.
A recent study by Jones (Jones 1986) of 548 patients with neurological conditions,
56 of whom had intention tremor, showed that the consistency and repeatability of
the JTHF was very high in keeping with Jebsen's findings. However an evaluation of
content validity was carried out through an analysis of hand movements and grips
used by normals and patients on the JTHF and ADL (dressing and feeding) and it
was found that there were no typical hand movements used in either the JTHF or
ADL testing of the patients. In analysis of hand grips used by patients and normals
on the JTHF and ADL, again a wide variation was found. Common grips could be
identified but once again no 'norm' was found.
Jones (Jones 1986) showed that the JTHF was not a valid test of grips used in ADL,
as originally described by Jebsen and argued that the usefulness of the test in a
clinical setting must therefore be other than a measure of grips used in ADL.
The test therefore does not use hand movements/grips used in ADL, other than by
chance. Nor does the JTHF correlate with ADL function. Jones cautions that the test
cannot be seen as a predictor ofADL performance but that the power of the test is in
its ability to detect neurological deficit and show change in the severity of the deficit.
The JTHF has been used in many studies in the past years. It has been used after
stroke (Jebsen et al. 1971; Spaulding et al. 1988), to monitor the effect of wrist
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motion on time required to complete manual tasks in normals and patients with
peripheral nerve injury (Carlson and Trombly 1983), to evaluate the correlation
between the functional ability and the number of joints affected in osteoarthritis
patients (Labi et al. 1982), and to evaluate the effect of therapy in patients with
chronic MS (Jones et al. 1996).
Chyatte (Chyatte and Birdsong 1972) used the JTHF as a comparative measure in a
study to evaluate a time and motion measurement system. This system was designed
for use in the assessment of motor performance of the upper extremity. A high
correlation was found between their predicted times and the actual standard time of
performance on the JTHF. Using their movement analysis it was found that each of
the subtests of the JTHF used different hand skills (e.g. those groups of hand
movements used for card turning were different from those used for simulated
feeding).
The JTHF has also been used in a longitudinal study of the recovery of head injured
patients (Panikoff 1983). Results of this study indicated that the JTHF showed
changes in patients' status up to six months after injury.
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2.4.4 Measurement of MDMD - Methods for Assessing
Handicap
2.4.4 (i) The London Handicap Scale
The London Handicap Scale (LHS) (Harwood et al. 1994a) uses the system
description given in the ICIDH. This has 6 'dimensions' (mobility, orientation,
occupation, social integration, physical independence and economic self-sufficiency)
on which the instrument generates a profile of handicaps, and an overall handicap
severity score. The definitions for each dimension are generally self-explanatory, but
need some clarification. Mobility is the ability to get from one place to another, using
whatever help, aids or means of transport that are normally available. The
disadvantage associated with being reliant for help on aids or another person for help
is covered under physical independence handicap. Orientation is the ability to
perceive and understand one's immediate environment, including thinking,
perception and communication. Occupation is doing what one wants or needs to do
with one's time, including work, housework and leisure activities. Social integration
describes the ability to maintain relationships with other people in the face of ill
health. Economic self-sufficiency includes both the effects of ill health on the ability
to earn a living and the use of resources to overcome disadvantages associated with
ill health.
A questionnaire has been written based on these dimensions, each of which has six
levels arranged in order of increasing disadvantage (Appendix 17).
83
The questionnaire emphasises what a patient is able to achieve in everyday life in
his normal physical environment, regardless of the help that might be required (eg.
human assistance, aids or adaptations). The scoring system was developed using a
novel marketing research approach called 'conjoint analysis' and has weightings
based on the opinions of a large representative population of healthy people. Once
the classification questionnaire is completed, six numbers (each representing a level
on a dimension) describe each individual. The appropriate score for each level of
each dimension is then applied and entered into the formula:
Handicap score = 50.54mm+ucc+upi+usj+uor+u€ss
where UnnUocUp,,^,,^^^^ are the scores of the appropriate level of each dimension
given in the scale weighs table (Appendix 18) and 50.5 is a constant. This results in a
score between 0 and 100, with 100 representing no disadvantage and 0 the maximum
possible disadvantage.
2.4.4 (ii) Handicap Questionnaire
The Handicap Questionnaire (Appendix 19) provides a quick and useful qualitative
insight into the social consequences of having tremor. It was devised by Bain and
Findley (Bain and Findley 1993) and used in a study evaluating tremor in patients
with essential tremor (Bain et al. 1994).
The patients were asked to answer the questions by putting a circle around the
appropriate letter and scored 1 for answering yes and 0 for answering no. This
resulted in a total score out of 9. The higher the score the greater the level of
handicap.
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Justification for these methods
The development of a useful handicap scale has met with mixed success. The
number of handicap scales appearing in the past few years has increased
significantly. Some of these are listed and discussed in the article by Harwood et al
(Harwood et al. 1994b). A handicap scale was included in the Minimal Record for
Multiple Sclerosis (Kurtzke 1981; Thompson et al. 1990). It was called the
Environmental Status Scale (ESS) and was intended to assess handicap more
specifically by grading a person with MS in terms of their work, financial situation,
home transportation, community assistance and social activity. However the
Environmental Status Scale has not gained wide acceptance in MS research.
Although many patient based QOL questionnaires had been developed over the last
decade, only one, the Disability Impact Profile (DIP) specifically addressed MS. The
DIP (Lankhorst et al. 1996) is a self administered questionnaire concerning 39
abilities/activities with parallel questions about (dis)abilities and their importance or
impact on the patient. Its use provides a profile of weighted scores measuring quality
of life (with a maximum QOL of 1.0 and a minimum QOL of 0.1). In this way
disability assessment is supplemented with information about subjective perception.
The reliability, validity and sensitivity of the DIP has recently been assessed. A study
involving 43 patients with MS in Denmark (Jonsson et al. 1996) evaluated the DIP as
a measure ofQOL and as a measure of outcome. The authors concluded that the DIP
seemed to be a promising instrument which may help to focus efforts on the
rehabilitation of patients with disabilities with a high impact on QOL. However, they
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also reported that some patients complained that the DIP was difficult and time
consuming to complete. It was therefore decided that it would not be suitable for use
in this study.
The Functional Assessment ofMultiple Sclerosis Quality of Life Instrument (FAMS)
(Cella et al. 1996) and The Multiple Sclerosis Quality of Life Instrument (MSQOL-
54) (Vickrey et al. 1995) have recently been developed as MS-specific QOL
instruments. The FAMS was developed as an extension to the Functional Assessment
of Cancer Therapy Instrument so that many of the items are not disease specific,
though those that are were generated via patients, providers and a literature review.
The MSQOL-54 comprises the short form 36-item health survey questionnaire and
18 additional items that are condition specific. The authors provide evidence of the
reliability and validity of both measures though no evidence of responsiveness is
given. Results of studies reporting the use of these scales were only evident at the
time or shortly after this study commenced and therefore they had not been widely
used. Also both are lengthy questionnaires involving 44 and 54 items respectively
and they would therefore not have been suitable.
More research is needed to develop clinically useful, valid measures of handicap
specific to patients with MS as none exists at present. The London Handicap Scale
which, although not specific for MS, seemed to have many of the criteria required to
be a useful measuring tool for handicap associated with MS and was therefore
chosen for use in his study. It has been carefully formulated to be quick and easy to
complete by the patient or carer or both. It requires a choice of one of six levels for
six parameters of handicap. It has been used in many studies and has undergone
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rigorous evaluation of its psychometric properties. The Handicap Questionnaire
was also used as it was quick and easy to complete and gave some insight into the
social consequences of living with a severe disorder ofmovement.
2.5 Measurement of MDMS - Methods for Assessing Aspects of
QOL Relevant to this Study
2.5.1 (i) Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (Zigmund and Snaith 1983) (HAD) was
designed for use in non-psychiatric hospital departments to screen for anxiety and
depression. The questionnaire includes fourteen items which most accurately reflect
the person's own feelings in the week prior to assessment. Each response is allocated
a score from 0 to 3 using a score sheet (Appendix 20) and separate totals are obtained
for anxiety and depression. The HAD indicates the probability of a patient having a
mood disorder: a score of between 0 and 7 indicates that there is probably no
evidence of mood disorder; between 8 and 10 is a borderline area suggesting that
mood disturbances might be present; a score of higher than 11 indicates the probable
presence of mood disorder. The highest possible score for anxiety or depression is
21.
Justification for use ofthe HAD
MS is the leading cause of disability in young and middle aged adults and is not
surprisingly known to be associated with a high risk of depression. Depressive
symptoms of sufficient severity and duration to warrant a diagnosis of major
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depression affect up to half of patients during the course of their illness (Sadovnik
et al. 1996). The prevalence of depression in MS exceeds that reported for other
neurological disorders (Schiffer and Babigian 1984). Depression in multiple sclerosis
has a complex multifactorial pathogenesis. Evidence has emerged that increased
social stresses and inadequate family and community supports are important
(Feinstein et al. 1992). It is currently unclear how much of what is called mental or
emotional change in MS is due to organic changes in the brain and how much is due
to the patient's response to the disease (Matson and Brooks 1977). The past decade
has undoubtedly brought a greater awareness of the behavioural sequelae ofmultiple
sclerosis. However, owing to the problems already highlighted with the continuing
use of the EDSS to assess patients with MS and the fact that it affords little weight to
psychopathology, the risk remains that depression is often not properly assessed.
It was important to try to gain some insight into the emotions of patients undergoing
thalamic DBS for DMMS as it seemed reasonable to expect a decrease in anxiety and
depression in patients if the outcome of the operation was favourable.
There was an assortment ofmeasures that could have been used to screen for a mood
disorder including a variety of observer and self-rating scales. Observer checklists
were considered to be inappropriate, as they usually require familiarity with the
patient's behaviour over a wide range of everyday activities. Patient contact was
relatively limited in this capacity as the emphasis at assessments was on measuring
of severity of tremor and upper limb function. A self rating scale such as the HAD
was ideal for the purposes of this study because the patients were sent the
questionnaires which they completed at home and then brought with them to the
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hospital on the day of their formal assessments. The evaluation ofmood took place
before the operation and then again 12 months after it.
2.5.1 (ii) Neuropsychological Assessment
A brief validated neuropsychological screening and monitoring test in routine use in
the Department of Clinical Neurosciences (Taylor 1997) was slightly modified to be
suitable for use in patients with severe tremor. The original collection incorporates
the Mini-Mental State Examination (Folstein et al. 1975) , almost all of the tests
recommended by the Medical Research Council Workshop Steering Committee
(Medical Research Council Alzheimer's Disease Workshop Steering Committee
1989) concerning Alzheimer's Disease (two questions from the latter concerning
people famous in the past having been replaced), and various other tests found useful
in neuropsychological practice (Taylor 1997). The original form of the test collection
required the person to:
• answer orientation questions concerning time, place, person, and current affairs
• repeat three words
• subtract 7s serially from 100
• recall the three words given
• repeat a name and address
• recall contents of last meal, a recent news item, name of last school attended,
name of any teacher there
• spell 'world' forwards and backwards
• recall the given name and address
• copy a figure (overlapping pentagons)
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• write a sentence
• recall (i.e. draw from memory) the figure
• complete a paper-and-pencil maze, and then a similar choice-free maze if
necessary
• draw a clock face
• attempt the Weigl sorting test (Weigl 1941)
• name or identify colours and shapes
• carry out five spoken verbal commands of variable length and complexity
• carry out then read aloud two written verbal commands printed on cards
• repeat the phrase 'No ifs ands or buts'
• pretend to wave goodbye, and brush teeth
• name or identify five body parts and five objects
• identify three objects photographed from unusual angles
• produce names of animals for one minute
• produce words beginning with the letter F for one minute
• say how three pairs of items are similar (from (Wechsler 1981))
• attempt four cognitive estimation items (from (Shallice and Evans 1978))
• recall the three words given earlier, the given name and address and the given
figure.
This original collection, with appropriate weighting of scores such that different
aspects ofmental functioning are substantially represented in the total score, yielded
a total score out of 210. It has been shown to be sensitive to the presence of brain
dysfunction of various types and in various locations (including subcortical), to be
reliable, to be sensitive to change over time, and to significantly relate performance
y\j
on other neuropsychological tests and to ratings of everyday mental functioning
made by neurological and neurosurgical patients themselves and ratings made by
their relatives or carers.
In the present study, minor modifications to normal materials or procedures were
made in the mazes and Weigl tests to allow for tremor. Drawing a clock face and
writing were often omitted because of severity of tremor. Copying a design and
drawing it from memory were replaced by simple multiple-choice perceptual and
recollective versions of these tasks. For purposes of analysis, scores in the omitted
tests were omitted for all patients (even for individuals who could make a valid
attempt at one or more of those tests), and each patient was consequently assigned a
score out of 174. The majority of patients (i.e. those with adequate visual acuity) also
completed a short yes-no face recognition test (in routine use in this department)
comprising presentation of ten target faces amongst ten filler items followed by
recognition testing of the ten targets presented amongst another ten fillers. The
pattern of results in this group of patients was essentially the same whether or not the
score from the face recognition test was included (by adding it to the total as
described above), so data from this test will not be considered further here.
Most patients who had stimulator implantation completed the test collection at
varying intervals before surgery and approximately four weeks after it. Most patients
who did not proceed to stimulator implantation completed the test collection once
only, during the initial study assessment period. All testing was carried out by one
experienced clinical neuropsychologist.
91
Justification of the methods used
It is now recognized that cognitive dysfunction is a common symptom in MS
occurring in between 43 and 65 percent of patients (Beatty 1993; Rao 1986). The
cognitive impairment may be subtle and simple bedside tests of higher mental
function commonly used to screen for dementia are not sufficiently sensitive for the
purpose although they contain more detail than the assessment of mental state
included in the EDSS.
Various very brief indices of cognitive impairment have been developed, primarily
for use by non-psychologists, most of which only take a few minutes to administer.
Traditional screening tests like the Mini-Mental State examination (MMS) (Folstein
et al 1975) which are useful in assessing 'cortical' dementia like Alzheimer's
disease, have proved to be relatively insensitive to the cognitive deficits of MS
(Beatty and Goodkin 1990). This is not surprising since MS does not produce gross
language disturbance or a dense amnesia as would be observed in a cortical
dementia. Instead MS results in a failure of retrieval (rather than a problem with
storage) and impaired performance on measures of abstract reasoning, sustained
attention, speed of information processing, visuospatial skills and verbal fluency
(Peyser et al. 1990).
Cognitive deficits have not been identified in any of the studies of thalamic DBS
reported in the literature to date. However, in the review by Haddow et al (Haddow
et al. 1997) transient confusion or other psychic symptoms were recorded in 6.7% of
patients with MS undergoing stereotactic thalamotomy for tremor. The psychic
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symptoms were not permanent in any of these cases. There was therefore a need in
this study for a moderately brief cognitive screening test that could not only
discriminate cognitively impaired from cognitively intact patients but also detect any
changes in mental functioning in the patients undergoing stereotactic surgery. It was
essential that the test did not require the large investment of time inherent in a
detailed neuropsychological assessment, but that it should provide broader or better
information than was given by brief screening tests currently available. The brief
neuropsychological assessment was found to be practical, informative and sensitive
to change in the cases of patients undergoing stereotactic surgery.
2.5.1 (iii) Fatigue Severity Scale
The Fatigue Severity Scale (FSS) (Krupp et al. 1989) was originally designed to
measure fatigue experienced by people with MS. It is a list of nine statements
designed to assess perceived fatigue (Appendix 21). Each statement (eg. 'I am easily
tired') is rated on a scale of 1 (strong disagreement) to 7 (strong agreement). The
individual's score is the mean of the numerical responses to the nine statements.
Krupp and colleagues found that healthy adults scored 3.3 ± 0.7.
The FSS has been found to identify successfully features of fatigue specific to the
medically ill and to distinguish between normal cohorts and patients with fatigue
related to MS. The FSS has been shown to have internal consistency, reliability,
stability over time, and sensitivity to clinically significant change (Krupp et al.
1989). .
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Justification for use ofthe FSS
Fatigue is a common complaint reported by many people with multiple sclerosis. In
fact, studies by Kraft (Kraft et al. 1986) and Layward (Layward et al. 1989) have
shown fatigue to be the most common symptom. Fatigue is not only frequent but also
appears in most patients. It has been estimated that 78% to 89% of patients with MS
experience symptoms of fatigue (Krupp et al. 1988) yet it is surprising that Kurtzke
does not include this symptom in the eight functional systems of his scale (Kurtzke
1983). Fatigue is not necessarily a permanent symptom of MS. It may vary not only
daily but hourly as well. In clinical practice it is customary to find patients with
significant fatigue, which may be severe enough to cause disability (Monks 1989).
Several trials have been performed to evaluate fatigue in multiple sclerosis. Different
authors have used visual scales (Weinshenker 1992) and subjective scales (Van
Diemen 1999) (Desrouleux and Weinreb 1999) to evaluate fatigue in therapeutic
trials but the most extensively used scale, has been the Fatigue Severity Scale (FSS),
which was proposed in 1989 by Krupp (Krupp et al. 1989) . Recently however, a
new scale, the Fatigue Descripive Scale (FDS) (Iriarte and de Castro 1994) has been
proposed which has been designed specifically to measure the severity, and to define
some characteristics ofMS fatigue. It enables the clinician to find out if the fatigue is
important enough for the patient to manifest it openly, how it shows up, how often it
happens and what limitations the fatigue produces. The FDS may thus have proved
useful for the purpose of evaluating the different characteristics of fatigue.
Measuring fatigue as a single number as with the FSS provides some information but
is not really enough to indicate how the fatigue really affects the patient; nor does the
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number itself give a clear idea about how severe or frequent the fatigue is. The
FDS appears to address these factors but unfortunately it was first published in 1994
and therefore was still undergoing preliminary evaluation at the start of this study. It
has since been validated and used in several published studies by its authors
(deCastro et al. 1995; Iriarte et al. 1996).
Reducing fatigue may be an objective of treatment of thalamic DBS in MS patients
with severe disorders of movement. In patients with large amplitude and more
complex tremor, it appears reasonable to adopt a limited objective which can consist
of reducing the state of fatigue induced by tremor and restoring minimum use of the
upper limb (Nguyen et al. 1996).
Geny (Geny et al. 1996) found in his study that almost all patients claimed that the
fatigue they experienced while performing some activities of daily living decreased
in relation to relief of tremor although fatigue was not measured specifically. It was
therefore important to measure the severity of fatigue in this present study and the
FSS was used for this purpose.
2.5.1 (iv) Assessment of patients' opinions of the operation
The patients were asked to give their opinion of how they felt about the operation at
the 12 month post-operative evaluation (Appendix 22). They were given the choices
of feeling enthusiastic, satisfied, moderately positive or negative about the outcome
of the operation and asked to circle one of the words.
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Justification for the methods
It was vital to include the patients'assessment of the result of the operations as not
only has research shown that professionals are relatively poor judges of both the
degree of disability experienced by patients and the impact that this has on their lives
but Bond and Thomas (Bond and Thomas 1991) have also shown that an outcome
perceived as positive by staff, may not be perceived as such by a patient. A self-
assessment form was therefore used which had been previously in a study evaluating
stereotactic thalamtomy for the relief of intention tremor in MS (Speelman and Van
Manen 1984). This was completed by the patients at the twelve month assessment.
2.6 Summary
Validated scales existed for measuring disability, handicap and QOL in patients with
MS. The influence ofMDMS on these dimensions was important to address as there
was a dearth of information in these areas.
There was no validated scale available however for measuring MDMS. The lack of
such a scale presented a major problem for this study as, in order to clinically
evaluate the effect of thalamic DBS, a scale was required for measuring MDMS that
had known validity, reliability and responsiveness. Therefore one of the most
important aims at the beginning of the study was to develop and validate a scale for
measuring MDMS for the purposes of assessing and objectively measuring
movement disorders in patients with MS who were referred for (potential) therapy
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using thalamic DBS. The next two chapters of this thesis respectively discuss the




DEVELOPMENT OF TESTS TO MEASURE
MOVEMENT DISORDERS IN MS
3.1 Development of a Tremor-Rating Scale for the Study
Fahn's Tremor-Rating Scale was chosen for use in the present study. The strengths,
weaknesses and justification for using the scale will be discussed. The methods used
were a modification of the existing methods originally described by Fahn (Fahn et al.
1988) and details are given of the modifications that were made.
3.1.1 Strengths, weaknesses and justification for the use of FTRS
Fahn's Tremor Rating Scale was designed for use predominately with patients with
Parkinson's disease rather than with MS patients specifically. Consequently there
were several limiting factors that needed to be addressed before it could be used with
a cohort ofMS patients.
Tremor is the only presenting symptom in patients with essential tremor. FTRS is
appropriate for use with these patients since there is no need to follow the
progression of other symptoms of the disease. This is not the case in Parkinson's
disease or MS where the patients present with other neurological symptoms. FTRS
has been used in studies with Parkinson's patients but its use was supplemented b.y
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use of the Unified Parkinson's Disease Rating Scale (Lang and Fahn 1989) to
follow symptoms other than tremor, relating to the disease. MS is a diffuse disease
often affecting many areas of the CNS and therefore causing other symptoms to arise
apart from tremor. Therefore, in order to assess the full extent of the disease a
complete neurological assessment was also required.
Patients with MS frequently present with a cerebellar syndrome, which usually
affects the proximal, more than the distal muscles. The head and trunk may also be
involved. It is therefore important to distinguish between the severity of tremor in the
proximal and distal muscle groups. Although in the original article, Fahn assessed
these postural muscle groups separately, he scored them together. He did not attempt
to separate goal-related movements from action/intention movements. It would
appear that it is important to do this as the kinetic tremor seen in patients with MS
persists or worsens with goal directed movement (Hallet 1986).
The controversy over this issue has already been raised in Chapter 1, and for the
purposes of this study it was decided that action (which was termed 'kinetic' in this
study, in keeping with the TRIG classification (Findley and Roller 1995)) and
intention tremor should be assessed and scored as one. However goal related tremor
is tremor that occurs to any significant extent during the performance of a task and in
MS patients should be considered separately from action/intention tremor.
Standard sets of conditions and definitions for tremor and its severity are provided to
help to ensure consistency not only between assessments by the same examiner on
different occasions but also among different examiners. The emphasis tends to be on
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assessing the upper limbs presumably because patients with Parkinson's disease
and essential tremor do not generally present with movement disorders affecting the
trunk. There are therefore only minimal instructions for assessing the head and trunk.
Patients with MS often have severe problems owing to titubation of the head and
truncal ataxia which results in truncal instability and the inability to sit unsupported.
It was therefore felt that these guidelines were not explicit enough for use in this
study.
Basing the severity of scoring the tremor on the size of its amplitude as specified by
Fahn had its limitations as the amplitude ranged from zero to only two centimetres.
The tremor commonly seen in MS patients tends to have large amplitude flailing
movements and the magnitude of tremor amplitude offered by the scale was going to
be inadequate to measure the tremor in MS patients.
Certain parts of the scale such as the inclusion of the assessment of tremor of the face
or tongue were not appropriate as movement disorders affecting these areas of the
body are generally not problematic in patients with MS.
There was a large emphasis on writing tasks in the original scale that included
handwriting, line drawing tests and drawing of spirals. Holding and using a pen may
be difficult for many patients with MS as a result not only of tremor but also owing
to other limiting factors such as sensory impairment, muscle weakness and abnormal
muscle tone. Fatigue was also a major physical handicap in many of these patients
with severe movement disorders. It was therefore apparent after trying out these tasks
included in Fahn's TRS with some patients with MS that it was going to be
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impossible to incorporate all of these tasks because of the severity of disability of
the patient group. Fahn et al standardized the test procedure to make the tests more
sensitive by stating that the patient should not rest the drawing hand or forearm on
the table. Attempting to apply this operational definition to patients with MS made
the tasks too difficult and in many cases impossible. Therefore the operational
definition for the drawing tasks required some modification.
The definitions provided for scoring functional disability (Part C) were found to be
misleading for many patients. Many patients with MS have speech difficulties that
are not due to tremor, but to the inability to co-ordinate the muscles required for
fluent speech resulting in dysarthria. Patients adopt a characteristic monotonous tone
with unnatural separation of syllables often referred to as scanning speech. Therefore
it was appropriate to assess whether or not the patient presented with a speech
problem particularly as dysarthria could present as a side effect of the operation.
However the words used to describe the severity of any speech difficulties required
that 'voice tremor' be replaced by 'dysarthria'.
In the statements relating to upper limb function the authors have not considered
hand dominance nor have they specified which hand is being assessed with regard to
the unilateral activities. It is also not clear whether the patient is being asked about
his ability to function specifically with his affected hand or whether he is being asked
about his overall ability to perform the tasks regardless ofwhich hand he uses.
Patients with the use of one arm only, which may or may not be the dominant arm
can learn to feed and care for themselves by learning new tasks. It may therefore
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have been more straightforward to assess the upper extremities separately when
evaluating the use of the hands for feeding and drinking. The statements provided to
score feeding are confusing: one statement suggests the use of one arm only, to bring
food to the mouth using a feeding implement; and another statement suggests the use
of two arms to cut food using a knife (as we assume a fork is used in the other hand
to fix the food that is being cut). Also when assessing the ability to dress the authors
include items such as doing up buttons which could be unilateral if the patient adopts
a compensatory strategy, with activities which are not possible without the use of
both arms, such as tying shoe laces. This is confusing for both the researcher and the
patient.
For the purpose of this study and to avoid any confusion we assumed it was the
target arm (i.e. the arm contralateral to the side of thalamic stimulation which the
DBS was aimed at improving) that was being assessed. Many patients have unilateral
movement disorders and are therefore still able to function independently with the
non-affected hand although bilateral activities will not be possible. The inability to
write legibly will depend on whether or not the movement disorder affects the
dominant limb but the statement which evaluates writing ability does not refer to
hand dominance. We can only assume that the statement is referring to the ability to
write with the dominant hand, which may or may not be disabled by tremor. Despite
these weaknesses it was decided to include Part C in the study as it was believed that
the outcome in terms of function and the ability to perform activities of daily living
is, in a patient's view, more important than reduction or elimination of a symptom
such as tremor.
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Quantifying functional aspects as in FTRS enables a judgement to be made on
the change in functional disability. However the functional activities assessed in
FTRS were limited predominately to upper limb function. Patients with MS often
have diffuse CNS involvement and therefore scales concerning functional disability
should not only assess the specific symptom-orientated improvement of abilities but
should also measure the general clinical condition of the patient. Therefore, further
evaluation of self care ability (using the self care section of the FIM) and the
patients' overall level of ability in performing more general ADL (using the BI) were
also established as described elsewhere.
In the original description of the scale the authors recommended that the sub-total
scores of Part A, B and C were calculated and then totalled. However, by
amalgamating the scores, valuable information about the natural histories and
differential behaviour of the components of tremor seen in different parts of the body
may be lost. It was therefore decided for this study not to calculate one total score but
to calculate total scores for the tremor components (rest, postural, action/intention
and goal-related) of each of the body areas.
The scoring form allows assessment of overall severity of tremor-related disability
by both the examiner and patient. Attempting to separate the disability caused by
tremor from disability caused by other associated impairments such as muscle
weakness, spasms, spasticity or sensory loss in patients with profound disability due
to advanced MS has its difficulties. Despite this, patients were requested to complete
this section at every follow-up visit, and make a subjective judgement of the impact
the disorder ofmovement had on their ability to carry out activities of daily living.
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It was anticipated that the subjective self evaluation (at the end of the FTRS
form) as to the effectiveness of the intervention made by the patients at every post¬
operative evaluation would be very useful to monitor the patients' opinion of the
effectiveness of thalamic DBS on reducing the severity of tremor over the long term.
The patients were asked to make a comparison assessment by scoring their subjective
assessment of their current status compared to their last visit. Another advantage of
the scale was that it allowed for the patients to carry out a subjective self-evaluation
as to the effectiveness of the intervention by asking them to score a comparison
assessment at each follow-up assessment (See Appendix 2).
Traditionally, outcome in studies evaluating the effect of surgery for movement
disorders in MS has been assessed on clinician-based measures that focus largely on
impairment. Recently, there has been greater recognition of the relevance of patients'
own perceptions of tremor on their lives (Sandell et al. 1999; Sandell and Thompson
1999). However there is a dearth of information in this area and on the patients'
perceptions of changed ability and subjective satisfaction of the outcome after
surgery. It was therefore important to address this issue and on initial evaluation it
appeared that the FTRS would allow a comparison of the alleviation of the
movement disorder to be made between visits, before and after surgery, as well as
being useful for determining the effectiveness of thalamic DBS on reducing the
severity of tremor.
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3.1.2 Modifications made to FTRS for this study
It was necessary to make some minor modifications to the original FTRS for the
purposes of this study. The modifications were made to Parts A, B and C of Fahn's
TRS and are outlined below. The subjective global assessment and patient's opinion
remained as described by Fahn.
3.1.2 (i) Changes to the form
Part A: Some minor modifications and omissions were necessary to the FTRS from
its original description in 1988, for its use in the present study with patients with MS.
The face, tongue, voice and lower limb tremor were omitted resulting in the
assessment of only 4 areas of the body (head, trunk, right upper limb and left upper
limb).
Severity of tremor in each of these areas was rated by amplitude but the definitions
of the size of the amplitude were modified base on those suggested by Geny (Geny et
al. 1996) who devised their tremor amplitude definitions specifically for patients
with MDMS: 0 = no tremor; 1 = slight tremor, barely perceivable, maximal
amplitude < 1cm, may be intermittent; 2 = moderate tremor, amplitude 1 - 5cm, may
be intermittent; 3 = marked tremor, amplitude 5-10 cm; 4 = severe tremor,
amplitude > 10cm.
The definitions describing postural tremor of the upper limbs were expanded so that
the postural tremor elicited with the arms maintained in an extended and a flexed
position was assessed in an attempt to separate distal muscles from proximal
muscles. Goal-related tremor was assessed separately rather than being grouped with
105
action/intention tremor. The examiner made a judgement of the severity of goal
related tremor after observing the patient perform the seven sub-tests of the Jebsen
Test of Hand function (JTHF) (see later in this chapter for a description of the
JTHF).
Part B: No changes were made to the wording but a line drawing and a writing task
were omitted.
Part C: It was made clear on the form that Part C is an evaluation by the patient of
his ability to carry out the tasks with the target arm or both (if a bilateral activity).
The form was changed with regard to the evaluation of speech, the wording being
altered so that voice tremor was replaced by dysarthria. Also the examiner was
instructed to complete this section only after referring to the guidelines which gave
an explicit explanation of how to complete this section.
3.1.2 (ii) The Modified Fahns Tremor-Rating Scale (MFTRS)
The modifications made to the original FTRS resulted in a modified version that was
referred to as the Modified Fahn's Tremor Rating Scale (MFTRS) and is described in
summary below (see appendix 4 for sample form for MFTRS).
Part A of the MFTRS included subjective rating of the severity of tremor for the
head, trunk, right upper extremity and left upper extremity for (i) rest tremor, (ii)
postural tremor elicited with the arms maintained in an extended position and a
flexed position, (iii) action/intention tremor and (iv) goal-related tremor. In total this
part of the assessment required 18 separate scores (see Table 4-1 of reliability study
of MFTRS). For each of these sub-tests or observations the movement disorder was
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defined as: 0 = none; 1 = slight, maximal amplitude <lcm; 2 = moderate,
amplitude 1 - 5cm; 3 = marked, amplitude 5-10 cm; 4 = severe, amplitude > 10cm.
Part B of the Modified FTRS included subjective rating of all the tasks described by
the authors, performed with each hand omitting line drawings and hand writing for
the reasons described in the sub-section on justification of the methods. These tasks
therefore included drawing of Archimedes' spirals (spirography) and pouring water
from one cup to another (volumetric test). This part of the MFTRS involved
assessment of 6 separate tasks (see Table 4-1).
Part C of the MFTRS assesses functional disability. Its items evaluate the severity of
tremor with speaking, eating (feeding), bringing liquids to the mouth, hygienic care,
dressing, writing and working including domestic tasks such as homemaking. These
scores, with the exception of speaking, are provided by the patients who are asked to
evaluate by using the definitions provided below their ability to carry out these tasks
using the target arm or both (if a bilateral activity). This part of the FTRS assesses
disability in seven aspects of function.
3.1.2 (iii) Revised guidelines
The guidelines although based on those by Fahn et al, were expanded. Revised
guidelines with explicit operational definitions were set out clarifying how to assess
each of the different components of tremor in each of the different areas of the body
and the upper limb tasks in a standardized manner to ensure consistency among
assessments (See guidelines for completing MFTRS - Appendix 5). Minor
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modifications were made to the operational definition for the upper limb tasks in
that the patients were permitted to rest their arm on the table whilst performing the
tests.
3.1.2 (iv) Revised definitions
The definitions for scoring severity of tremor in Part A were modified (see
Definitions for Rating Tremor Severity using the MFTRS - Appendix 6) and set out
clearly on a separate sheet along with the definitions assessing functional disability
(Part C). A paragraph was added to clarify the role of unilateral activities in Part C in
assessing the function of the target extremity, and bilateral activities in assessment of
the functioning of both upper limbs.
3.1.2 (v) Revised scoring system
It was decided that calculating the total score would lose valuable information
relating to tremor in different areas of the body. Therefore for the purposes of this
study it was decided not to calculate one overall total score but to calculate total
scores for each of the body areas in Part A. The scores for the different components
of tremor in each area of the body were amalgamated. This had an advantage that it
allowed a specific evaluation to be made of the target upper limb, which was
important for the purpose of this study. Subtotal scores for Parts A (the target upper
limb only), B and C were then calculated. Patients with severe movement disorders
could potentially score a maximum of 20 for Part A, 12 for Part B and 28 for Part C
giving a total possible score of 60 for the upper limb. The percentage severity for the
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upper limb was also calculated by expressing the patient's score as a percentage
(see Appendix 5 for guidelines on the scoring system).
3.2 Development of a Test of Upper Limb Function for this
Study
The JTHF was chosen to measure specific upper limb function in the present study.
3.2.1 Strengths and weaknesses of the JTHF as it related to this study
The JTHF was easy to set up and relatively portable; the equipment needed was
readily available at little cost; and the reliability of the JTHF had been established
with neurological patients although patients with MDMS were not included in the
group.
The only item that needed to be constructed was the test board that was of a simple
design. It consisted of a wooden board with a centre ledge made out of a piece of
plywood. The centre ledge was offset to the right of the board to allow it to be placed
on a 'secretary type desk with a right knee hole'. This presented two minor problems.
One was that the wooden ledge did not allow video recording of the patient
performing the task as it was necessary to set the video camera up so that it was
facing the patient to enable the movement disorder to be seen to its best advantage.
When trying out the JTHF with MS patients with severe movement disorders several
points became apparent. Movements of the patients' limbs were often wild and
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flailing and it was felt that it would be necessary to fix the board securely to the
table. Many of the patients had truncal ataxia with poor trunk control. To overcome
this problem it was often necessary to adapt the sitting posture in the wheelchair of
many severely ataxic patients. This might involve reclining the back of the
wheelchair, using wedge cushions and extending the arm supports to enable the
person to be positioned safely in sitting and to be moved from place to place. As a
result of these adaptations it was not always possible to position a patient close to the
table to enable them to perform the test. Consequently with these patients there was
no option but to attempt to perform the functional activities comprising the test from
this disadvantageous position. In this situation it was important to position the
wheelchair as close to the table as possible. If this was not successful the only other
option was to use an electric plinth which could be elevated to accommodate the
raised arm rests on the wheelchair.
A trial of the sub-tests with MS patients with mild to severe movement disorders
suggested that the JTHF was going to be an appropriate test to use in the study as
even patients with severe tremor were able to complete successfully at least one or
two of the sub-tests (usually card turning and moving the weighted cans). Also hand
function is not an isolated aspect of patient function but is dependent on the proximal
part of the upper extremity to position the hand for function. Lack of proximal
control is often a significant problem with ataxic patients and they often resort to
using a compensatory strategy when attempting to use the arm that involves holding
the limb close to the trunk to obtain a degree of fixation. Some of the sub-tests
allowed this to occur for example stacking the chequers on the board directly in front
110
of them. However, others required that the patient reached the arm away from the
trunk to successfully perform the sub-test (eg. picking up small objects and placing
them into a tin, reaching across the body to lift cans onto the board).
Other factors such as strength, dexterity, sensation, motivation, eyesight, joint
mobility, co-ordination needed to be considered as they could also influence the
patient's functional ability of the upper limbs. The JTHF not only allowed the impact
of the movement disorder on upper limb function to be established but it also
permitted identification of those patients with underlying limb dysfunction due to
motor and sensory impairments.
Some of the patients took a long time to perform the tests or were unable to
successfully complete the subtests. This was a major limitation as the original test
only assessed speed of performance of the successfully completed task. It did not
allow for patients who might not be able to achieve this. It was therefore apparent
that modifications would have to be made to the scoring system of the JTHF for it to
be used in this study.
3.2.2 Modifications made to the JTHF for this study
3.2.2 (i) Positioning Of the patient and the test equipment
The patient was seated at a table, preferably a dining table which allowed him to be
pushed in close to the table so that the arms of the wheelchair or chair could fit
underneath the table. If the patient was wheelchair bound and the arms of the
wheelchair did not fit underneath the table the arms were removed for the duration of
the assessment. This however was not always possible especially if the patient had
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loss of trunk control or severe truncal ataxia which made it dangerous to remove
the side supports of the chair. In this situation the chair was pushed as close as
possible to the table or if necessary an electric plinth was used as a table and elevated
to accommodate the arms of the wheelchair. A note highlighting this necessary
modification to the assessment position was made on the assessment sheet to ensure
that exactly the same position was adopted for subsequent assessments.
Standardized positioning of the patient in relation to the table and the board was
important. The subject's midpoint was taken to be his nose and his midline was an
imaginary vertical line through this point The subject was seated with his midline
centred on the board when performing the sub-tests that required the use of the
board. For the other sub-tests the patient's midline was centred on a fixed marker-
point on the table. Markers were fixed to the assessment table to enable the
equipment for each sub-test to be laid out in a standardized manner at every
evaluation. However in the original article these markers were pieces of tape applied
to the edge of the table and it was felt that they therefore did not ensure accurate
placement of the equipment. To reduce any error made by the researcher in setting
out the equipment specific marker points were used signifying the exact position of
the test material on the table. The procedure for setting out the test equipment and the
verbal instructions for all seven subtests were standardized as described by Jebsen et
al (Appendix 8).
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3.2.2 (ii) Modifications to the test equipment
The design of the board was modified (see Appendix 9). The board was constructed
of perspex rather than wood to overcome the problem of being unable to video
record the limb performing the sub-tests The dimensions of the board were also
altered slightly so that the board could be placed on top of an ordinary table rather
than a desk with a kneehole.
Because many patients with MS had poor fine finger function and were unable to
manipulate a ballpoint pen into the correct position so that it was angled to allow it to
write, a rollerball felt pen was provided as patients seemed to find it easier to write
with. The only other modification was that one side of the cards had a cross marked
on them so that there was no doubt as to whether or not the subject had successfully
turned the cards over.
3.2.2 (iii) Instructions for performing the sub-tests
To ensure the accuracy of timing and to establish consistency, general instructions
were given before each evaluation, asking the subject to prepare for the starting
command, to begin immediately, and to work as quickly as possible in a manner in
which he would normally perform the activity. The researcher gave the patient the
instructions and made sure that they were clear by asking the patient if he understood
the instructions. They then instructed the patient to start by saying, "'Ready?" "Go".
To record the time required to complete each activity the researcher manually
activated a stopwatch simultaneously with the "Go" command to the patient and
again at the completion of the task as described by Jebsen (see Appendix 8 for verbal
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instructions given to patients). Two minutes was the maximum time allowed to
perform each subtest.
3.2.2 (iv) Expansion of the scoring system
It was decided to expand the scoring system (as well as a time score for successful
performances) to include a pass or fail score for each subtest. Precise definitions of
what resulted in a subject passing or failing a sub-test had to be defined. Guidelines
for what constituted a pass/fail and how each test was scored are laid out below.
Test l\
Pass: the patient can write or print the sentence. The writing must be legible (ie
someone who does not know what it is supposed to say must be able to read it).
Fail: if the patient tries but is unable to write e.g. if he cannot hold the pen or if the
sentence is illegible.
Test 2
Pass: the patient must turn all cards over. No accuracy of placement is necessary.
Fail: if the patient tries but is unable to pick up the cards, if the patient drops any
cards onto the floor or if he is unable to turn all five cards over.
Test 3
Pass: the patient must be able to pick up all six objects in the correct sequence and
put them into the coffee can. .
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Fail: if the patient tries but is unable to pick up all the objects, if the patient drops
any of the objects onto the floor or if the coffee can is displaced or knocked over.
Test 4
Pass: the patient must use the spoon to pick up all five beans and put them into the
coffee can without knocking it over.
Fail: if the patient tries but is unable to pick up any beans with the spoon, if the
patient drops any beans onto the floor, if he cannot hold the spoon, if he cannot pick
up and place all five beans into the coffee can or if he displaces the coffee can or
knocks it over.
Test 5
Pass: the patient must pick up the chequers (in any order) and stack them one on top
of each other, on the board. He is allowed several attempts, i.e. if he knocks them
over he can try again as long as no counters fall onto the floor.
Fail: if the patient tries but is unable to pick up the checkers, if the patient drops any




Pass: the patient must pick up and place all five empty cans onto the board. If one of
the cans is knocked over and it does not roll off the table he may try picking it up
again.
Fail: If the patient tries but is unable to pick up the cans or if the patient knocks any
cans over and the can rolls onto the floor.
Test 7
Pass: the patient must pick up and place all five heavy cans onto the board. If one of
the cans is knocked over and it does not roll off the table he may try picking it up
again.
Fail: if the patient tries but is unable to pick up the cans or if the patient knocks any
can over and the can rolls onto the floor.
No assistance is to be given to the patient in order to help him perform any of the
tests. If the patient drops an object he may pick it up again, if he is able to, as long as
it does not fall off the table onto the floor. The time that the patient takes and
whether the test is passed or failed is entered on the score sheet (Appendix 10).
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CHAPTER 4
VALIDATION OF THE MODIFIED FAHN'S TREMOR
RATING SCALE
4.1 Examiner Reliability of the Modified Fahn's Tremor
Rating Scale in Patients with Multiple Sclerosis
In order to use the Modified Fahn's Tremor Rating Scale (MFTRS) as a measure of
the severity of tremor amplitude to evaluate the effectiveness of thalamic DBS it was
essential to determine the applicability of the MFTRS in a cohort of patients with
multiple sclerosis. Studies of both the intra-examiner reliability, inter-examiner
reliability and validity of the MFTRS in patients with movement disorders due to
multiple sclerosis were undertaken (Hooper et al. 1998).
4.1.1 Patients
Ten patients who all fulfilled the criteria for definite MS (Poser et al. 1983)
participated in the reliability study. The mean duration of disease was 11 years
(range 6-19 years). There were three males and seven females; with mean age 40
years (range 31 - 56). All were right handed. Seven were wheelchair bound and the
remaining three could walk short distances but had significantly impaired mobility.
All of the patients underwent a full neurological examination from which the
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expanded disability status scale score (Kurtzke 1983) (EDSS) was obtained. The
mean (range) EDSS was 6.5 (4.5 - 8.5). The patients all had severe postural and
intentional tremors.
4.1.2 Methods
Video recordings were made of the patients being assessed according to a
standardized protocol. The video recording included the following components: 1)
'at rest' in supported sitting and/or supine lying; 2) performing specific purposeful
movements such as voluntary movements of the head, drinking from a cup (held by
both the examiner and when possible the patient), maintaining the upper limbs in
certain positions and performing intentional movements and the finger/nose test; 3)
attempting to sit unsupported for 60 seconds; stand unsupported for 10 seconds; and
walk 10 metres; 4) performing spirography described above; 5) performing a
volumetric test (the operational definitions for these tests being described in detail in
Chapter 2 where Part B of FTRS is described); and 6) performing hand writing and
card turning from the Jebsen Test of Hand Function (Jebsen et al. 1969) (JTHF). A
composite and edited video of all 10 patients performing these tasks was compiled
and distributed to each examiner (described below) who used the scale as follows.
The MFTRS comprises three parts, A, B and C as discussed earlier. Part C assesses
functional disability as scored by the patient and consequently is not included in this
reliability study. In total 24 separate scores, 18 for Part A and 6 for Part B were
obtained for each patient (See Table 4-1).
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4.1.3 Assessment of the patients
For the intra-examiner assessment one examiner (JH) rated the 10 patients on each of
the 24 tests on two separate occasions, 3 months apart. For the inter-examiner
assessment eight examiners (3 medical practitioners and 5 physiotherapists) were
approached (Appendix 12) and issued with copies of the scoring guidelines (see
Appendix 5), definitions of tremor severity (Appendix 6), scoring sheets (see
Appendix 13) and instructions for the examiners (see Appendix 14). The examiners
were asked to familiarize themselves with all of these. They were then asked to
watch the videotape of the 10 patients and to rate each patient's tremor on each of the
24 tests.
Six of the examiners worked in clinical neurosciences in different units within
Edinburgh and two of the examiners were Physiotherapy lecturers involved in
teaching neurology at under-graduate and post-graduate level. None of the examiners
had any experience before the study using either the original Fahn's Tremor Rating
Scale or the modified version that was being evaluated. All ratings were performed
independently.
4.1.4 Statistical analysis
Non-parametric statistics were used throughout. Intra-examiner reliability (somewhat
analogous to test-retest reliability) data were analysed using Spearman correlations
and Wilcoxon matched-pairs signed rank tests. Data on inter-examiner reliability
were analysed using Kendall's Coefficient of Concordance (from which average
119
inter-examiner Spearman correlations can be derived) and Friedman Analysis of
Variance. Statistical calculations were performed using SPSS for Windows.
4.1.5 Results
All examiners completed the requisite assessments and did not comment upon any
particular difficulties. Once the examiners had familiarized themselves with the scale
it was found to be easy to use and tremor was rapidly assessable.
4.1.5 (i) Intra-examiner reliability
The intra-examiner reliability coefficients (Spearman correlation coefficients (rs)) are
shown in Table 4-1; and range from 0.85 - 0.97 for the different categories of head
tremor, 0.64 - 0.93 for trunk tremor, 0.92 - 0.99 for the right upper limb tremor, 0.81
- 0.99 for the left upper limb tremor and 0.87 - 1 for the tremor evident when
performing upper limb tasks (spirography and volumetric test). Levels of reliability
were high except when certain categories of tremor in the trunk were assessed
(postural tremor rs = 0.64 and goal related rs = 0.72).
Correlations could not be computed for rest tremor of any of the four body parts
because nearly all patients received identical ratings of 0, indicating that rest tremor
was not present in these patients with MS.
The Wilcoxon matched pairs signed rank tests showed no significant differences (p
values all > 0.05) between the level of ratings of tremor on any of the 24 measures
when rated by the same rater on two different occasions 3 months apart, indicating
that there was no 'drift' to more stringent or more lenient rating (Table 4-1).
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4.1.5 (ii) Inter-examiner reliability
The average value of the Spearman correlations between all possible pairs of
examiners was calculated by Kendall's Coefficient of Concordance to determine the
overall agreement for each measure among the 8 examiners' sets of scores. The inter-
examiner reliability coefficients range from 0.69 - 0.99. The scores for rest tremor,
where nearly all ratings on these measures were zero ranged from 0.01 - 0.28,
confirming the absence of rest tremor in this patient sample.
Friedman Analysis ofVariance was used to establish whether some examiners scored
patients more strictly or more leniently than did other examiners. Results in Table 4-
1 show a number of significant differences in the rating levels (those with p values
<0.05) indicating that although there was good agreement amongst examiners as
regards the ranking of the severity of tremor in different patients, examiners varied in
their interpretation of the severity of tremor required for allocation to given points on
the 0 to 4 scale. Subsequent analysis showed that the two non-medically qualified
academic examiners, who are not in regular clinical practice, tended to rate tremor as
more severe than did the medical staff and the physiotherapists, working in clinical
neuroscience practise within the NHS, who tended to differ little amongst
themselves.
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Table 4-1: Intra-examiner and inter-examiner reliability of the Modified
Fahn 's tremor rating scale
Intra-examiner reliability Inter-examiner reliability
Wilcoxon
average
Warman *Spearman matched pairs Freidman
correlation signed ranks
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l.Rest not computed 1 0.28 0.002
2.Postural 0.92 0.56 0.87 0.004
3.Kinetic/Intention 0.97 0.32 0.82 0.001
4.Goal 0.85 0.41 0.77 0.002
TRUNK TREMOR
5. Rest not computed 1 0.01 0.02
6. Postural 0.64 1 0.84 0.166
7. Kinetic/Intention 0.93 0.16 0.76 0.001
8.Goal 0.72 0.68 0.72 0.008
RIGHT UPPER LIMB
9.Rest not computed 1 0.22 0.001
10. Postural a) 0.99 0.16 0.87 0.009
11.Postural b) 0.99 0.32 0.86 0.489
12. Kinetic/Intention 0.92 1 0.87 0.001
13. goal 0.94 0.16 0.84 0.009
LEFT UPPER LIMB
14. Rest not computed 1 0.19 0.001
15. Postural a) 0.94 1 0.86 0.001
16. Postural b) 0.99 0.32 0.9 0.005
17. Kinetic/Intention 0.93 1 0.73 0.001
18. Goal 0.81 0.66 0.69 0.003
Upper LIMB TASKS
19. Large spiral-right 1 1 0.93 0.005
20. Large spiral-left 0.99 0.32 0.81 0.232
21. Small spiral-right 1 1 0.93 0.292
22. Small spiral-left 0.87 0.16 0.92 0.912
23. Pouring-right 1 1 0.97 0.195
24. Pouring-left 0.99 1 0.99 0.333
* derived from Kendall's coefficient of concordance
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4.2 Validity Of The Modified Fahn's Tremor Rating
Scale
The MFTRS has high face validity. Aspects of its validity were assessed by
calculating the correlation coefficients between the ratings of tremor in the MFTRS,
the spiral tests (large and small), the volumetric test (pouring water) and the total
number of passes on the Jebsen test of hand function using data collected at the pre¬
operative assessment in 32 patients with MS (Table 4-2). Correlations between the
different components of tremor within the MFTRS (excluding rest tremor) ranged
from 0.58 to 0.94 and correlations between the ratings for the different components
of tremor and the number of passes on Jebsen THF ranged from 0.37 to 0.63. The
ratings of the different components of tremor correlated between 0.42 and 0.64 with
performance on large spirals and between 0.43 and 0.88 with performance on the
pouring test. However correlations with the performance on the small spiral drawing
ranged only from 0.30 to 0.51. These correlations provide evidence for the validity of
these tests in the assessment of tremor.
The concurrent validity of the MFTRS was further assessed by calculating the
correlation coefficients between the different component parts of the MFTRS and
measures of impairment, disability and handicap (Table 4-3).
There was moderate to good correlation, ranging from 0.53 to 0.75, between all the
components of the MFTRS (except the large spiral) and the cerebellar functional
system score of the Kurtzke, providing further evidence of validity in that the tremor
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scored by a neurologist on clinical examination correlates with tremor scored on
the MFTRS.
Table 4-2: Correlations (Spearman's rho) between the different ratings of tremor,
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** correlation is significant at the 0.01 level (2-tailed)
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Table 4-3Correlations (Spearman's rho) between the different component parts of
the modified Fahn's TRS and other measures of impairment, disability and
handicap. N ofcases =32
Post a) Post b) Kin/int Goal Total Large Small
JTHF 0.29 -0.13 -0.42 -0.53 -0.80 -0.36 -0.58
LHS 0.27 0.04 -0.10 0.17 0.15 0.35 0.08
FSS -0.48 -0.10 -0.20 0.35 -0.25 0.25 0.36
FIM 0.13 -0.19 -0.24 -0.09 -0.09 0.12 0.13
CBFS 0.12 0.75* 0.71* 0.56 0.56 0.29 0.53
HAD -0.17 0.32 0.02 0.36 0.10 -0.24 0.12
HO 0.21 -0.21 -0.08 0.09 0.03 0.31 0.16
EDSS -0.30 0.12 0.07 0.09 0.04 -0.11 -0.04
♦Correlation is significant at the 0.05 level (2-tailed)
Legend for Tables 4-2 and 4-3: The abbreviations in the first rows of the tables relate to the different
components of tremor of the target arm where: Rest = rest tremor, Post a) = postural tremor when the
arm is maintained in an extended position. Post b) = postural tremor when the arm is held in a flexed
position, kin/int = Kinetic/intention tremor, Goal = goal related tremor, Total = total tremor score for
the upper limb, Large = drawing of large spiral and Small = drawing of a small spiral, Pour water = a
volumetric test involving pouring water from one cup to another.
The abbreviations in the first column of table 4-3 relate to the measures of impairment, disability and
handicap where: JTHF = Jebsen Test of Hand Function, LHS = London Handicap Scale, FSS =
Fatigue Severity Scale, FIM = Functional Independence Measure, CBFS = Cerebellar Functional
System of the Kurtzke Functional Systems Scale, HAD = Hospital Anxiety and Depression Scale, HQ
= Handicap Questionnaire, EDSS = Expanded Disability status Scale.
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CHAPTER 5
DESIGN OF THE STUDY AND ASSESSMENT OF
EFFICACY OF THALAMIC DBS
5.1 Selection of Patients
5.1.1 Referral of patients
Patients "with medically refractory and disabling movement disorders were referred
by their general practitioners or neurologists to the Department of Clinical
Neurosciences (DCN) at the Western General Hospital in Edinburgh for assessment
and inclusion in the study. They were therefore an incidental sample. The
neurologists within Lothian region were aware of this study and were issued with
detailed patient information sheets (Appendix 23) to inform suitable patients about
the study. There was a waiting list of patients with severe movement disorders due to
MS who were prepared to be assessed and to be considered for thalamic DBS, if after
extensive evaluation they were deemed suitable candidates.
5.1.2 Criteria for inclusion
Criteria for inclusion in this study were adult patients :
a) with an established diagnosis of MS (Poser et al. 1983) with a movement disorder
causing significant functional disability
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b) in whom unilateral or bilateral severe tremor of the upper limbs had been
present for at least six months and which was deemed disabling by the patient and
the research team
c) in whom a neurologist had determined that the patient's movement disorder could
not be controlled adequately by medications
d) who were able to give informed consent
e) who were available for appropriate follow-up times throughout the length of the
study.
5.1.3. Criteria for exclusion
Were:
a) severe sensory-motor disability in the tremulous limb
b) major cognitive dysfunction such that QOL was unlikely to be altered by
resolution of the movement disorder.
5.1.4 Aims of surgery in patients selected for the study
Patients with severe upper limb movement disorders that caused a major functional
deficit and in whom it was considered there was potential for improvement were
selected. After the initial assessment of each individual patient the target upper limb
was identified for treatment.
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5.1.5 Initial pre-operative consultation
Most patients were assessed initially in the outpatient clinic by the consultant
neurosurgeon to determine their suitability for the study and the probable target
upper limb. During this initial consultation the history was taken, a 'screening'
neurological examination was performed, the nature and aims of the study outlined,
and the need for more comprehensive clinical assessment emphasized. Some patients
were excluded from further assessment after initial consultation, since their poor
clinical and /or cognitive status precluded the likelihood of any useful amelioration
of the functional condition by thalamic DBS. Those patients considered 'possible'
candidates for the study were later subjected to intensive clinical examination,
neuropsychological assessment and video recording; and confirmation of the target
arm.
5.2 Patient Consent
Patients who met the criteria for admission and were considered appropriate
candidates for DBS after extensive assessments were given a detailed patient
information sheet about the nature of the study (Appendix 23). A standardized
consent form was signed by patients to acknowledge their agreement to participate in
the study (Appendix 24) and for visual records to be taken (Appendix 25) and an
entry form was completed by the neurosurgeon (Appendix 26). Where the movement
disorder precluded signing of the consent form a close relative was asked to sign
instead. The study was approved by the Lothian Health Board Ethics Committee.
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5.3 Design of the Study
The design of the trial was a prospective, same-subject design involving patients with
MS. Each subject served as his or her own control since the thalamic DBS could be
turned on and off. MS subjects were tested extensively preoperatively over a two day
period at the Astley Ainslie Hospital whilst the patients were in-patients in the
neurorehabilitation wards for an overnight stay. This enabled the patient's level of
functional independence to be observed whilst staying on the ward. It also enabled
the patients to relax and have rest periods if required, lying down between the
assessments. This was felt to be important in view of the fact that many of the
patients were easily fatigued.
Where possible an interview was carried out with the patient and his main carer so
that levels of independence in the home environment could be established.
Postoperative evaluations were carried out during day admission to the Astley
Ainslie Hospital so that reassessments could be performed by the researcher in the
morning and by the doctor in the afternoon after the patient had eaten lunch and had
a rest. The post-operative evaluations (apart from the 12 month evaluation) took less
time to complete than the initial pre-operative evaluation as they involved
performing fewer tests (test battery I only- see section 5.4.1 (i)). Only the target arm
was evaluated at one month, three months and six months post-operatively but at
twelve months both the target arm and the other arm were evaluated. Test battery II
(see section 5.4.1 (ii)) was also repeated at this time.
Two identical evaluations (involving completing test battery I twice) were
performed post-operatively on the target arm of each patient, one with the thalamic
stimulator switched on and the other with the thalamic stimulator switched off. The
assessments were carried out in the sequence shown in Figure 5-1; the evaluations
were performed in random order (see randomisation of assessment sheet in Appendix
26) to minimize practice effects and the researcher was blind with respect to the
on/off status of the stimulator (ie. to the order of the assessments). It was not possible
for the patients to be blind to stimulator status as some of them experienced a
'kicking in' effect when their stimulator was turned on.
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A = Fahn's Tremor Rating Scale
B = Jebsen Test ofHand Function
C = sitt/stand/lOm walk
D = Kurtzke EDSS
E = Neuropsychology
F = Functional Independance Measure
G = hospital Anxiety and Depession Scale
H = Handicap Questionnaire
I = London Handicap scale
J = Fatigue severity Scale
Test battery I = A, B, C
Test battery II = F, G, H, I, J
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5.3.1 Procedure for 'blinding' the researcher
Before starting the assessments at each post-operative evaluation the researcher
asked a member of the nursing staff on the ward to help with the study by setting the
stimulator to the mode shown on the Patient Assessment Randomization Sheet
(Appendix 27). These sheets were compiled by the statistician in the Department of
Clinical Neurosciences and given to the researcher in a sealed envelope.
First, the researcher demonstrated to the nurse how to turn the stimulator on and off
using the programming console. The nurse then followed written instructions (see
Appendix 28) to put the stimulator into the correct mode for the first assessment This
was done once the researcher had left the room to ensure that she was not aware of
*
whether the thalamic DBS had been switched on or off. The first assessment was
then carried out and the nurse was then asked to follow the instructions written on the
randomization sheet for the second assessment and change the setting of the
stimulator accordingly. Once again the researcher left the room while this took place.
5.4 The Clinical Evaluations
5.4.1 Tests comprising the test series
The complete series of tests comprised test battery I, test battery II, scoring of the
Kurtzke EDSS and a neuropsychological assessment. The various scales and tests
which compiled the test batteries have already been listed in this chapter and were
described earlier in Chapter 2.
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5.4.1 (i) Test Battery I
Test battery I comprised the primary outcome measures for the study. The
assessments in test battery I covered three main areas:
1. Assessment of the disorder of movement (tremor/ataxia) using the Modified
Fahn's Tremor Rating Scale.
2. Assessment of upper limb function using the Jebsen Test ofHand Function
3. Assessment of truncal and lower limb involvement using protocols for sitting,
standing and walking 10 metres.
Test battery I was carried out at every evaluation during the study.
5.4.1 (ii) Test Battery II
Additional information, comprising Test battery II was also collected at two time
intervals during the study, at the pre-operative evaluation and again at 12 months
after operation. Test battery II comprised of subjective scales. The self-care section
of the Functional Independence Measure (FIM) was completed by the researcher.
The other scales, the London Handicap Scale, the Hospital Anxiety and Depression
Scale, the Fatigue Severity Scale, the Handicap Questionnaire and the assessment of
the patient's opinion of the operation were all completed on the basis of the patient's
own report.
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5.4.1 (iii) Neurological Assessment
A member of the medical team also completed a full neurological assessment at the
preoperative assessment and at the 12 month assessment and the Kurtzke EDDS was
subsequently scored for each assessment.
5.4.1 (iv) Neuropsychological Assessment
The neuropsychologist in the Department of Clinical Neurosciences performed a
brief neuropsychological assessment preoperatively and again at one month after
operation.
5.4.2 Sequence of the performance of the tests
The tests were always performed in the sequence shown in figure 5-2.
Fig 5-2: The sequence of the performance of the tests
First Dav- TEST BATTERY T
Assessor rated the patient's:
1. tremor - using the modified Fahn's Tremor Rating Scale
2. drawing of spirals
3. pouring ofwater from a cup
4. sitting for 1 minute
5. standing for 10 seconds
6. walking 10 metres
Patient was given a 15 minute rest
Assessor scored and timed the patient performing:
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7. subtests of the Jebsen Test ofHand Function
(The above assessments were performed first with the probable target arm and then
with the other arm)
Patient was asked to :
9. score the ADL questions in the modified Fahn's TRS.
Assessor and patient:
10. provided an overall, complete rating of the effect of tremor on disability
End of researcher's evaluation. Patient was given lunch and time to rest
Neurologist carried out a full Neurological Assessment (to include Kurtzke's
EDSS).
Second Day- TEST RA TTFR V IT
Assessor scored the patient's level of functional ability using:
1. the Functional Independence Measure
Patient completed the:
2. London Handicap Scale
3. Hospital Anxiety & Depression Scale
4. Fatigue Severity Scale
5. Handicap Questionnaire
End of researcher's evaluation. Thepatient was given a long rest
Neuropsychologist carried out the neuropsychology assessment.
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5.4.3 Video protocol of the tests
The assessments of Test Battery I were carried out by the researcher in a
predetermined sequence and a video recording was made of the patient performing
the tests.
Fig 5-3: The video protocol of Test Battery I and the requests made of the patient
by the researcher
1) Patient sitting on chair, with forearms lying on thighs 30s
*Patient asked to move head and look to the right, left, up and down
* Patient asked to move head and take a drink from a cup with a straw, held stationary by the
examiner.
Speaking:
* Ask patient to tell his or her history of the disease.
2) Posture holding:
* Arms outstretched, wrists slightly extended, fingers abducted 15s
* Arms held with elbows flexed, shoulder abducted and fingers
spread apart, index fingers opposed at level of the chin 15s
3) During Action
* Finger to nose, three times each side 15s
4) Drawings:
* Fahn's rating scale for tremor, 2 spirals
Test each hand 60s
5) Pouring:
* Fahn's rating scale for tremor. Ask patient to pour water from
one cup to another. Test each hand separately 30s
6) Patient lying supine: 30s --
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7) Sitting unsupported on plinth for 1 min 1
min
8) Arising from a chair and standing for 10 sees 15s
9) Gait
* 10 metre walking test
The patient is then given a 15 minutes rest before performing other goal specific
tasks
10) Jebsen Hand Test:
7 Subtests
Each test is performed first with the non-dominant
hand and then with the dominant hand 20mins
5.4.4. Clinical grading of the various components of tremor
The clinical grading of the various components of tremor was performed in the
following way: the rest component of head tremor was assessed with the patient
lying flat on the bed, with the head supported by pillows, and the postural component
whilst the patient was sitting without head support looking straight ahead. The upper
limbs were also assessed with the patient sitting. The rest component of tremor was
scored whilst the arms were relaxed and totally supported in the patient's lap and the
postural component whilst the arm were first held out in front, with the hands
pronated and the fingers spread apart (postural a)) and then secondly when the arms
were maintained with the elbows flexed and the forefingers near but not touching the
nose (postural b)). The kinetic/intention component was measured as the subject's
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index finger approached a target during the finger nose test. The examiners finger
was placed at the limit of reach.
Detailed operational definitions for carrying out the tests 1 - 3 in test battery I are
provided in Appendix 6 (Definitions for the clinical grading of the various
components of tremor using the MFTRS) and Appendix 5 (Guidelines for
completing the MFTRS). Results were recorded on the Modified Fahn's Tremor
Rating Scale scoring form (Appendix 4)
5.4.5 Clinical assessment of the functional tests
The standardized protocols for performance and assessment of tests 4 - 6 are
provided in Appendix 5. Results were recorded on the same sheet (Appendix 4).
Detailed operational definitions for were set out for the JTHF in Appendix 8 and
included information on: the specification for placement of the test equipment and
the subject; the equipment required and standardised procedures and instructions for
completion and assessment of the subtests of the JTHF. The results were recorded on
the 'Jebsen Hand Test-pre-operative assessment form' (Appendix 10) at the pre¬
operative assessment and at subsequent reassessment after implantation of the
thalamic DBS the 'Jebsen Hand Test-post-operative assessment form' (Appendix 11)
was used.
5.4.6 Test environment
Because concentration was required the assessments were carried out in a quiet room
on the ward. This enabled the same table and chair to be used for the upper limb
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tasks although if the patient was confined to a wheelchair he remained seated in it
for the duration of the assessments. The only assessment that was not performed in
the room was the timed 10 metre walk test. This was carried out at the far end of the
ward where fixed, standardized markers had been placed on the floor.
5.5 Implantation And Programming Of The Thalamic Deep
Brain Stimulator And Pulse Generator.
5.5.1 Neuroradiological investigations
Each patient had a cranial magnetic resonance imaging (MRI) scan performed prior
to the surgery to enable the width of the third ventricle, the thalamus and capsule to
be measured and the presence of atrophy, ventriculomegaly, location and number of
plaques to be determined.
5.5.2 Thalamic DBS implantation
Implantation of the thalamic DBS took place in two stages.
5.5.2 (i) Stage 1: Neurophysiological exploration of the thalamus and implantation of
the DBS lead
Patients were given a general anaesthetic using propofol infusions and the
stereotactic headframe was affixed. The pin sites were infiltrated with local
anaesthetic. A coronal burrhole was drilled, the dura opened, and the wound loosely
closed. The Brown-Robert-Wells (BRW) computerized tomography (CT) localizer
140
system was then fitted to the base ring and a BRW CT performed to localize the
anterior commissure (AC) and posterior commissure (PC). Once the appropriate CT
gantry tilt was obtained the AC-PC plane was identified and the fiducial, AC, PC co¬
ordinates obtained. Targets were selected beginning 1mm behind the AC-PC
midpoint and between 11-15 mm lateral to the midline. The stereotactic co¬
ordinates were calculated.
The patient was returned to theatre, the propofol infusion stopped, the burrhole
wound opened and the entry point obtained for insertion of the electrode. A
Guildenberg stimulating electrode was then passed towards the target, once the
patient was awake and co-operative. Stimulation began 5mm short of the target. The
electrode was advanced in 2mm steps with low (2Hz), intermediate (20Hz) and high
frequency (100Hz) stimulation at each locus. Effects on motor and sensory function,
eye movements, language and articulation were assessed. The ideal point for
electrode insertion was that at which stimulation at 1.5 - 2.0 V produced suppression
of tremor with no neurophysiological side effects. The DBS lead was then implanted
via a cannula at this site. The deepest DBS electrode was implanted 1mm deep to this
site so that the 4 electrodes straddled the region ofmaximal suppression of tremor. A
burr hole ring and cap was used to stabilize the lead on the cranium. An external
stimulating lead was then connected to the DBS electrode, tunnelled subcutaneously
and brought out above the ear. This enabled a period of testing of the efficacy of the
DBS to be carried out in the ward. Information regarding the first stage of the
procedure was recorded on the 'Lead Implant Data Collection' form (Appendix 29).
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Figure 5-4: Location of the target site for DBS in the ventrolateral nucleus of
the thalamus
This is the site of stimulation most commonly used for ameliorating tremor. The
horizontal axis is that of a horizontal plane drawn at the AC-PC line. The vertical
axis represents a horizontal plane drawn through the midpoint of the AC-PC line.
VOA, ventralis oralis anterior; VOP, ventralis oralis posterior; STN, subthalamic
nucleus; II, cranial nerve II. Figure taken from Atlas for Stereotaxy of the Human
Brain (Schaltenbrand and Wahren 1977).
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Initial testing and assessment ofmicrothalamotomy effect
Some patients experienced a 'micro thalamotomy' effect due to lead implantation,
which resulted in immediate suppression of tremor. This effect usually waned in the
first weeks after surgery and it was sometimes necessary to delay stage two of the
procedure until tremor reappeared. However, in most cases, tremor became evident a
few days after the first stage of the procedure and the patient was tested using an Itrel
Screener (a temporary external power source used to test the effect of the
stimulation) to confirm persistent suppression with appropriate thalamic stimulation.
5.5.2 (ii) Stage 2: Implantation of the IPG
Between five and seven days later, with the patient under general anaesthesia, the
Itrel II IPG was placed subcutaneuosly in the subclavicular region. The IPG was left
in the off position. An extension wire was connected to the lead and threaded
subcutaneously to pass caudally behind the ear, down the neck, and it was then
connected to the IPG. Information regarding stage 2 of the procedure was recorded
on the 'IPG Internalization' form (Appendix 30).
5.5.2 (iii) Justification of the surgical methods
Until recently, thalamotomy was the only technique which could be used to treat
tremor refractory to medical treatment (Nguyen et al. 1996). However, despite the
reliefof tremor afforded in the short term by thalamotomy to suppress MDMS its use
remains controversial. There are reservations regarding the thalamotomy operation
first because of the residual ataxia and secondly because of the high risk of serious
complications, particularly if thalamotomy is performed bilaterally, as the procedure
143
is irreversible. One of the main reasons for the limitation of the use of
thalamotomy is the reluctance to cause permanent lesions of the CNS (Geny 1996).
Continuous stimulation of deep brain structures in the treatment of disorders of
movement is an attractive method of avoiding permanent side effects which can
follow a stereotactic localized destruction.
Long term thalamic DBS and thalamotomy have the same co-ordinates of the
surgical target and the improvements of tremor in MS seem the same in the short
term but it has the advantage of being reversible and adjustable and the morbidity
appears less (Geny et al. 1996; Schuurman et al. 2000).
5.5.3 Initial IPG programming
IPG programming was performed 24 hours after operation when the complete DBS
system had been implanted. For the purpose of programming the device, the Itrel
Console Programmer was used to select parameters of stimulation that provided the
greatest degree of suppression of tremor with the least side effects. Adjustable
parameters included amplitude of stimulation (intensity of the stimulation signal),
pulse duration and rate, and selection of electrodes and their polarity. All four
electrodes could be selected to be negative or positive polarity, or off. The IPG case
could be assigned a positive polarity or off. At least one negative and one positive
contact (electrode or IPG case) were required to complete the electrical circuit.
The neurosurgeon (IRW) and the researcher (JH) made all programme adjustments.
The recommendations made by Medtronic (amplitude < 3V, pulse width 60ps, rate
130 - 185Hz) were followed at the initial setting of the programmable parameters but
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the preference of electrode setting depended on the exact location of the DBS
electrode in the thalamus. Verification of these initial settings was made ad hoc and
then adjustment of the parameters of stimulation was performed as needed for
optimum tremor suppression.
There were two amplitude settings available for programming: the normally
programmed amplitude setting and the magnet amplitude setting. Both features are
necessary if the patient is required to switch from one amplitude setting to another as
required when the system is used as a dorsal column stimulator to relieve pain.
However for the purposes of this study, where the stimulator was used to stimulate
the thalamus, this was not necessary. The researcher therefore always set the magnet
amplitude to be equal to the normally programmed amplitude. The final stimulation
parameters were recorded on the 'Stimulation IPG Parameters' form (Appendix 31).
5.5.4 Education of the patient and carer
The patients were provided with a control magnet and they and their carers were
instructed in its use: the patient could then turn the stimulator on and off by placing
the hand held control magnet over the IPG for a few seconds (Appendix 32). All
patients were instructed to turn the stimulator off before retiring each night to extend
the IPG battery cell life. Readjustments of the IPG parameters were made as needed
during scheduled study visits or during interim visits if loss of benefit developed.
Either the patient attended the hospital for this or the researcher visited the patient at
his home.
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The patient was also given an information booklet produced by Medtronic,
outlining some important aspects of the thalamic DBS. Patients were cautioned about
potential hazards such as theft control devices. They were also issued with an
identification card to carry with them at all times listing the serial numbers of the
implanted components and an emergency contact number at the Department of
Clinical Neurosciences.
5.6 Other information Collected at the Post-operative
Follow-Up Evaluations
5.6.1 Alterations to the stimulation parameters
It was often necessary to make minor adjustments to the parameters of stimulation to
obtain an optimum effect. This was always recorded (see Appendix 33 for 'Follow-
up' form).
5.6.2 Assessment of adverse effects
Safety information was recorded throughout the study on standardized case report
forms (See Appendices 34 & 35 for 'Therapy Adverse Events' and 'Systems
Complications' forms). Information regarding the severity, duration, and suspected
aetiology of any reported complications or adverse effect was collected, and any
intervention recorded. Whether the adverse effect was observed with and or without
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electrical stimulation was also noted. All complications and adverse effects were
recorded on the case report form as soon as they were known.
5.6.3 Assessment of patient's ability to turn the stimulator on and off
In the immediate post-operative period some patients had difficulties turning the
stimulator on and off using the hand held magnet supplied for this purpose.
Therefore at every subsequent evaluation they were asked who was responsible for
turning the stimulator on and off in the morning and evening (Appendix 36).
5.7 Health Economic Measurement of the Cost Benefit of
Thalamic DBS
5.7.1 Methods used to assess the related costs
5.7.1 (i) The costs involved in assessing the patient
The patients were referred to the neurosurgeon for their suitability for implantation
of a thalamic DBS to be assessed. The patient was then seen as an outpatient, for an
initial consultation in the outpatient clinic of the Department of Clinical
Neurosciences. If deemed an appropriate candidate they were then admitted at a later
date to the Astley Ainslie Hospital so that extensive baseline assessments could be
carried out. These assessments were carried out over a two-day period, which
necessitated an overnight stay on the rehabilitation ward.
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This was an experimental study and it was not possible to recruit adequate
numbers ofMS patients with movement disorders from Lothian region for the study.
Patients living elsewhere were therefore also accepted. However to determine
whether or not they were appropriate candidates it was necessary that they came to
Edinburgh for the pre-operative assessment. In all cases, even for patients living in
Edinburgh, they were admitted for an overnight stay to enable the pre-operative
evaluation to take place over two days. In cases where the patients lived a
considerable distance form Edinburgh, the neurosurgeon also saw the patient whilst
they were in the ward at Astley Ainslie Hospital, rather than seeing them initially in
the outpatient clinic, which was the procedure for patients living more locally. The
relevant costs involved in the initial assessment stage of each patient were calculated
from costs provided by the local Trust providers.
5.7.1 (ii) The costs involved in implanting the thalamic DBS
Prices were calculated for operations as an average charge (average specialist tariff)-
In calculating this average charge several factors are taken into account. These were
the type of operation (each operation having a procedure code), the average length of
stay for that particular operation, consumables utilized (syringes, food, drugs), staff
salaries and time and overheads incurred by the unit. Thalamic DBS was a new
technique and was being performed in only a small number of cases so the Finance
Department included it under the code for stereotactic operations.
The Western General Hospital NHS Trust had a contract with Lothian Health Board
to treat patients within Lothian at a contract cost. Patients were also referred to the
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study from outwith Lothian. For these patients although the resource use was the
same, the cost of the procedure was higher as they were charged an Extra Contractual
Referral Rate (ECR). Authorization for ECRs had to be sought from the referring
Health Authority by the Contracts and Planning Department before the procedure
could be carried out.
It became apparent that some of the patients required a short period of intensive
training of their target upper limb after the operation. This was organized on an in¬
patient basis in the majority of cases at the Astley Ainslie Hospital. However some
patients required more intensive rehabilitation to return to their preoperative level of
functional ability in addition to intensive retraining of the target upper limb. The
researcher often had to make frequent visits to the rehabilitation hospitals during the
first month after the operation as it was often necessary to carry out some 'fine
tuning' of the patient's thalamic DBS using the Itrel Console Programmer. This
involved lengthy sessions lasting several hours in some cases where the researcher
adjusted the parameters of stimulation until the optimum effect was achieved.
The costs involved in the admission to the Western General Hospital for the
implantation of the thalamic DBS and the subsequent costs incurred at the
rehabilitation hospital (which was dependent on the length of stay) were calculated
from costs provided by the local trust providers.
The cost for the number of visits made to the hospital by the researcher was
calculated from the rate quoted for a visit by a senior physiotherapist in the Personal
Social Services Research Unit unit costs (Netten and Dennett 1996).
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5.7.1 (iii) The costs involved in follow-up
The patients were required to attend for review at one, three, six and twelve months
post-operatively. The follow-up assessments took place at the Astley Ainslie
Hospital where the patient attended as a day case and stayed on the ward for the day
so that the assessments could be carried out in the morning and afternoon. There was
an obvious direct cost to the NHS for these follow-up assessments which were
calculated. There were also indirect costs to patients and their carers as there was a
cost in relation to their time in attending these follow-up out-patient appointments.
This cost was hard to measure. None of the patients was still able to drive a car
owing to their levels of disability and were therefore unable to transport themselves
for these visits. Relatives were therefore encouraged where possible to provide or
organize transport. Attention was given to the transport costs to and from the
Western General Hospital and Astley Ainslie Hopital because in some cases, for
example in patients living in England, transport costs were high. There was a
standard scale of charges for ambulance journeys, which was based on area in
Scotland and on distance in England. The cost of any transport whether it was by
ambulance, private car or taxi was not included in the overall calculation of the cost
of thalamic DBS.
Readjustments of the IPG parameters were made, as needed during scheduled study
visits or during interim visits either of the patient to the hospital or of the research
fellow to the patient's home where distance allowed. Again where it was necessary
for the physiotherapist to visit the patient at home the cost of these visits was
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calculated from the Personal Social Services Research Unit unit costs (Netten and
Dennett 1996).
5.7.2 Comparison of the resource use before and after thalamic DBS
The majority of the patients referred for thalamic DBS were moderately to severely
disabled (the mean EDSS was 7, range 4.5 - 8.5) and were mostly wheelchair bound.
Many of these patients were receiving assisted living services at home either from
relatives or community services to maximise their independence and QOL before
being referred for implantation of a thalamic DBS. The informal (unpaid) carers were
typically spouses who provided physically demanding care often over a long period
of time. Carers experience a substantial burden affecting their physical, mental and
social well-being. The cost of this burden is well documented (Holmes et al. 1995)
and was not discussed here.
The amount of assistance required by patients for activities of daily living was
estimated at the pre-operative assessment and then at the 12 month assessment by
completing the self-care section of the Functional Independence Measure. The study
aimed to discover whether there was a substantial improvement in functional ability
with regard to performing activities of daily living with the target upper limb and
whether it resulted in any economic benefits (savings in future care costs) in this
cohort of patients.
5.7.2 (i) Justification for the methods used
There is increasing emphasis on clinical and cost-effectiveness in the Health Service,
which is faced with rising demands but limited resources. Therefore difficult choices
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have to be made about how the NHS should use its resources in the most
effective overall way. In order to carry out an economic analysis of a new treatment
such as thalamic DBS it was necessary to identify the total cost of the procedure and
the resources used.
There is also evidence to suggest that this particular group of patients has substantial
annual burden costs on the National Health Service. Several studies have shown that
the use of and the need for medical and community support services is primarily a
function of the MS individual's level of disability (Kraft et al. 1986) (Cervera-Deval
et al. 1994). The study mentioned above by Holmes et al (Holmes et al. 1995) which
investigated the cost of multiple sclerosis reinforced this finding by showing that
annual NHS costs depended on the patient's level of mobility and that there was a
considerable escalation in NHS costs in patients who are wheelchair-bound. These
costs were principally associated with hospital in-patient and out-patient visits, and
other treatments not related to general practitioners. Furthermore when considering
the social handicaps of patients with MS it was evident that MS patients with
cerebellar disorders had significantly more problems with transportation. This
finding was relevant to our study, as there was a requirement for the patients to
attend the hospital on four occasions during the twelve months after the thalamic
DBS was implanted and transport to and from the hospital presented as a problem in
many cases.
The overall aim of this study was to evaluate the effectiveness of thalamic DBS and
its broader impact on patients and their families. However it was also important to
establish the overall cost of the intervention as this has not been addressed, in
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previous studies. Thalamic DBS has high initial costs but in addition the
intervention entails further, perhaps unforeseen costs, which are related to a long-
term commitment to maintaining and replacing the pulse generator. However if it
were possible to demonstrate that as a result of thalamic DBS there would be a
reduction in the use of resources in the longer term then the cost of the intervention
might be offset. It was therefore an aim of the study to establish the cost of this




6.1 Pre-Operative Presenting Characteristics of Patients
with MS
6.1.1 Assessment of suitability for thalamic DBS
6.1.1 (i) Demographic characteristics
During the 4 year study period 37 patients with movement disorders due to multiple
sclerosis were referred for assessment of suitability for thalamic DBS. Of the 37
patients referred, 23 (62%) were female and 14 (38%) were male. 34 (92%) patients
were right handed and 3 (8%) were left handed. The mean age at the onset of the
disease was 29 years. The characteristics of these patients are shown in the table
below. The data relating to subject characteristics were found to approximate a
normal distribution: therefore, mean data are reported.
Table 6-1: Mean age, duration ofMS and ofMDMS in patients referred to the
study (N=37)
Minimum Maximum Mean S.D.
Age (years) 25 54 40.1 7.9
Duration of MS (years) 3 20 11.1 5.1
Duration of MD (years) 1 13 4.8 3.2
There was variation with regard to the part of the body affected by the movement
disorder within the 37 patients referred to the study. The most common presentation
in 30 (81%) of the patients was for the movement disorder to involve the upper
limbs, head and trunk. In six (16%) patients the movement disorder affected the
upper limbs only (unilateral in four (11%) patients and bilateral in two (5%) patients)
and in one (3%) patient the movement disorder predominately affected the axial
muscles of the trunk and head.
The upper limbs were therefore affected by a movement disorder in 36 (97%)
patients (unilateral in seven (19%)), the head in 31 (84%) patients and the trunk in 28
(75%) patients.
Fifteen patients underwent surgery and 22 patients were deemed not suitable for
thalamic DBS for the following reasons: predominant axial tremor (N=6); severe
associated neurological dysfunction (N=5); minimal associated disability (N=2);
refused operation (N=7); referred for detailed assessment only (N=2).
6.1.2 Patients who underwent surgery
Of the 15 patients who underwent surgery there were seven females (47%) and eight
males (53%). Fourteen patients (93%) were right handed and one patient (7%) was
left handed. The characteristics of those patients who underwent surgery are shown
in Table 6-2. The mean duration of MS was 13 years (range 6-30 years, SD 6.55).
The mean duration of time from diagnosis of MS to onset of the movement disorder
was 8 years although this ranged from only 1 year to 22 years. The mean duration of
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the movement disorder was 6 years and again this ranged from as little as 2 years
to 12 years. The patients were moderately to severely disabled (EDSS 4.5 - 8.5) with
8 of the patients being confined to wheelchairs and the other 7 being able to walk
only very short distances with the assistance of a walking aid.
Table 6-2: Mean age, duration of MS, details of MDMS and EDSS score of
patients who underwent surgery (N=15
Mean Median S.D. Minimum Maximum
Age (years) 41.5 42 7.9 27 52
Duration ofMS (years) 13.3 12 6.6 6 30
Duration from diagnosis to 7.8 7 6.1 1 22
onset ofMD (years)
Duration of MD (years) 5.5 5 2.8 2 12
EDSS score 6.9 7 1 4.5 8.5
6.1.2 (ii) Clinical subtype
Of the 15 patients who underwent thalamic DBS and were followed up over the
course of the study 10 patients (66%) had entered the secondary progressive phase of
MS having initially been diagnosed with relapsing-remitting disease. Five patients
(33%) developed cerebellar signs early on in the course of the disease and had what
appeared to be a more aggressive form of MS which could probably be classified as
progressive-relapsing MS. The disease course was progressive from onset in these
patients, with clear acute relapses but periods between relapses were characterized by
continuing progression.
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6.1.2 (iii) Other neurological symptoms
A neurological examination was carried out at the pre-operative assessment by a
neurologist. The Kurtze Functional systems were then scored to provide a baseline
assessment of the neurological deficits present in each patient. All 15 patients
showed pyramidal and cerebellar dysfunction and the brainstem, sensory and visual
systems were affected in the majority of the patients. Only 40 % of patients showed
some form of cognitive deficit when assessed with the scale for mental functioning
included in the Kurtzke FS.
Table 6-3: Kurtzke FS showing the neurological dysfunction present in patients
who underwent surgery (N=15)
Kurtzke's FS N=
Pyramidal dysfunction 15 (100%)
Cerebellar dysfunction 15 (100%)
Brain stem dysfunction 13 (87%)
Sensory dysfunction 13 (87%)
Visual dysfunction 13 (87%)
Bladder and bowel dysfunction 11 (73%)
Cerebral dysfunction 6 (40%)
Other neurological dysfunction 0
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6.2 Results of Surgical Procedures
6.2.1 Surgical treatment of patients
Fifteen patients underwent exploration of the thalamus between October 1996 and
February 2000. Four patients had exploration of the right side of the thalamus for a
movement disorder of the left arm and 11 patients had exploration of the left
thalamus for a movement disorder of the right arm. The dominant arm was the target
arm in 11 patients.
The DBS system (DBS electrode and IPG) was implanted in 10 patients. The mean
number of passes of the DBS electrode ranged from 1-11 (mean 4.9, median 5). In
three patients it was not possible for the surgeon to locate a target during the
operation to permit an electrode to be implanted to suppress tremor and therefore
these patients did not proceed to implantation of any of the DBS equipment and were
regarded as unsuccessful attempts. Two of the 12 patients implanted sustained a
microthalamotomy effect as a result of the exploration of the thalamus and
consequently did not require implantation of the pulse generator
6.2.2 Co-ordinates for the thalamic target
The type of operation performed, the side of the thalamus targeted, the target co¬
ordinates of DBS electrode implantation and the number of passes of the DBS
electrode during the operation are listed in table 6-4.
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Final target co-ordinates and target
points tried in patients in whom a target
could not be found
Number
of passes
1(4.) left (11,9, 0) 5
2(*) left (12,12, 2) 4
3(4.) left (12,10,3) 5
4(4.) left (16, 9, 3) 6
5(4.) left (13, 12, 1) 3
6(4.) left (16,10,3) 4
?(♦) left (14,14, 4) 3
8(4.) left (15, 9, 2) 3
9(4.) left (12.5, 9, 2) j
10(4.) right (14, 13,0) 5
11 (♦) right (13,13,0) 1
12 (4i) right (14,14, 5) 5
13 (#) right 13,0 13,3 13,-1 14,+2 15,-1 13,+1 17,-3
17,+2
8
14 (#) left 11,-4 12,-2 13,-1 13,-5 14,-4 15,0 12,2 7
15 (#) left 13,-2 15,-4 17,-2 19, -2 20, -5 18, 0 18, 4 23.
-3 23, 0 23, 3 24, -5
11
Legend for table 6-4:
4. = Patients who had the DBS system implanted (DBS electrode and IPG)
♦ = Patients in whom a DBS electrode only was implanted
# = Patients in whom a thalamic target could not be located to implant an electrode to
suppress tremor, therefore no DBS equipment was implanted
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Final target co-ordinates (x, y, z) where:
x = distance lateral to AC - PC line (mm)
y = distance from the PC along the AC - PC line
z = distance below the AC - PC line
AC = the anterior commisure, PC = the posterior commissure and AC - PC line = a
line connecting the anterior and posterior commissures.
6.2.3 Adverse effects of the procedure
Three patients sustained small thalamo-capsular haematomas (patients 7, 8 and 15).
Patients 7 and 8 both had 3 passes of the DBS electrode and patient 15 had 11. They
all became symptomatic only after the procedure (patient 7 one hour after and
patients 7 and 8 twenty four hours after). Two of the three patients who sustained
haematomas (patient 7 and 8) were left with minor residual motor deficits in the
upper limb, lower limb and hand at 12 months (see section 6.6.2 (i)). In addition one
of these patients (patient 7) had sensory inattention on the hemiparetic side and
poorer short term memory than before the operation and the other (patient 8) had
transient dysphasia with recovery. Both patients however, had better function in the
target limb due to reduction in severity of tremor than pre-operatively. One patient
sustained a hypoxic episode (case 6) during scalp closure as a result of hypnoea after
propofol dosage. This patient recovered well and was no worse post-operatively on
the neuropsychological tests than pre-operatively. The two patients with transient
limb weakness (cases 4 and 15) recovered fully to pre-operative levels of general
functional status after rehabilitation (as assessed on the Barthel Index).
One patient had a grand mal seizure one week after the IPG was implanted and
another 8 weeks after implant. Neither patient had seizures pre-operatively. At the
time of the seizures, the stimulation voltages were 3.3V and 3.8V respectively.
One patient developed a staphlococcus aureus infection in the IPG site in the
pectoral region one month after the IPG was implanted. Aspiration of the collection
and antibiotic therapy (oral and intra-venous) was given and the infection seen to
resolve. However due to reactivation of the infection the IPG and extension lead
were removed 11 months after operation. The DBS electrode was left in situ.
6.2.4 Record of follow-up assessments
Eight of the 10 patients (1, 2, 3, 4, 5, 6, 9 and 10) who had thalamic DBS systems
implanted (*) were compared pre-operatively and 12 months after operation with the
DBS off and only 7 of the same 10 patients (1, 2, 3, 5, 6, 9 and 10) were compared
pre-operatively and 12 months after operation with the DBS on as patient 4 had the
IPG removed one month before the final assessment. Twelve month data was not
available for patients 8 and 12. Patient 12 had implantation of a thalamic DBS in
February 2000 and consequently one month data only could be obtained due to the
time limit of the study. Patient 8 did not attend for the 12 month follow up
assessment despite several dates being arranged. The researcher had problems
contacting the patient in order to try to arrange for her to be visited at home which
was not straight forward because of geographical inaccessibility.
There were also problems with collection of data in the two patients (7 and 11) who
had thalamic DBS electrodes implanted only (♦). Patient 11 could not be assessed
because of the time limit of the study. Patient 7 lived in Sheffield and after operation
required rehabilitation which was organised locally in Sheffield. The researcher
travelled to Sheffied to carry out the one month post-operative assessment. However
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when the 12 month post-operative assessment was due to be performed the
patient's parents refused assessment.
Follow-up assessments using the MFTRS and the JTHF were performed on the three
patients in whom no equipment was implanted (#). The data is presented in the
graphs shown in the individual patient case studies (section 6.5).
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on/off on off on off on off on off
Reasons for missing data
1 * * * * * * * * *
2 * * * * * * * * *
3 * X X X X * * * * DNA
4 * * * * * * * * - * IPG removed at 11 m
5 * * * * * * * * * *
6 * * * * * * * * *
7 (♦) * - * - - - - - X geographical inaccessibility
8 +
* * * * * * * X X
DNA -social problems
Geographical inaccessibility
9 * * * * * * * * * *
10 * * * * * * * * *
11 (♦) * - * - X - X - X Time limit of study
12 * * * * X X X X X X Time limit of study
13 (#) * - * - * - * - * No DBS to assess
14 (#) * - * - * - * - * No DBS to assess
15 (#) * - * - * - * - * No DBS to assess
* = DBS system implanted (DBS electrode and IPG)
♦ = DBS electrode implanted
# = Unsuccessful attempts
DNA = did not attend, * = Assessment completed, X = missing data, - = no
assessment required
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6.3 Results of stimulation
6.3.1 Parameters for stimulation with the IPG
Patients required their own unique parameters for stimulation to suppress tremor.
Reprogramming of the stimulator was often required especially if the patient had
experienced a microthalamotomy effect which tended to wane in the first months
after surgery. Some patients required many visits to achieve optimum tremor
suppression as time progressed whereas others only needed a few: the mean number
of visits for reprogramming was 5, range 2 - 14. The mean amplitude, frequency and
pulse width on discharge from hospital and at 12 months were 2.7V, 120Hz, 120ps
and 3V, 160Hz, llOps respectively. The most common arrangement of electrode
polarity was to assign a positive polarity to the IPG casing and to have a negative
contact at the tip of the DBS electrode in the thalamus.
Parameters for stimulation (amplitude, frequency, pulse duration) and the electrode
arrangement on discharge from hospital and at 12 months are shown in Table 6-6.
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Table 6-6: Stimulation details
Patient DBS parameters on D/C Finai DBS parameters
Amp Freq Pulse Electrode Amp Freq Pulse Electrode
(V) (Hz) dur. polarity (V) dur. polarity
(ps) (Hz) (ps)
1 1.6 135 60 3+ 2- 2.2 135 90 Case+ 2-
2 2.9 145 60 2+0- 3.5 185 120 Case+ 1-
3 3.3 70 160 Case+ 3- 2.8 130 90 Case+ 3-
4 3.3 30 120 3+0- 2.5 135 60 3+0-
5 3.3 30 150 2+0- 3 170 120 Case+ 0-
6 3.3 145 90 3+ 1- 3.5 170 90 3+ 1-
7 2.2 185 120 Case+ oth- 2.2 185 120 Case+ oth-
8 2.9 135 150 Case+ oth- 5 135 150 Case+ oth-
9 2.2 135 150 Case+ 0- 3.9 160 150 Case+ 0-
10 1.8 130 120 Case+1- * * * *
Mean 2.7 114 118 3 153 110
Median 2.9 135 120 2.9 148 120
Legend for table 6-6: amp = amplitude measured in Volts, freq = frequency
measured in pulses/sec (Hertz), p.width = pulse width/duration measured in micro
seconds (ps), electrodes = polarity of electrical contacts on the tip of the electrode
(numbered 0, 1, 2, 3 where 0 is the deepest in the thalamus). Case = the IPG casing
which can either be positive or off, oth = all other electrodes. * = Parameters for
stimulation unchanged from those at discharge as operation performed in February
2000.
Ib5
6.3.2 Adverse effects of thalamic DBS
There were no intractable complications related to thalamic DBS. Problems due to
the thalamic stimulation were typically mild and were generally reversible or easily
controlled when the parameters of stimulation were changed or stimulation was
discontinued. Some patients reported transient paraesthesiae when they first turned
the DBS device on each day. Typically the paraesthesiae involved the target side of
the body and mostly affected the target upper limb. The abnormal sensation usually
abated within several seconds after turning the device on. In two patients unwanted
side effects in the form of dysphasia and diplopia persisted when certain electrode
arrangements were tried and the DBS was switched on. IPG parameters were
therefore adjusted to eliminate or reduce these unwanted side effects.
6.3.3 Patient's ability to turn the DBS on and off
Turning the thalamic DBS on and off was not straight forward and only three of the
10 patients who had DBS implanted were able to do this independently using the
hand-held magnet. The other seven relied on others to do it for them.
All patients were issued with a transistor radio to enable them to check whether or
not the stimulator had been turned on or off successfully with the magnet. The
patient was instructed to turn the radio on and tune it to 530 kHz on the AM
waveband. The patient then held the radio over the stimulator (IPG) and if it was
switched on an interference sound was emitted from the radio. If the stimulator (IPG)
was off only the faint hissing noise from the radio could be heard.
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6.4 The Effect of Thalamic DBS
The hypothesis that the severity of tremor amplitude would decrease and
performance of upper limb function would improve after implantation of thalamic
DBS was proposed (Chapter 1 - section 1.7)
The MFTRS was used to investigate change in severity of tremor and the JTHF was
used to measure functional performance of the upper limb. Comparisons were made
between scores of severity of tremor and the number of successful Jebsen subtests at
the pre-operative and later assessments (1month, 3 months, 6 months and 12 months)
and form the basis of the following findings.
The mean and median scores for the rating of severity of tremor and successful
number of Jebsen subtests scored were compared and there was little difference
between them (Appendix 37 and 38). As the majority of data is at the ordinal level of
measurement, non parametric statistical presentation of the results was most
appropriate. Further it was argued in Chapter 2 that items on such scales are most
appropriately viewed as a profile of the individuals severity of tremor (in the case of
the MFTRS) and ability to perform ADL (in the case of the FIM and Barthel Index).
However, in order to use these measures to look at change in outcome during the 12
months of the study, a pragmatic approach was taken and therefore for some analysis
the data was summated. Data was collected at pre-operatively and at 1 month, 3
months, 6 months and 12 months after operation. At each of the post-operative
evaluations the researcher carried out two assessments: one with the DBS on and one
with the DBS off.
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6.4.1 The effect of thalamic DBS on severity of tremor over time
6.4.1 (i) Comparison between the total tremor rating scores with the DBS on and off at
pre-operative and post-operative assessments
The components of tremor (postural a), postural b), kinetic/intention and goal-
related) were scored on a 5 point scale (0 - 4), with a higher score indicating
increased severity of tremor. The scores for the different components were summed
to give a total tremor score for the target arm (the best possible score = 0, the worst
possible score = 16).
Figure 6-1 illustrates the median scores, inter-quartile ranges and extreme values for
the total tremor scores of the target arm at the pre-operative and later assessments
with the DBS on and off. Pre-operative tremor rating scores ranged from 7-15.
After operation with the DBS on the scores ranged mainly from 1-10 although there
was an outlying score of 16 at the 6 month assessment. After operation with the DBS
off the worst possible tremor rating score of 16 was present at the 3, 6 and 12 month
assessments. Tremor severity scores were lower at the 1 month post-op assessment
with the DBS off (scores ranged from 1 - 15) due to the beneficial influence of a
microthalamotomy effect in some patients in the first month after implantation. The
median total tremor scores when the DBS was on were either 5 or 6 and were lower
than when the DBS was 'off when the median scores range from 7 to 9. However
the median scores when the DBS was off were all lower than the pre-operative
median score indicating that there was a reduction in severity of tremor scores even
without any stimulation which was still evident 12 months after the operation.
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Wilcoxon matched pair tests were used to compare conditions and involved only
the patients tested on both occasions. Tabulated data included all patients tested on
one or both occasions. P values were given without adjustment for the number of
comparisons made as this was an exploratory/pilot study and common adjustments
such as the Bonferroni procedure were considered too conservative in this context.
The severity of tremor when the DBS was on at each of the 4 post-operative
assessments was significantly reduced compared with pre-operatively. It was also
significantly reduced when the DBS was off at the 1 month assessment, perhaps as a
result of a microthalamotomy effect.





6.4.1 (ii) Comparison of the total severity of tremor with the DBS on and off at post¬
operative evaluations
At each of the post-operative evaluations two assessments were carried out by the
researcher: one with the DBS off and one with the DBS on. The assessments were
performed in a random order and the researcher was blind to the nature of the
assessment. The results of the 2 assessments at each post-operative evaluation were
compared : there was a significant reduction in severity of tremor between the mean
total tremor rating scores for the target arm when the DBS was on compared to when
it was off at all the post-operative assessment intervals (1, 3, 6 and 12 months).
Table 6-7: Significance levels concerning total tremor scores in the target arm with









Total tremor score with DBS ON versus
OFF 0.02* 0.01* 0.03* 0.04*
* = p<0.05. Wilcoxon matched pairs tests were used to compare on with off.
6.4.1 (iii) Comparison of the different types of tremor between pre-operative and 6
month evaluations
The mean scores for the different types of tremor in 9 patients assessed pre¬
operative^ and at 6 months after implantation of a thalamic DBS (patients 1, 2, 3, 4,
5, 6, 8, 9, and 10) with the DBS on were compared. The mean scores of goal-related
tremor severity were higher than all other components of tremor at both the pre¬
operative and the 6 month post-operative evaluations; some change was apparent in
all components of tremor, especially in the severity of postural b) tremor at 6
months, compared with pre-operative scores.
Figure6-2:Meanratingsofthediff rentyp stremoratpre-op rativendm nthass ssm tswi hthDBS Posta)Postb)KirVinGo l componentsoftrem rLegend: Posta)=posturaltremor Postb)=posturaltremor Kin/int=kinetic/intentiontremor Goal=goal-rel tedtremor
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6.4.1 (iv) Comparison of the different types of tremor in individual patients
The different types of tremor in the target arm (postural a), postural b),
kinetic/intention and goal-related) were scored on a 5 point scale (0 - 4). The
severity of tremor was rated by amplitude and the definitions of the size of the
amplitude were: 0 = no tremor; 1 = slight tremor, maximal amplitude <lcm; 2 = mild
tremor, amplitude 1 - 5cm; 3 = moderate tremor, amplitude 5-10 cm; 4 = severe
tremor, amplitude >10cm. A higher score therefore indicated increased severity of
tremor.
In all patients ratings of the different types of tremor either stayed the same or
improved apart from in one patient (patient 9) whose postural b) tremor worsened by
one point on the scale (from 3 to 4) when a comparison of the tremor rating scores
was made between the pre-operative and the 6 month post-operative assessments
with the DBS on (N=9).
Two patients (patients 2 and 3) had no evidence of postural a) tremor before or after
operation. There was no change in the rating of postural a) tremor in 2 patients
(patients 4 and 9) at the 6 month post-operative assessment. In the other 5 patients in
whom the rating of postural a) tremor ranged from 1 to 3 pre-operatively, postural a)
tremor decreased and was absent in 3 patients at the 6 month post-operative
assessment.
There was a wide variation in scores of severity of postural b) tremor amongst the
nine patients, with all grades of severity of tremor being present pre-operatively (1 -
3). The majority (N = 6) of patients had marked postural b) tremor before operation
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and all patients except patient 9 demonstrated an improvement at the 6 month
post-operative assessment.
Tremor was most severe pre-operatively for kinetic/intention and goal-related types
of tremor. The scores for kinetic/intention tremor and goal related tremor stayed the
same (patient 4 scored 3 before and after for kinetic/intention tremor and patients 4
and 6 scored 4 before and after for goal-related tremor) or improved at the 6 month
post-operative assessment.
Figure 6-3 (i-iv): Comparison of the tremor rating scores for different types of
tremor in the target arm of individual patients at pre-operative and 6 month
assessments with the DBS on
i. postural a) tremor

































6.4.2 The effect on the total number of successful Jebsen subtests with the
target arm
6.4.2 (i) Comparison of the total number of successful Jebsen subtests with the DBS on
and off at the pre-operative and post-operative assessments
The 7 subtests of the Jebsen Test of Hand Function ranged in order of difficulty and
meant that even the patients who were most disabled by the movement disorder in
the target arm were usually able to perform at least one subtest successfully. Some
subtests, which involved turning over cards and lifting heavy cans onto a shelf, were
easier to perform than some of the other subtests such as picking up kidney beans
with a teaspoon and putting them into a container. The writing task was probably the
most difficult subtest both before and after operation Patients with severe upper limb
movement disorders had great difficult trying to grasp the pen and put the pen onto
the paper and had even greater difficulty writing. Other factors such as reduced
sensation and muscle weakness in the hand and poor eyesight also influenced the
performance of the subtest and many patients had not attempted to write for many
years.
The test was scored by counting the number of successful subtests performed by the
patient: allocating 1 for a pass and 0 for a fail. The higher the score the better the
performance on the subtests (best possible score = 7, worst possible score = 0).
Figure 6-4 shows the median Jebsen scores, the interquartile range and extreme
values for the total number of successful subtests of the Jebsen Test of Hand
Function. The median scores when the DBS was on were either 5 or 6 indicating that
patients performed more subtests successfully than when the DBS was offwhere the
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median scores were only 1.5 or 2. The median scores when the DBS was offwere
the same as the median score pre-operatively. The range of scores was small pre-
operatively (0 - 3) and was larger at the post-operative assessments, where scores
ranged from 0-7 regardless ofwhether the stimulator was on or off.
As shown in Figure 6-4 the total number of Jebsen subtests passed at each of the 4
post-operative assessment was significantly greater when the DBS was on than the
total number of Jebsen subtests passed pre-operatively. There was also a significant
increase in the number of Jebsen subtests passed when the stimulator was turned off
at the one month post-operative assessment compared with the pre-operative
assessment. This was attributable to a microthalamotomy effect which subsequently
waned. The differences in the number of subtests passed at the other assessment
when the DBS was off compared with pre-operative assessment were not significant.























p<0.05,greaternumbofsuccessfulbte tswithDBSthanrei plant n/s=otsignificant
Min-Max 25-75percentiles Medianvalue
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6.4.2 (ii) Comparison of the total number of successful Jebsen subtests with the
DBS on and off at the post-operative assessments
When a comparison was made between the assessment when the DBS was on
compared with the assessment when the DBS was off at the same evaluation, there
was a significant difference in the number of Jebsen subtests passed at the 1 month, 3
month and 12 month evaluations showing that the DBS was having an effect.
However, there was no difference at the at the 6 months post-operative evaluation.
Table 6-8: Significance levels concerning the total number of successful Jebsen










Number of successful subtests with the
DBS ON versus OFF 0.02* 0.02* 0.07 0.04*
* = p<0.05. Wilcoxon matched pairs tests were used to compare on with off
6.4.3 Comparison of pre-operative and 6 month post-operative assessments of
the non-target arm
Fourteen patients (93%) had some evidence of a movement disorder in the non-target
arm. The target arm was assessed in a total of 11 patients (cases 1, 2, 3, 4, 5, 6, 9, 10,
13, 14 and 15) at both the pre-operative and 12 month post-operative assessments.
The mean total tremor score for the non-target arm pre-operatively was 8.7 (median
score = 8, scores ranged from 0 to 15) and 9.4 (median score = 10, scores ranged
from 1 to 14) 12 months after operation. The mean number of Jebsen subtests passed
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pre-operatively was 3.3 (median score = 2, scores ranged from 1 to 7) and 2.5
(median score = 2, scores ranged from 0 to 7) 12 months after operation. The mean
and median scores suggested some slight deterioration although this change was not
significant in the total score for severity of tremor (p = 0.53) or the number of Jebsen
subtests passed (p = 0.08) with the non-target arm at the 12 month post-operative
assessment compared with the pre-operative assessment.
6.4.4 The effect on cognitive function
Twelve of the fifteen patients who underwent stimulator implantation completed the
brief collection of neuropsychological tests described in Chapter 2, at varying
intervals up to 4 weeks before surgery and approximately four weeks after. Two of
the patients who had thalamic DBS implanted had no preoperative
neuropsychological assessment through oversight (but when assessed post¬
operatively were typical of other participants). One patient had no post-operative
assessment because of geographical inaccessibility but was typical of other
participants when assessed pre-operatively. Most patients who did not proceed to
stimulator implantation completed the collection of tests once only (as part of their
initial assessment). One experienced neuropsychologist (R. Taylor) carried out all the
testing.
Most participants showed neuropsychological impairment preoperatively when
compared with 54 normal volunteer control participants (22 male, 32 female; mean
age = 38.4, SD = 15.2) tested on two occasions on average 6 (SD = 2) weeks apart.
In those who proceeded to implantation, the mean initial test score (142, SD = 13)
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was far below the level of comparable normal controls (168, SD = 4; n = 54).
Only one patient who proceeded to implantation (and one patient who did not) scored
at or better than the fifth centile level (score = 159) of normal controls.
On this test collection, normal controls show a small mean test-retest practice effect
of+1.4 (SD = 3) points. For patients assessed both before and after surgery, the mean
score was 142 (SD = 13) before surgery and 140 (SD = 15) after (Mean change -2,
SD = 6; Wilcoxon p = 0.476; paired t-test, p = 0.397). The lack of significant change
was not attributable to ceiling or floor effects on the tests used. Two patients showed
more decline than the fifth centile level of decline in normal controls (5 points; N =
54). One of these showed a decline of 16 points and the other 7 points, both probably
as a result of vascular complication. The one patient who was not tested post¬
operatively (for geographical reasons) may have shown some decline as a result of a
thalamic haematoma which occurred during the operation. All other patients showed
little or no change on assessment ofmental functioning.
There was no correlation between mental function and severity of tremor in the
patients referred to the study with MS (Spearman's p = 0.15, p = 0.48, N = 24) or in
the group of patients who were selected for operation to implant a thalamic DBS (p =
0.16, p = 0.61, N = 13) when tested pre-operatively. The only significant correlation
found between neuropsychological performance and illness variables was that poorer
mental functioning correlated with longer duration ofMS (p = -0.610, p = 0.004, N =
20). This was not surprising.
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6.5 Individual Case Studies of Patients who Underwent
Surgery
The following pages display graphic presentations of individual case studies of the
15 patients who underwent surgery. They show both the microthalamotomy effect if
present and the effect of thalamic DBS over time on both the scores for severity of
tremor in the target arm and the number of sucessful Jebsen subtests performed with
the target arm.
Two figures are shown for each patient (figures a and b). The legends, labelling and
titles shown in the figures for patient 1 apply to all the subsequent figures and have
been omitted to avoid repetition and aid clarity. The score for severity of tremor is
the total tremor score for the different components of tremor in the target arm and is
referred to in the text as the 'tremor score'. The score for the performance of upper
limb function is the number of subtests of the JTHF passed by the patient with the
target arm and is referred to in the text as the 'Jebsen score'.
Figures 6-5 - 6-19: Effect of thalamic DBS (and microthalamotomy) over time on
total tremor scores and the number ofJebsen subtests performed successfully with
the target arm
Figure a
Figure a shows the changes in total tremor rating score (MFTRS) for the target arm
over time. Data are shown for pre-operative (baseline) assessment and for one, three,
six and twelve month follow-up with the DBS on and off.
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Figure b
Figure b shows the total number of successful Jebsen subtests with the target arm
over time. Data are shown for pre-operative (baseline) assessment and at one, three,
six and twelve month follow-up assessments with the DBS on and on.
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Figures 6-5: Patient 1
A 36 year old man with MS for 10 years with a movement disorder affecting the dominant right arm













1 month 3months 6months
assessment occasion (months after implant)
The figures show that the patient has experienced a persisting microthalamotomy effect since the
operation. The patient shows some improvement in tremor scores and Jebsen scores as a result ofDBS
and a microthalmotomy effect at the 12 month post-operative assessment.
Figure b
preoperative (baseline) score of the total number of Jebsen subtests
Pre-op 1 month 3months 6months
assessment occasion (months after implant)
baseline score




Figures 6-6: Patient 2
A 52 year old man with MS for 20 years with a movement disorder affecting the dominant right arm





Pre-op 1 month 3months 6months 12months
assessment occasion
microthali
The figures show that there was no microthalamotomy effect after implantation. There is considerable
benefit in both the reduction in the severity of tremor and improved successful performance of the
Jebsen subtests 12 months after operation.
Figure b
6months 12months
effect of thalamic DBS
o
Pre
* No microthalamotomy effect
-op 1 month 3months
assessment occasion
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Figures 6-7: Patient 3
A 33 year old woman with MS for 6 years and a movement disorder affecting both of the upper limbs,
the head and trunk. The target arm was her dominant right arm.
Figure a
No microthalamotomy effect was present after the operation. The patient demonstrated a reduction in
the severity of tremor and improved performance on the Jebsen subtests at the 12 month assessment.
Figure b
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Figures 6-8: Patient 4
A 46 year old woman with MS for 8 years with a movement disorder affecting both of the upper








continued once the IPG was
explanted al 11 months due to
The figures show that the patient benefited from a microthalamotomy effect after operation. The
thalamic DBS had a small beneficial effect on the tremor score and the Jebsen score but the IPG had
to be removed 11 months after the operation due to an infection. After removal of the IPG the patient
still demonstrated an improved tremor score although the performance on the Jebsen test was not
altered by this persisting microthalamotomy effect.
Figure b
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Figure 6-9: Patient 5
A 50 year old woman with MS for 19 years with a movement disorder affecting both of the upper




This patient showed a considerable microthalamotomy effect which resulted in greatest improvement
in the tremor score at the 1 month post-operative assessment. At 12 months after the operation the







Figure 6-10: Patient 6
A 37 year old man with MS for 11 years and a movement disorder affecting the upper limbs, the head





The patient showed a microthalamotomy effect which was present after operation and persisted
resulting in a reduction in the tremor score at the 12 month post-operative assessment (it did not
influence the Jebsen score). Thalamic DBS had no effect on the tremor score and only a small
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Figures 6-11: Patient 7
A 27 year old man with MS for 7 years with a movement disorder for 3 years which affected both of











This patient had a marked microthalamotomy effect after implantation of the thalamic DBS electrode
and therefore did not proceed to implanation of the IPG. When assessed 1 month after operation the
microthalamotomy effect persisted and resulted in an improved tremor and Jebsen scores. The patient








Figure 6-12: Patient 8
A 44 year old woman with MS for 7 years and a movement disorder for 3 years affecting the upper
limbs, the head and trunk. The target arm was the dominant right arm.
Figure a
\ microthalamotomy effect
\ \ DBS OFF
\ effect of thalamic DBS '
\ uda UM
Pre-op 1 month 3months 6months
assessment occasion
Patient 8 showed a marked microthalamotomy effect which reduced the tremor score at the 1 month
assessment but did not influence the Jebsen score until the 3 month assessment. Thalamic DBS also
had a beneficial effect at 1 month and 3months post-operatively but had no effect at 6 months. Twelve
month assessment data was not obtained because the patient deteriorated and required admission to
hospital. She was unable to be positioned in a chair to be assessed because of severe lower limb
spasticity and sacral pressure sores.
Figure b
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Figures 6-13: Patient 9
A 46 year old woman with MS for 16 years and a movement disorder for 5 years which affected the
upper limbs, the head and trunk. The target arm was the dominant right arm.
Figure a
assessment occasion
This patient had a marked microthalamotomy effect which increased with time and was maximal at
the 6 and 12 month assessments. The DBS had a small beneficial effect on Jebsen scores, 1 and 3
months after the operation but the effect was not evident at the 6 and 12 month post-operative
assessments. The patient was 'better' when the DBS was off at the 12 month assessment than before
the operation which is shown on the video tape of the patient performing the volumetric test with the
DBS off and on.
Figure b
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Figure 6-14: Patient 10
A 39 year old man with MS for 10 years affecting the upper limbs, the head and trunk. The target arm














* No microthalamotomy effect
1 month
There was no post-operative microthalamotomy effect present when the tremor scores were
considered. However, there was a small microthalamotomy effect which improved the Jebsen scores
at the 1 and 3 month post-operative assessments. The effect of thalamic DBS was greatest at the 6
month assessment. The DBS was reprogrammed and a small benefit resulted in a reduction in severity
of tremor and improved performance on the Jebsen subtests.
Figure b
0




Figures 6-15: Patient 11
A 42 year old woman with MS for 8 years and a movement disorder affecting the upper limbs, the




There was a microthalamotomy effect present after the operation but this patient's functional use of
the arm was greatly limited by severe involvement of the head (titubation). This can be seen on the




Figures 6-16: Patient 12
A 51 year old man with MS for 16 years and a movement disorder for 9 years affecting the upper
limbs, the head and trunk. The target arm was the non-dominant arm because the function was better
preserved in this arm.
Figure a
assessment occasion
There was a small microthalamotomy effect with an additional small beneficial effect from thalamic
DBS. Optimal programming of the thalamic DBS was limited in this patient by dysarthria which was




Figures 6-17: Patient 13
A 36 year old woman with MS for 6 years and a movement disorder for 5 years which affected the
upper limbs, the head and trunk. The target arm was the right dominant arm. Patient 13 had undergone




This patient had thalamic exploration performed only. Thalamic DBS was unsuccessful and no target
could be found during the operation. Figures a and b show a slight deterioration in severity of tremor
and performance on the Jebsen subtests over the 12 months after the operation.
Figure b
thalamic exploration only - no DBS electrode or IPG
implanted
1 month 3months 12months
assessment occasion
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Figure 6-18: Patient 14
A 31 year old man with MS for 15 years and a movement disorder for 3 years affecting the upper
limbs, the head and trunk. The target arm was the non-dominant left arm. The patient had undergone
thalamotomy 5 years previously for a movement disorder in the right arm.
Figure a
This patient had thalamic exploration performed but did not proceed to implantation of any DBS
equipment, as a target could not be found. The figures show little change in the severity of tremor but




Figure 6-19: Patient 15
A 51 year old man with MS for 30 years and a movement disorder for 8 years affecting the upper
limbs. The target arm was the dominant right arm.
Figure a
This patient had thalamic exploration performed but did not proceed to implantation of any DBS
equipment as a target could not be found. The figures show that despite the fact that the operation was
regarded as unsuccessful the patient had a marked beneficial microthalamotomy effect after the




Ten of the 15 patients who underwent surgery had an initial microthalamotomy
effect after the operation which either reduced the severity of the tremor score in the
target upper limb, improved the performance on the Jebsen subtests or had a
beneficial effect on both outcome measures. The thalamotomy effect occurred in 7
patients (patients 1, 4, 5, 6, 8, 9 and 12) after implantation of the full DBS system; in
2 (patient 7 and 11) after implantation of the DBS electrode only and in 1 (patient
15) in whom the operation was unsuccessful, after thalamic exploration.
The patients all continued to show a persisting beneficial microthalamotomy effect at
the 12 month post-operative assessment although patients 7, 8, 11 and 12 were not
formally assessed because of reasons discussed in section 6.2.4 (record of the follow-
up assessments).
6.6 Long-term Effects of Thalamic DBS
The long term effects of thalamic DBS were divided up into the effects on
impairment, disability, handicap and aspects of QOL. Comparison was made of the
scores of the different scales and tests before operation with the scores 12 months
after operation in the patients who had implantation of DBS equipment (excluding
those who had unsuccessful attempts (N = 3)). The number of patients assessed
before operation was 12. However the number of patients assessed at 12 months after
operation was smaller because the assessments could not be completed on some
patients for various reasons. One patient (patient 4) had the thalamic DBS removed
at 11 months. Because of the time limit of the study twelve month follow-up data
was not available on the last two patients who underwent operations in Nov 1999 and
Feb 2000 (patients 11 and 12). The two patients who suffered thalamic haematomas
(patients 7 and 8) were not able to return to DCN for reassessment at 12 months and
therefore it was not possible to complete the Kurtzke FS or the EDSS as a
neurological examination was necessary. The assessment forms had to be posted to
the patients for completion and patient 7 did not return the forms. The FIM and BI
were scored by telephone conversation.
The mean and median values for the measures used in the study are shown in the
following tables. The level of significance between the scores of the measures before
operation and the scores 12 months after operation using the Wilcoxon signed ranks
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test are also shown (in patients assessed on both occasions). P<0.05 was the level
accepted for significant difference.
6.6.1 Effects on impairment/ disability
The Kurtzke Cerebellar FS and the EDSS were scored. No significant change was
found between the assessments before operation and 12 months after although the
scores of both the Kurtzke Cerebellar FS and the EDSS were worse at the 12 month
follow-up assessment than they were pre-operatively.
Table 6-9: Details on the Kurtzke Cerebellar Functional Systems and the EDSS
N Mean Median P value
Kurtzke FS (cerebellar)
Best possible score = 5
Worst possible score = 0
Pre-operative = 12






Best possible score = 0 Pre-operative = 12 7 7
| 0.32
Worst possible score = 10 12 m after operation = 7 7.3 7.5
6.6.2 Effects on disability
6.6.2 (i) FIM and Barthel Index total scores
The total score of the self-care section of the FIM was used to provide a measure of
the patient's ability to perform activities of daily living which included eating,
grooming, dressing upper body, dressing lower body, bathing and toileting. These
ADL covered a range of activities which required the patient to use the target upper
limb. In 6 (67%) of the 9 patients the total score for the self-care section of the
FIM was either the same or better at 12 months after operation than before. Three
patients showed deterioration in scores (patients 3, 7 and 8).
The Barthel was included as a more global measure of disability to enable a
comparison to be^ade of activities of daily living which were influenced more by
general mobility rather than upper limb function. In 7 (78%) of the 9 patients the
total Barthel score was either the same or better at 12 months after implantation of
DBS compared with pre-operatively. The 2 patients (patients 7 and 8) who showed
considerable deterioration in Barthel scores (16 - 5, 15 - 2) both suffered thalamo-
capsular haematomas after implantation.
There was no significant difference in the FIM (self-care) (p = 0.67) or the Barthel (p
= 0.67) scores between the pre-operative and 12 month post-operative assessments.
The mean and median FIM scores were slightly better at 12 months after operation
than before the operation indicating a slight reduction in the amount of assistance
that patients required to perform the activities included in the self-care section of the
FIM. The mean and the median Barthel scores were lower (the median score being
50% lower) at 12 months after operation than before operation suggesting that the
patients' general level of ability in performing ADL had decreased.
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Table 6-10: Details on the measurement ofdisability
N Mean Median P value
FIM (self-care section)
Best possible score = 42 Pre-operative = 12 22.9 23.5
r 0.67
Worst possible score = 6 12 m after operation = 9 23.7 24
J
Barthel Index
Bestpossible score = 20 Pre-operative =12 10.3 13
)
Worst possible score = 0 12 m after operation =12 9 6.5 j 0.67
6.6.2 (ii) FIM and Barthel Index items
As deterioration in one item of the FIM or Barthel in a particular patient could be
counteracted by improvement in another resulting in the total score remaining the
same it was necessary to look at changes in individual items for each patient.
There was some improvement in all items of the self-care section of the FIM but
especially for the dimensions of eating (7 patients improved) and grooming (4
patients improved). The feeding dimension of the BI also showed improvement in 3
patients, dressing in 1 and toileting in another patient because he was able to perform
intermittent self-catheterisation independently after implantation.
The 2 patients (patients 7 and 8) who suffered thalamo-capsular hemipareses post¬
operatively showed deterioration in items of both the FIM and the Barthel as the
motor weakness resulting from the hemiparesis not only limited the functional ability
to perform activities of daily living with the target upper arm but also had a severe
impact on their ability to perform more general activities of daily living such as
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transfers, bathing and walking. Both patients developed problems with
incontinenece due to their reduced levels ofmobility.
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Table 6-11: Change in F1M (self-care) and Barthel Index scores from pre¬
operative assessment to 12 month follow-up (N = 9)
FIM Dimension: No change Improved Deteriorated
Eating 3 7 1
Grooming 5 4 2
Bathing 7 1 2
Dressing upper 5 2 3
body
Dressing lower body 4 3 3
Toileting 5 2 3
Barthel Dimension: No change Improved Deteriorated
Bowels 9 1









6.6.3 Effect on handicap
The LHS and the Handicap Questionnaire were the 2 scales used in the study to
estimate change in handicap due to thalamic DBS. There was no significant change
in handicap experienced by the patients 12 months after operation compared with
before the operation.
Table 6-12: Details on the measurement ofhandicap
N Mean Median P value
LHS
Bestpossible score = 100
Worst possible score = 0
Pre-operative = 12







Best possible score = 0 Pre-operative = 12 6.6 6.5
Worst possible score = 9 12 m after operation = 8 6.9 7 10.10
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6.6.4 Effects on aspects of QOL
The only significant change between the scores before operation and 12 months after
operation were in the anxiety score of the HAD. Patients perceived themselves to be
less anxious 12 months after operation compared with before the operation (p = 0.03)
However the number ofpeople assessed at 12 months was small (N = 8).
Table 6-13: Details on measurements ofaspects ofQOL:
N Mean Median P value
Fatigue Severity Scale
Best possible score = 1
Worstpossible score = 7
Pre-operative = 12







Best possible score = 0 Pre-operatively = 12 14.8 13 } 0.18Worst possible score =42 12 m after operation = 8 9.4 5
HAD (anxiety)
Best possible score = 0 Pre-operatively = 12 7.5 7
} 0.03Worst possible score = 21 12 m after operation = 8 4.4 3
HAD (depression)
Best possible score = 0
Worst possible score = 21
Pre-operatively = 12





6.6.5 Effects on percentage of functional disability
The percentage functional disability score was calculated by expressing the patient's
total upper limb score as the sum of Parts A, B and C of the MFTRS in % terms as
suggested by Fahn{Fahn et al. 1988). The figure given in the column headed
'change' is simply the pre-operative % minus the 12 month % and is not a ratio.
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Table 6-14: The percentage functional disability between pre-operative and 12
month evaluations
Patient Pre-operative 12 month follow-up change
1 75% 58% 17%
2 72% 45% 27%
3 * 78% 68% 10%
4 * 75% 68% (DBS removed at 11 months) 7%
5 * 68% 52% 16%
6 4* 88% 83% 5%
7(4) 63% not assessed owing to geographical limitation
8 78% DNA
9 * 87% 28% 59%
10 * 85% 77% 8%
11 (♦) 70% not assessed owing to time limit
12 * 75% 55% (*1 month-op Feb2000) 20%
13 (#) 73% 78% 5%
14 (#) 78% 87% 11%
15 (#) 75% 48% 27%
Mean 76% 68% 18%
* = DBS system implanted (DBS electrode and IPG)
♦ = DBS electrode implanted
# = Unsuccessful attempts
The change in percentage functional disability ranged from 5 - 59% overall (mean
score = 18%) when all 15 patients were considered. In those patients in whom DBS
were implanted 50% of patients change scores fell between 8 - 20% and there was
one outlying change score of 59% in patient 9. One of the patients (patient 15) in
whom a thalamic target could not be located intra-operatively (therefore regarded as
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an unsuccessful attempt) had a marked improvement in the change in percentage
of functional disability (change of 27%) at 12 months, despite the fact that no DBS
equipment was implanted.
6.6.6 Patients' perceptions of the outcome of the operation
When asked about their opinion of the operation the patients expressed varying
degrees of satisfaction as shown in table 6-15. None of the patients were enthusiastic
about the outcome of the operation. The five patients who were negative about the
outcome of the operation were the three patients in whom the surgeon was unable to
locate a target (unsuccessful attempts in patients 13, 14 and 15), the patient who
suffered a thalamic haematoma immediately after operation (patient 7) which
resulted in hemiparesis and some memory dysfunction and a patient who had a
marked beneficial effect on the severity of tremor in the upper limb after
implantation of the DBS electrode due to microthalamotomy effect but perceived no
benefit as the movement disorder also affected the head and severe head titubation
persisted after operation which negated the benefit in the upper limb. The opinions of
the last 2 patients who underwent surgery in November 1999 (patient 11) and
February 2000 (patient 12) are included despite the fact that only a short period of
time had elapsed.
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6.6.7 Differences between the overall assessment of the examiner versus that of
the patient of tremor related disability postoperatively
Both the patients (excluding the 3 who were unsuccessful attempts and did not have
any DBS equipment implanted) and the examiner tended to rate the patient's tremor
related disability as less severe after surgery than before. The figure shows that at
every evaluation the tremor related disability as rated by the patient and compared to
that of the examiner differed, patients' ratings of (their) disabilities tending to be
marginally less severe than the examiner's ratings.
Figure6-20:Meanlobalassessmentoftremor-related,disabiliti sbyhexam n rnp tie tslev luations Pre-op1month3months assessmentintervals6months
12months
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6.7 Cost-Effectiveness of Thalamic DBS
The operations performed in this study were carried out between October 1996 and
February 2000. Fifteen patients underwent stereotactic exploration of the thalamus,
10 patients had implantation of the DBS system, two patients had implantation of the
stimulating electrode only and in three patients the surgeon was unable to locate a
target for DBS and the procedure was abandoned. The costs involved in thalamic
DBS were categorized into three main areas of interest: the cost of assessment, the
cost of the intervention and the cost of follow-up.
6.7.1 Costs involved with thalamic DBS
6.7.1 (i) Assessment costs
The patients were referred to the neurosurgeon to be assessed for their suitability for
implantation of a thalamic DBS. The patient was then seen as an outpatient, for an
initial consultation in the out-patient clinic of the Department of Clinical
Neurosciences which cost £84. If deemed an appropriate candidate they were then
admitted at a later date to the Astley Ainslie Hospital so that extensive baseline
assessments could be carried out. These assessments were carried out over a two-day
period, which necessitated an overnight stay on the rehabilitation ward in Charles
Bell Pavilion costing £127.37 which included all staff costs. The subtotal cost for the
initial assessments was £211.37 per patient.
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6.7.1 (ii) Intervention costs
There were substantial equipment costs associated with this procedure which were
not incurred in this study as the MS Society funded the provision of the hardware,
the cost of which is approximately £7,000 (£715 for the thalamic stimulation lead,
£135 for the extension wire and £6,160 for the pulse generator (costs provided by
Medtronic 1998).
Prices were calculated for operations as an average charge (average specialist tariff).
In calculating this average charge several factors are taken into account: these were
the type of operation (each operation having a procedure code provided by the Office
of Populations and Consensus), the average length of stay for that particular
operation, consumables utilised (syringes, food, drugs), staff salaries and time and
overheads incurred by the unit. The average length of stay for a stereotactic operation
was 7 days (information provided by the Information and Statistics Division, NHS in
Scotland).
However, all patients who had surgery in this study except those patients who were
unsuccessful attempts stayed in DCN longer than 7 days: the mean length of stay was
in fact 15 days. Therefore in order to reflect this extra cost incurred to the hospital
due to a longer stay in DCN for thalamic DBS, the cost of the additional days was
calculated by multiplying the number of additional days exceeding the 7 allowed for
stereotacic operation by the cost of one nights stay in hospital (£127.37/night).
Thalamic DBS was a new technique and was being performed in only a small
number of cases so the Finance Department in the Trust included it under the code
for stereotactic operations (code A03). The charge for operation included under this
code was £4,602 (provided by the local NHS Trust finance directorate). However if
the patient had thalamic exploration performed without the implantation of any
equipment (as was the case in those patients in whom DBS was unsuccessful), or had
implantation of a thalamic DBS electrode only (as was the case in those patients who
had a microthalamotomy effect as a result of the surgery) the charge was £1,982.
Therefore the intervention cost for implantation of the thalamic DBS system was
£11,602 (ie. full equipment costs + charge of £4,602 for in-patient stay in DCN); the
cost for DBS electrode implantation was £2,697 and the cost for thalamic exploration
was £1,982 (ie reduced equipment costs + reduced charge for shorter in-patient stay
in DCN).
6.7.1 (iii) Follow-up costs
It became apparent that some of the patients required a short period of intensive
training of their target upper limb post-operatively. This was organised on an in¬
patient basis in the majority of cases at the Astley Ainslie Hospital. Also some
patients required more general intensive rehabilitation to return to their preoperative
level of functional ability. The charge for rehabilitation was £127.37 per day. The
mean length of stay (LOS) for all 9 patients who had a period of rehabilitation was
54 days (median 25 days). Three patients had exceptionally long stays due to the
development of post-operative complications. Patients 7 and 8 developed thalamic
haemorrhages and patient 4 had a grand mal seizure. Patients 5 and 6 were the most
severely disabled patients who were referred for thalamic DBS and were maintained
at home owing to maximum care provided by both Social Services and private care
organisations. Both patients had regular respite admissions to the Young disabled
Unit at Liberton Hospital and consequently they were transferred there post¬
operatively to receive a short period of rehabilitation focusing on retraining of the
target upper limb. This was followed by an extended period of respite care whilst the
support from the various care organisations was restarted before final discharge
home. Consequently there was an unforeseen general rehabilitation cost incurred in
some patients which turned out to be quite substantial in some cases.
The researcher often had to make frequent visits to the rehabilitation hospitals during
the first month following the operation as it was often necessary to carry out some
"fine tuning" of the stimulation parameters to achieve the optimum effect. The cost
for these visits was £19 per hour{Netten & Dennett 1996). Readjustments of the IPG
parameters were made, as needed during scheduled study visits or during interim
visits either of the patient to the hospital or of the research fellow to the patient's
home where distance allowed. The number of visits for reprogramming varied
between patients (range 2 to 14) but the average number of visits was 5.
Also, there were difficulties encountered by the patients and the nursing staff with
regard to swiping the IPG with the magnet in order to turn the thalamic DBS on and
off. Patients were often not sure whether they had swiped the IPG successfully or not
and whether the DBS stimulator was switched on or off. The only solution to this
problem appeared to be to issue each patient with a small transistor radio, which
produced a buzzing sound (caused by interference of the radio waves) if held over
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the IPG when it was switched on. The cost of purchasing the radios (which cost £20
each) was a cost which had not been anticipated at the outset of the study.
The patients were required to attend for review at one, three, six and twelve months
post-operatively. The follow-up assessments took place at the Astley Ainslie
Hospital where the patient attended as a day case and stayed on the ward for the day
so that the assessments could be carried out in the morning and afternoon. There was
an obvious direct cost to the NHS for these follow-up assessments (£73.50
/assessment x4 = £294).
6.7.1 (iv) Additional costs
Transport costs to and from the Western General Hospital and the Astley Ainslie
Hospital are mentioned because in some cases, for example in patients living in
England, these costs were high. There was a standard scale of charges for ambulance
journeys of £20 per hour and £7.55 per mile which was based on area in Scotland and
on distance in England. There was also an additional charge of £20 per hour for
providing a 2-man crew, which was mandatory for long distance journeys from
England.
The procedure involves an ongoing maintenance cost as the patients required to be
monitored for any adverse side effects related to the stimulation. Also at some stage
the IPG battery will need to be replaced depending on the life expectancy of the
patient. There will therefore be additional follow-up costs if patients survive more
than 4 or 5 years.
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Table 6-16: Length of stay (LOS) in DCN, length of stay in rehabilitation unit












K*) 7 14 14 4
2(+) 16 14 5 4
3 (4») 7 7 3 4
4(*) 19 68 2 4
5(4.) 10 43 6 4
6(4.) 21 25 2 4
7 (♦) 9 253 0-Electrode only 1
8(4.) 41 103 2 4
9(4.) 11 - 2 1
10(4.) 12 10 5 4
11(f) 10 - 0-Electrode only 1
12(4.) 12 - 0 1
Mean 15 days 54 days 4.5 visits 3 visits
Median 12days 25days 2.5 visits 4 visits
13 (#) 5 - - 4
14(#) 5 - - 4
15 (#) 5 5 - 4
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6.7.1 (v) The average cost per patient implanted with a thalamic DBS
The average cost per patient implanted with a thalamic DBS was £14,279.65. This
figure estimates the total costs for the entire programme of assessment, intervention
and follow-up including the costs for assessment of 22 patients who were assessed as
not suitable candidates for operation and the costs involved in treating those patients
in whom DBS electrodes only were implanted (♦) and those who were unsuccessful
attempts (#).
The substantial equipment costs were met by the MS Society in this study. The
hardware, (thalamic stimulation lead, extension wire and pulse generator) associated
with this procedure costs approximately £7,000 and the equipment costs have
therefore been included in the costing exercise.
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1(*) 211.37 7,000 4,602 1,783.18 295 266 20 14,177.55
2(*) 211.37 7,000 4,602 +
9 days
1,783.18 295 95 20 14,006.55
3(4.) 211.37 7,000 4,602 891.59 295 54 20 13.076.96
4(4.) 211.37 7,000 4,602 +
12 days
8,661.16 295 38 20 20,827.53
5(4.) 211.37 7,000 4,602 +
3 days
5,476.91 295 54 20 17.719.28
6 (4.) 211.37 7,000 4,602 +
14 days
3,184.25 295 38 20 15.350.62
?(♦) 211.37 715 2,697 +
2 days
32,224.61 73.50 - - 37,826.48
8(4.) 211.37 7,000 4,602 +
34 davs
13,119.11 295 38 20 25.285.48
9(4.) 211.37 7,000 4,602 +
4 days
- 295 38 20 12,166.37
10(4.) 211.37 7,000 4,602 +
5 days
1,273.70 295 95 20 13.497.07
11(4) 211.37 715 2,697 +
3 days
- 73.50 - 5,601.87
12(4.) 211.37 7,000 4,602 +
5 days
- 73.50 - 20 11,906.87
13 (#) 211.37 - 1,982 - 295 - - 2,488.37
14 (#) 211.37 - 1,982 - 295 - - 2,488.37
15 (#) 211.37 - 1.982 636.85 295 - - 3.125.22
Total Cost (excluding the assessment costs of those not proceeding to operation) £209,544.59
Assessment costs of patients not proceeding to operation (22 x £211.37) £4,650.14
Total cost (including the assessment costs for those not proceeding to operation) £214,194.73
Average cost per patient of implantation with a thalamic DBS £14.279.65
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Legend: *= patients in whom thalamic DBS system was implanted, ♦ = patients in
whom a DBS electrode only was implanted and # = unsuccessful attempts, Equip =
cost of equipment, LOS = cost of length of stay, Rehab = cost of rehabiliatation,
Follow-up = cost of follow-up assessments, PT visit = cost of physiotherapist's visits
to reprogramme the DBS, Radio = cost of the transistor radio given to patients to
confirm whether DBS was on or off.
6.7.6 Resource use (home care) after implantation
The majority of patients referred for thalamic DBS were severely disabled by the
movement disorder and the MS and received assistance with ADL such as eating and
drinking, either from a relative or from social services.
The amount of assistance required by patients at home with activities of daily living
was estimated at the pre-operative assessment and then at the 12 month assessment
by completing the self-care section of the Functional Independence Measure (FIM).
As noted above, two primary outcome measures were used to detect change in the
target upper limb at the four follow-up assessments: the MFTRS measured change in
severity of tremor and the JTHF measured change in the performance of functional
tasks.
There was a statistically significant improvement in both severity of tremor
amplitude and functional performance of the Jebsen subtests in the target arm at all
the follow-up assessments when the stimulator was switched on as reported earlier in
the results. However this improvement did not have clinical relevance in that scores
on the self-care section of the FIM did not show a significant change (p= 0.67, N=9).
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There was no difference between the amount of assistance required by patients to
carry out activities of daily living before the operation compared to 12 months after
the operation. Consequently there was no reduction in the amount of help provided
either by a relative or by homecare services after the thalamic DBS was implanted
and therefore there was no saving on the cost of the homecare resources as patients,




This chapter contains a discussion of the results of the study in terms of whether the
purposes have been achieved and relevant hypotheses supported or rejected, and of
issues that have emerged. The purpose of the study was first to devise and validate a
standardized test for use with patients with MD due to MS and secondly to provide a
preliminary evaluation of the relative merits and demerits of thalamic DBS and
thalamotomy in management of patients with tremor due to MS. The emphasis was
on measuring outcome in terms not only of quantitative change in tremor, but of
changes in disability, handicap, aspects of quality of life and patient perception of
effectiveness. The third aim of the study was to investigate the costs of thalamic DBS
in relation to its benefits.
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7.2 Methodological Difficulties
7.2.1 Ascertaining the clinical subtpe ofMS
It was difficult to ascertain the clinical subtype of the majority of patients referred to
this study (N = 37) either from the referral letter or the case notes where these were
available. This was presumably because although the terms used to describe the form
or clinical stage of the disease had been used for many years, there was no consensus
among clinicians for the meaning of these terms before 1996 (Lublin and Reingold
1996). This classification is based on the evolution of MS-related impairment over
time and many of the patients in the present study did not have regular contact with a
neurologist so that the disease subtype had often not been determined.
Of the 15 patients who underwent thalamic DBS and were followed up over the
course of the study 10 patients had entered the secondary progressive phase of MS
having initially been diagnosed with relapsing-remitting disease. Secondary
progressive MS tends to affect whichever system has bome the brunt of the disease
earlier in the course and the cerebellar system is more frequently involved than in
primary progressive MS (Matthews 1988).
In the present study the mean time after diagnosis of the disease to onset of the
movement disorder was 7.8 years in the patients who underwent surgery (N = 15)
suggesting that movement disorders were not the presenting feature of the disease.
Five patients developed cerebellar signs early on in the course of the disease and had
what appeared to be a more aggressive form of MS which could probably be
classified as progressive-relapsing MS. The disease was progressive from its onset in
these patients, with clear acute relapses but continuing progression in the periods
between relapses.
Despite the fact that the majority of patients who underwent surgery had secondary
progressive MS and were therefore a particular subgroup of the MS population, there
was wide variation with regard to the presentation ofmovement disorders within this
group of patients. The group could be further subdivided into: patients in whom the
MD predominately affected the upper limbs (16%); those in whom it predominately
affected the axial muscles of the trunk and neck (3%); and those with movement
disorders affecting both the axial and limb musculature (81%).
It appears that the patients referred for this study were at the severe end of the
spectrum with regard to severity of disease and severity of movement disorder. Five
patients were deemed not suitable for thalamic DBS because of severe associated
neurological dysfunction and 6 patients were unsuitable because they presented with
either predominant axial tremor or a combination of axial and upper limb tremor. In
the latter sub-group thalamic DBS was unlikely to have a useful effect on the upper
limb because of the severity of the movement disorder affecting the midline
musculature.
In the present series, the most common presentation, in 30 (81%) of patients, was for
the movement disorder to affect the upper limbs, head and trunk. A recent study by
Alusi et al (Alusi et al. 1999b) assessed 100 patients in the MS Unit of the Central
Middlesex Hospital and found that 57 exhibited tremor. There were major
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differences between the patients in their study and those in the present study with
respect of the presentation ofmovement disorders (See Table 7-1). They found that
head tremor occurred in 7% and trunk tremor appeared in 5% of the patients and
suggested that the movement disorders in these locations of the body were present in
isolation as no mention was made ofmovement disorders affecting different areas of
the body in combination. This seems unlikely given the findings of the present study
in which 6 (16%) patients had movement disorders affecting the upper limbs only
and none of the patients had a movement disorders affecting just the head: it always
appeared in combination with tremor in the trunk. Also, a much higher proportion of
patients had involvement of the head, upper limbs and trunk in the present study
suggesting that they were more severely affected by the MDMS. This is perhaps not
surprising since the patients were referred for specific intervention to treat their
movement disorders.
Table 7-1: Comparison of the presenting movement disorders of patients in
Alusi et al's study and the present study




Alusi et al's study
N = 57
Arms 97% 55%
(unilateral in 17%) (unilateral in 31%)
Head 86% 7%
Trunk 27% 5%
Legs Not assessed 11%
Combination 81% no data given
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7.2.2 Recruitment problems
The numbers of patients referred to this study was small and this must be taken into
account when considering the findings. Incidental sampling of patients was used to
recruit patients consecutively as they were referred to the neurosurgeon. In the case
of this study it was necessary to assess all available cases to achieve satisfactory
numbers. However patients were only selected if they were appropriate candidates
for thalamic DBS implantation.
Thirty seven patients were assessed in order to recruit 15 patients for surgery and out
of this group only 10 patients had implantation of the full thalamic DBS system.
Therefore thalamic DBS is only appropriate for a small number of patients with
MDMS and explains why there were difficulties in recruiting large numbers of
patients. A multi-centred study would have been necessary to perform a randomized
control trial. However this would have been extremely difficult to co-ordinate and
probably impractical. A UK register of strereotactic surgery for MDMS may help to
further address the role of stereotactic surgery in these patients.
The patients who had implantation of the thalamic DBS system were to some extent
their own controls in that the DBS could be turned off and on at each of the post¬
operative assessments. However when patients' DBS were turned off at the post¬
operative assessments their ratings of severity of tremor and their performance on the
Jebsen subtests often did not return to their initial pre-operative baseline scores. This
was due to a beneficial microthalamotomy effect resulting from the operation.
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Another difficulty which limited recruitment of patients was the organization of the
NHS in 1996. Extra contractual referrals (ECRs) were required from the referring
Health Authority/Board for patients living outwith Lothian region to be treated by
the Western General NHS Hospital Trust. The GPs and neurologists of such patients
faced administrative difficulties in attempting to secure an ECR for the patient. This
involved numerous phone calls to make arrangements and letters requesting
authorization. There were frequently problems with agreement of funding for the
operation and for transport to and from Edinburgh. Unfortunately the requirement for
ECR in the NHS at the time the study began imposed many barriers and severely
limited our ability to perform the study other than on a regional basis.
The study was therefore carried out in as practical a way as possible although certain
constraints militated against an ideal study design. The selection of patients for
inclusion in the study was however likely to be representative of the population of
MS patients with movement disorders referred for thalamic DBS, to which the results
would be applied.
7.2.3 Problems with measurement
7.2.3 (i) Confounding variables
Confounding variables are those factors other than the treatment variable (thalamic
DBS) that can cause differences in the dependent variables (severity of tremor,
performance of the Jebsen subtests and all other measures). The main confounding
variables which were present in this study were:
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Bias
In this study the effect of thalamic DBS was confounded by the patients' knowledge
of the treatment they received. This threat to validity was not possible to avoid as
patients could not be 'blind' to the fact that they had had a surgical procedure
performed. The patients were also given an information sheet before the operation
which may have led to expectation bias, and influenced the patients' responses to
questions on the different subjective questionnaires which were used to measure
outcome in the study.
The examiner was aware of the treatment the patients received, which may have
caused expectation bias in examiner ratings. The assessment of tremor and upper
limb function was performed in a single blind fashion since the examiner was
unaware of the status of the DBS but it was not possible to 'blind' the patients as
they experienced a 'kicking-in' effect when the DBS was switched on. Although I
was blind to whether the DBS was switched on or off at the post-operative
assessments, the patients were well-known to me and the nature of the setting of the
DBS was therefore often apparent. One way to control for this bias would have been
for another examiner to replicate all assessments. This was not practical because
patients with MS are easily fatigued and it was necessary to carry out 2 assessments
(one with the DBS on and one with the DBS off) at each post-operative visit.
Obtained independent ratings of videotape recording of all assessments was not
practical and would not have eliminated some possible influence of examiner bias.
Many of the design limitations and potential sources of bias might have been
expected to exaggerate the apparent effectiveness of thalamic DBS. ~
232
7.2.4 Limitations relating of the tests
7.2.4 (i) Limitations of tremor rating scale (MFTRS)
Measuring tremor clinically is difficult because tremors manifest themselves in
different and often complex ways. Tremors have characteristic on/off triggers and
natural fluctuations in amplitude and to a lesser extent frequency (Bain 1998). The
amplitudes of physiological and pathological tremors exhibit significant diurnal
fluctuations (Elble and Koller 1990).
The characteristics of a tremor are influenced by a variety of factors including the
experimental environment and the patient's physical, emotional and mental state as
well as the tremor's natural cycles. In most clinical studies, tremor is evaluated for
only a brief period of time, usually minutes. Thus the major problem in patient with
MS is how to obtain a representative sample of a movement disorder that is rarely
stable. Also there could be some practice effect on tests used to assess severity of
tremor as a result of repeated testing but there is no direct way of measuring this
without a control group. However practice effects would be unlikely to be
differentially potent when the DBS was on compared with off at any given
assessment.
Intermittent 'jumps'of the patient's hands were observed by 4 examiners rating
severity of tremor in 12 patients with ET and 8 patients with 'dystonic' tremor (Bain
et al.1993) and these frequent 'aperiodic' but sudden increases in tremor amplitude
would be the events most likely to cause a patient to spill a cup of coffee or ruin a
piece ofwriting.
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Another problem of assessing patients with severe flailing movement disorders in the
upper limbs like those seen in patients with MS is that patients are usually unwilling
to allow their arms to thrash about for even a few seconds (Bain 1998). This problem
introduces a significant subjective bias to the observation and measurement of such
movement disorders.
Holmes (Holmes 1917) suggested that fatigue might play an important role in the
genesis of cerebellar postural tremor. Cerebellar postural tremor of the extremities is
often asymptomatic until the patient has maintained a steady posture for several
seconds (Gilman 1981). This was considered when assessing postural tremor in
patients with MS as the patients were asked to attempt to maintain the posture for 15
seconds. The possibility that fatigue could underlie cerebellar postural tremor has
not been adequately investigated.
In 1917 Holmes (Holmes 1917) made detailed observations of patients with
cerebellar injuries and he observed that simple actions which required movement at
one joint only were fairly accurately performed, though complex movements were
ataxic and irregular. Evidence of this was apparent in many of the patients in this
study when they performed the finger nose test. They were often able to touch
objects that they could reach with their fingers with their limbs fully extended more
easily than when movements at the elbow or other joints were necessary. It may
therefore have been advantageous to ask patients to touch the examiner's finger
positioned at different distances in front of the patient - some close and some at the
limit of the patient's reach.
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The finger nose test was designed to quantify an accurate intentional movement and
the kinetic/intention component of a movement disorder was measured by observing
the patients move their index fingers towards a target (the examiner's finger). The
examiner's finger is commonly placed at the limit of the patient's reach and therefore
probably does not reveal the true extent of the kinetic/intention tremor resulting in
the test having weak validity.
Holmes also noted that irregularity in direction and range was always more marked
in rapid than in slow movements. In fact when the patients were asked to execute the
movement slowly, or were urged not to hurry, there was little or no obvious
disturbance (Holmes 1917). This observation may also have a bearing on the finger-
nose test. There is no literature describing the methods for performance of the finger
nose test or of the speed at which the test should be performed. This was a weakness
of the present study and in hindsight it might have been beneficial to have asked the
patient to perform the test at different speeds and then record the worst (highest)
rating of kinetic/intention tremor.
Part C of MFTRS included questions about ADL which were confusing for both the
examiner and the patient. The questions were concerned with unilateral and bilateral
upper limb activities and did not specify which hand was being assessed. Therefore
the patients who had no involvement (3% of patients) or unilateral upper limb
involvement only (17% of patients) fared better than the patients with bilateral upper
limb involvement (80% of patients) as they were still able to perform the tasks with
the unaffected hand. The majority of patients had both upper limbs affected by the
movement disorder and it might therefore have been better to omit this section of.the
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MFTRS especially as the self-care section of the FIM provided a detailed assessment
of upper limb function which was valid and reliable for the measurement of ADL in
this group of patients (Granger et al.1990).
Patients and the examiner also had difficulty separating tremor-related disability
from overall disability caused by the MS when making a judgement upon the
severity of tremor-related disability. It is likely that severe disability resulting from
progressive MS may have influenced the scores of tremor-related disability.
Consequently because the subjective assessment scores of the examiner and the
patients of overall tremor-related disability did not provide a valid measure of tremor
related disability the results of the comparison at each evaluation should be regarded
with caution.
7.2.4 (ii) Limitations of the EDSS
The Kurtzke Scales are the only widely used and recognized scales in multiple
sclerosis research but they are impractical in clinical practice and very insensitive to
changes in impairment and disability. The severity of tremor in a patient's target arm
may improve but this will not be reflected in the Kurtzke cerebellar functional
system as the scale does not allow for different areas of the body to be scored
individually but provides an overall score of the severity of tremor. The type of
tremor or location of the tremor are not considered. Thus it is a very crude measure
of tremor severity.
The neurologist scored the cerebral functional system of the Kurtzke Scale at the pre¬
operative assessment and scores showed cognitive deficits in 40% of the patients
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who subsequently underwent implantation of a thalamic DBS. Detailed
neuropsychological assessment revealed that in these patients the mean initial test
score (142, SD = 13 N = 15) was far below the level of comparable normal controls
(168, SD = 4, N = 54). Only one patient who proceeded to implantation scored above
the fifth centile level (score = 159) of normal controls.
The Kurtzke FS has poor validity for severity of tremor and cognitive function. Not
surprisingly in relation to both its reliability and responsiveness the EDSS has been
subject to considerable criticism (Noseworthy et al. 1990; Whitaker et al. 1995;
Willoughby and Paty 1998).
7.2.4 (iii) Limitations of tests of upper limb function (JTHF)
To perform a motor task with a limb a patient requires an adequate background of
postural control and stability of the trunk and limb girdle so that the movement can
be executed in a smooth and co-ordinated fashion. To reduce the truncal ataxia and
achieve a degree of truncal stability the patients in the present study often had to be
provided with a supported sitting position which necessitated reclining the back of
the wheelchair slightly and in more severe cases providing some restraint by using a
thoracic harness. This reclined position created a problem when patients attempted to
use their upper limbs for function as the distance to a table in front of them was
increased and the angle of the head limited their visual control of the task in
question. Visual control is important in improving accuracy of movements
(Jeannerod 1984; Prablanc et al. 1979) and the cerebellum plays a significant role in
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co-ordinating all sensory inputs with motor activity to ensure smooth voluntary
movements take place (Costeff et al. 1990).
Holmes (Holmes 1917) noted that disturbances of movement were not improved by
vision and patients were as bad at performing movement with their eyes open as with
their eyes closed. However it has been observed that in some patients with cerebellar
tremor, removal of visual feedback improves movement (Findley 1988). Removal of
visual feedback probably has an effect by influencing the abnormal dysmetric
component occuring with the movement. Several patients in this study reported that
it was easier for them to keep their heads still whilst being fed by others if they did
not see the food coming towards them.
Difficulties arise in the measurement of upper limb function because it is a product
of a multiplicity of factors, many of which are vaguely defined. The personality and
motivation of patients will contribute to their willingness to perform the test. In
addition the physical (eg. visual impairment, sensory abnormalities, fatigue) and
mental state of the patient will also affect participation and may negatively influence
the patient's performance.
Slowness, awkwardness and irregularity of finger movements were apparent when
MS patients handled objects. The difficulties in bringing each finger of the affected
hand separately and accurately to the tip of the thumb have been described in detail
(Holmes 1917). These disorders ofmovement became even more apparent when the
patient attempted to use simple and familiar tools. For example, in writing the pencil
was held incorrectly and insecurely, often grasped too tightly, and its point was
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pressed much too firmly into the paper. The letters were frequently unequal in size
and irregularly spaced: the individual letters were badly formed and their lines were
often jerky and angular. As patients attempted to write they paused frequently,
especially between the up-and down-strokes of the pen and the movement of the pen
was consequently interrupted and discontinuous.
Another major influence on the patients' ability to perform the test may be the
environment in which the test is performed. A test performed in a hospital
environment may give a very different picture of the patients' ability from that in
their home environment.
There are limitations to the inferences that can be made from the JTHF. Jebsen et al
(Jebsen et al. 1969)chose activities that they thought to be representative of hand
functions normally used in the performance of ADL. However, no correlation was
observed by the authors between the performance of the tests and performance of a
standardized upper extremity ADL test to test the validity of the subtests. Therefore
the validity of the JTHF is questionable as the theoretical argument that supports the
use of the JTHF for specifically measuring ADL was not proven.
Lack of evidence for validity and reliability is one of the principle problems in much
of the research on assessments that are currently in use. However from the literature
it is apparent that efforts are now being made to rectify this problem. The work of
Jones (Jones 1986) was not considered until the JTHF had been chosen for use in the
present study and it revealed that the JTHF is not a predictor of ADL but is
predictive of change and is able to detect mild dysfunction in patients with tremor.
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However the JTHF fulfilled most of the criteria which should be demonstrated by a
scale which provides accurate assessment of function (Liang and Jette 1981) : it had
been shown to give consistent scores when repeated in patients with neurological
conditions and to give good agreement in scores when administered by different
observers; data collection methods had been standardized; and it included a range of
functional activities which were problematic to patients with MDMS.
Changes in the successful performance of subtests were of greatest importance in
following the patients with MDMS in this study. If a patient was unable to pick up
the kidney beans on the teaspoon before the operation but was able to accomplish the
task after operation, it was concluded that there had been an improvement in
performance on this task. Assessment of the total number of successful Jebsen
subtests (out of a total of 7) with the DBS on and off, provided an estimate in change
in performance in the subtests over the study period but it was not used to draw
conclusions regarding function in ADL.
There are many different and complex movements involved in upper limb function
and it is probably not possible to devise a test which incorporates them all.
The clinical assessment of the patients in this study with MDMS involving the upper
limbs, trunk and head highlighted two important points. First upper extremity
function cannot be thought of in isolation. In this group of patients although severe
upper limb movement disorders were often the main reason for seeking help 81% of
the patients had involvement of the head and trunk also. In some cases movement
disorders affecting predominately the axial musculature greatly contributed to the
240
difficulties in using the upper limbs (shown in the video tape). Function of the hand
is therefore not only dependent on the integrity of the shoulder and elbow but also on
trunk stability to allow the appropriate positioning of the hand in space to complete
the desired task. In upper motor neurone lesions a fully functioning hand is useless if
the proximal function of being able to hold and place the limb is not present and vice
versa one can have normal proximal stability which is useless if one does not have a
functioning hand.
Secondly this study showed the importance of thinking of upper extremity function
in the context of the patient's overall physical condition. All 15 patients who
underwent thalamic exploration had other impairments due to MS besides cerebellar
dysfunction. They all showed pyramidal or cognitive dysfunction. The brain stem,
sensory and visual systems were affected in 87% of patients and bladder and bowel
function was impaired in 73% of patients. The diffuse damage to the CNS resulted in
a multiplicity of symptoms which contributed to overall disability and necessitated
assistance from others in ADL.
As a consequence, improvement in performance of the Jebsen subtests did not
increase independence in ADL in the majority of patients. The majority of patients
still required the same level of assistance with ADL and home care resources. This
study does not demonstrate that upper limb function was unimportant to these
patients but it merely indicates that upper limb function must be placed in the context
of the patient's total physical, mental and social status. There was an improvement in
the number of successful Jebsen subtests passed after implantation of the thalamic
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DBS. The study provides further evidence that the JTHF does show change over time
in performance of the subtests but it does not predict performance of ADL.
The Assessment ofMotor and Processing Skills (AMPS) has very recently been used
to show that thalamic DBS in PD and ET patients resulted in a variable improvement
in domestic tasks of daily living (Hariz et al. 1998). The AMPS consists of 56
standardized domestic tasks which vary in degree of difficulty. The patients choose
to perform at least two different tasks with which they were familiar and usually
performed in their daily life (eg. making a sandwich, hoovering, ironing a shirt). The
AMPS might have been a suitable test to use in the present study in that its use has
been extensively documented in the assessment of MS patients and reliability and
validity have been reported to be satisfactory. In patients with tremor, the advantage
of using the AMPS is that it clarifies whether the underlying impairment affects the
patient's ability to perform routine domestic activities of daily living. However
examiners require special training to learn to score the AMPS and its administration
is time-consuming when used to assess both on and off states in Hariz's study the
assessment lasted 80 - 100 minutes. Patients in the present study might not have
been able to tolerate this lengthy assessment owing to the problem of fatigue which
affects many patients with MS. It is important that evaluation of stereotactic surgery
for tremor should include careful assessment of the patient's abilities in performing
ADL but patients with MS may be more limited in this area by other impairments
owing to the disease resulting in a greater disability than in patients with PD and ET.
There would also have been a floor effect if the AMPS had been used in the present
study as only two of the patients (patient 2 and 9) who underwent thalamic DBS ~~
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were able to participate in domestic tasks such as household management and
preparation ofmeals after the operation.
7.2.4 (iv) Limitations upon the measurement of upper limb disability
The scales (self-care section of the FIM) and tests (JTHF) which measured the
functional disability relating to tremor in the target arm were important in this study.
The BI was used to provide an overall measurement of functional ability. This was
important as in 2 patients the severity of tremor improved after operation but due to
surgical complications (thalamic haematomas which occurred at the time of the
operation) the patients were less independent 12 months after the operation compared
with before. All other patients' Barthel Index scores were either the same or better 12
months after operation. This deterioration in general functional ability was not
evident from scores on the self-care section of the FIM but it was from scores on the
BI. The mean and median FIM scores were slightly higher 12 months after the
operation (mean = 24, median = 24) than before the operation (mean = 23, median =
24) indicating that there was little or no reduction in the amount of assistance
required by patients to perform the activities included-in the self-care section of the
FIM. Barthel Index scores were lower (mean = 9, median = 7) 12 months after
operation than before operation (mean = 10, median = 13) indicating that the patients
general level of ability in performing ADL had if anything decreased.
The ability to feed oneself more easily was the item that showed most improvement
when the 12 month assessment was compared with the pre-operative assessment
using the FIM (7 patients improved, N = 9) and the BI (3 patients improved, N = 9).
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7.2.4 (v) Limitations of self-report scales
Although it is important to obtain subjective evaluations by the patients about their
perception of the outcome of any intervention or treatment it is important to be aware
that patients with MS often have cognitive deficits which may affect their memory
and their insight into their problems. A significant correlation was found between
poorer mental functioning and longer duration ofMS (p = -0.61, p = 0.01, N = 20).
This is not surprising as it is now recognized that cognitive dysfunction is a common
symptom in MS (Beatty 1993; Rao 1986). The extent of neuropsychological
impairment shown by most of the patients in this study was likely to invalidate self
report estimates of change as a result of surgery and perhaps self report estimates of
tremor related disability.
At every evaluation the tremor related disability as rated by the patient and compared
to that of the examiner differed: patients' ratings of their disabilities tended to be less
severe than the examiner's ratings. Radatz et al's study (Radatz et al. 2000) which
looked at the functional outcome after unilateral and bilateral pallidotomy for
Parkinson's disease also highlighted this discrepancy: patients described greater
postoperative functional gains than the people who looked after them on equivalent
questionnaire measures of outcome.
Most of the patients in the study required assistance to fill out the questionnaires
because of their inability to write. This is a potential source of bias and it should
therefore have been quantified by asking the additional question 'Did anyone help
you to complete this questionnaire and if so who?'
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7.3 Problems Associated with the Use of Thalamic DBS
7.3.1 Operative problems
Accuracy is paramount for the safety ana efficacy of thalamic DBS. Localization
techniques vary from one centre to another, and include microelectrode recording
and CT/MRI guided stereotaxy and image fusion techniques using functional maps
of the brain (Goldman and Kelly 1995). In this study CT imaging was used to
estimate the target site in the ventrolateral nuclear complex after consideration of the
pre-operative MRI. Adjustments were made after intra-operative stimulation.
However stimulation at the predicted co-ordinate location for the ventrolateral
nucleus of the thalamus did not always elicit the expected response. In many of the
patients the neurophysiological responses usually elicited during stereotactic
thalamo-capsular stimulation or improvement in the movement disorder were absent
despite preserved contralateral limb function. The responses to rostral midbrain
stimulation (induced eye movements and pupillary changes) were however
preserved. Under these circumstances the surgeon elected not to insert an electrode
purely by anatomical localization.
In a series of thalamotomies involving 9 MS patients (Whittle and Haddow 1995)
similar difficulties with locating the target were reported and may be related to the
focal and diffuse cerebral atrophy caused by MS. A common finding at autopsy is the
significant percentage of patients with MS exhibiting enlargement of the ventricular
spaces (Brownell and Hughes 1962). Brownell and Hughes have suggested that
ventricular dilatation may be a compensatory change due to loss of peri-ventricular
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white matter. Interestingly the results of the Whittle/Haddow study were almost
identical to a thalamotomy series using CT/MRI image fusion techniques (Aziz
2000) in terms of immediate outcome, complications and impact on the movement
disorder.
7.3.2. Complications resulting from operation
Complications associated with stereotactic surgery can result in transient deficits
which are probably related to focal trauma caused by insertion of the stereotactic
probe (Tomlinson et al. 1991). Permanent deficits can also occur and are due to
inaccurately placed lesions or ablative lesions that are too large. Any gains achieved
by thalamic DBS must therefore be weighed against both predictable and
unanticipated risks of the surgery to the individual patient. In respect of
complications occurring either during or after the procedure, the risks remain unclear
as results in the literature are often ill-defined. For example, many post-operative
deficits are reported as being transient but adequate description of the gradient or
extent of recovery is characteristically lacking and indeed may be impossible in a
progressive degenerative disease such as MS. Furthermore, a clear distinction is
generally not made between intra-operative complications (eg. haemorrage) that may
or may not have long term sequelae and post-operative complications (eg. seizure,
dysphasia) that may be associated with a well placed lesion and an otherwise good
neurological outcome.
7.3.2 (i) Haemorrahge
There is the question of whether multiple passes associated with intra-operative
stimulation to locate a suitable target may increase the risk of complications.
However the potential risk of haemorrage from multiple probe passes must be
balanced against the risk of injury to the vital structures which surround the
ventrolateral nucleus of the thalamus. An inaccurately placed DBS electrode may
lead to long term adverse consequences for the patient.
The mean number of tracks made during stage one of the procedure in which a
successful thalamic target was located was 5 (range 1 - 11, N = 15). The notion that
a greater number of tracks might be associated with increased morbidity was found
not to be the case. The patients in whom haemorrhagic complications occurred
(patients 7, 8 and 15) had 3, 3 and 11 passes of the DBS electrode respectively.
Patient 4 who had 6 passes of the DBS electrode, had transient limb weakness which
recovered fully to pre-operative levels after rehabilitation (as assessed using the
Barthel Index). CT scans were performed to confirm or exclude the presence of
haematomas in the patients. However patients 7 and 8, who both had only 3 passes,
were left with minor residual motor deficits in the target upper limb and lower limb
at 12 months, and paradoxically a reduction in their movement disorders. The small
haemorrhages which occurred in these patients probably began during electrode
placement but the associated deterioration in clinical condition was not apparent until
after the operation (1 hour and 24 hours post-operatively). Experience with DBS in
Parkinson's disease and ET has revealed a very low rate of intracerebral
complications (Benabid et al. 1991). Benabid et al's study, which also included 4
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patients with MS, described one MS patient with a small haemorrhage around the tip
of the electrode, noted 10 days after implantation. The patient developed a mild
aphasia and slight right hemiplegia which supposedly improved within 2 months
although no information was provided to clarify to what extent the improvement took
place.
Geny et aVs study (Geny 1996) of thalamic DBS was performed on 13 patients with
MS. The general status of the patients and severity of MS pre-operatively was not
defined. Similarly Schuurman et al (Schuurman et al. 2000) claimed that thalamic
DBS is safe despite the fact that one of the patients in the study, a man with
Parkinson's disease, died after suffering an intracerebral haematoma. The results of
the present study showed that 3 of the 15 patients (20%) who underwent thalamic
exploration suffered thalamic haematomas, of whom 2 had long-term adverse
sequelae which resulted in reduced independence in ADL. This may be a slight
underestimate of the risk of haemorrage as another patient (patient 5) presented with
transient lower limb weakness after the operation although a haematoma could not be
identified by MRI scan.
The chance of haemorrhage occurring as a result of the operation was discussed with
the patients pre-operatively and the risk of this happening was given as 1% if the
patient was under the age of 40 and 5% if the patient had high blood pressure or was
older. These estimates were based on the studies carried out by Benabid and others
(Benabid et al. 1991; Benabid et al. 1996a) and were an underestimate of the risk of
haemorrhage in patients with MS undergoing similar surgery.
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It would therefore seem that there is greater risk of haemorrhagic complications
associated with thalamic DBS in patients with MS than either Parkinson's disease or
ET. Certainly the side effects of thalamotomy in patients with MS are known to be
more severe than those observed in PD and ET. In their series of 11 patients
Speelman et al (Speelman and Van Manen 1984) reported permanent hemiparesis in
four cases in their series of 11 patients, and one died of an aspiration pneumonia 3
weeks after surgery; Bamett et al (Barnett et al. 1992) observed permanent
hemiparesis in two out of six thalamotomy patients. Also there was concern that
stereotactic thalamotomy might provoke relapse in multiple sclerosis patients
(Speelman and Van Manen 1984) and relapses have been reported after implantation
of thalamic DBS (Geny et al. 1996) but the association between thalamic DBS and
resulting deterioration is difficult to establish because of the progressive nature of the
disease.
The findings of this study therefore show that there can be significant procedural
morbidity associated with DBS insertion in patients with MS with advanced disease
(Goldman and Kelly 1995).
7.3.2 (ii) Infection
One patient in the study (patient 4) developed a staphlococcus aureus infection in the
IPG site one month after the IPG was implanted. Aspiration of the collection and
antibiotic therapy (oral and intra-venous) was given and the infection seen to resolve.
However owing to reactivation of the infection around both the IPG and the
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extension lead they were both removed 11 months after operation. The DBS
electrode was left in situ
Equipment-related complications have occurred in 2 studies which included patients
with MS in their cohorts but the patients who suffered complications were not
identified by their diagnoses in either study. Benabid et al's series of 117 patients
(Benabid et al. 1996) (of whom 4 were patients with MS) reported local skin
problems in 5 patients: 3 had late scalp infections and erosion necessitating removal
of the DBS electrode and connector; 2 patients had a granuloma along the connector
extension wire track and one patient had a transient fluid collection in the
subclavicular pouch of the IPG. In the other more recent study of 34 patients who
underwent thalamic DBS, 5 patients with MS were included and there were two
equipment related complications (Schuurman et al. 2000). In one patient the pulse
generator site became infected and the IPG needed to be replaced after antibiotic
therapy, and one patient had a haematoma near the pulse generator.
7.3.2 (iii) Seizures
Two of the patients suffered solitary seizures after the operation but it is not clear
whether they were related to the to the thalamic DBS. Neither patient had seizures
pre-operatively. One patient had a grand mal seizure one week after the IPG was
implanted and another 8 weeks after implantation. At the time of the seizures, the
stimulation voltages were 3.3V and 3.8V respectively.
250
7.3.2 (iv) Mood disturbance
Mood disturbances occurred in 5 patients after surgery either because the operation
was unsuccessful (a target could not be located that suppressed tremor) or the result
was not considered to be the expected outcome. This occurred despite the fact that
the research team adopted an extremely cautious approach to this therapy and often
the main but rather limited objective was to restore minimum use of the upper limb.
The patients were informed at length of what might be expected from the operation
and the risks involved. Unrealistic expectations in patients with MS have been
reported in association with thalamotomy in the past (Speelman and Van Manen
1984).
7.3.3 Microthalamotomy effect
A microthalamotomy effect due to lead implantation, which results in immediate
suppression of tremor is a well documented effect of thalamotomy and thalamic DBS
(Pollack et al. 1993). Benabid reports that this effect is responsible for 'a transitory
tremor suppression for a few days' (Benabid et al. 1993). As this effect wanes, the
parameters of stimulation must be adjusted and Pollack et al reported that the
stimulation intensity necessary to alleviate tremor, increased after implantation,
reaching a plateau after approximately 6 weeks, and then remained steady in the
majority of patients. In a recent study of thalamic DBS in patients with Parkinson's
disease and ET the researchers waited for 1 year to elapse after surgery before
assessing patients assuming that the eventual microthalamotomy due to implantion of
the electrode would have vanished (Hariz et al. 1998).
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The speed at which the microthalamotomy effect wanes would therefore appear to be
debatable. Also the extent to which the effect can be said to have worn off is also not
clear in any of the papers and the beneficial effect on severity of tremor has not been
measured objectively. To assess the effect of thalamic DBS with confidence, the
microthalamotomy effect should have disappeared completely thus tremor should be
present at the pre-operative severity when assessed with the DBS switched off.
This was not possible in the present study as waning of the microthalamotomy effect
did not occur completely and was still present to a varying extent in 10 of the 15
patients assessed 12 months after operation. The extent of the microthalamotomy
effect on severity of tremor and performance of the Jebsen subtests can be seen in
the individual patient graphs (section 6.5 Figures 6.5 - 6.19).
In patients 7 and 11 the beneficial microthalamotomy effect was so pronounced
immediately after the operation that the patients did not proceed to implantation of
the IPG and in 7 other patients (who did proceed to implantation of a thalamic DBS)
a beneficial microthalamotomy effects was still evident at the one month post¬
operative assessment when assessment involved either or both of the primary
outcome measures (shown on either the tremor figure or the Jebsen figure for each
individual patient in Section 6.5). Three patients in the present study did not proceed
to implantation of the IPG but showed persisting microthalamotomy effects after
surgery: 1 patient after thalamic exploration (patient 15) and 2 patients after
implantation of thalamic electrodes (patient 7 and patient 11).
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It is possible that the improvements reported in previous studies of thalamic DBS in
patients with MS may have been related to microthalamotomy rather than to
functional inactivation of the presumed thalamic pacemaker by thalamic DBS
(Benabid et al. 1996b; Brice and McLellan 1980; Geny et al. 1996b; Nguyen and
Degos 1993; Schuurman et al. 2000; Siegfried 1993). None of these studies
presented data to enable a comparison to be made between the effect produced when
the DBS was on compared with the effect when the DBS was off at the post¬
operative evaluations. Therefore it is not possible to deduce whether improvement
reported in the outcome measures was due to the effect of the DBS or to the effect of
microthalamotomy. Claims that the improvement was due to thalamic DBS can
therefore not be accepted with confidence from these studies. Benabid et al (Benabid
et al. 1991) reported a patient with MS in their series who presented with a small
haemorrhage around the tip of the electrode 10 days after implantation of a thalamic
DBS. At the time of the haemorrhage the tremor was totally controlled by
stimulation and disappeared even when the stimulation was turned off and never
recurred. It therefore seems plausible that this excellent outcome in terms of
suppression of tremor may in fact have been due to a microthalamotomy effect rather
than the stimulation effect.
The present study was the first study to evaluate the effect of thalamic DBS by
presenting data that compares tremor severity with the DBS on and DBS off at each
of the post-operative assessments with the pre-operative score of severity of tremor.
By doing this the study allowed the extent of the microthalamotomy effect of the
operation to be objectively measured at each of the post-operative assessments. The
253
findings of the present study suggest that the beneficial persisting microthalamotomv
effect has probably been under estimated in previous studies.
It also raised the question of whether the microthalamotomy effect associated with
the surgical procedure of implanting a thalamic DBS electrode was the same as the
microthalamotomy effect associated with the ablative procedure used in
thalamotomy. This is an important question and it is likely that the effects are not
identical. The effect that results after thalamotomy appears to wane as studies
demonstrate that patients show reoccurrence of tremor at 12 months (Aziz 2000;
Haddow et al. 1997; Hooper and Whittle 1998) after thalamotomy. Ten patients in
this series however still showed a beneficial effect 12 months after operation when
the DBS was off which can only be due to the placement of the electrode within the
thalamus.
Thalamotomy produces a lesion at a specific site of the thalamus. This accounts for
the marked improvement in tremor suppression immediately after thalamotomy
which wanes with time as the dysfunctional volume contracts. However in DBS the
electrode is left in situ and this may account for the seemingly permanent beneficial
effect when the DBS is off coupled with an added beneficial effect when it is
switched on. This is demonstrated on the video tape of the second patient showing
the effect of thalamic DBS 12 months after operation, performing the volumetric
tests with the DBS off and then on.
The presence of a microthalamotomy effect would also explain why the effect of
thalamic DBS seemed to be more pronounced immediately after the operation but
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then appeared to be less effective with time. Most patients in this study required
adjustment of the stimulation parameters in the first 6 months after operation owing
to a reported reduction in the benefit of the DBS. However despite lengthy sessions
aimed at readjustment of the parameters of stimulation it was not often possible to
repeat the initial post-operative result and a sub-optimal result had to be accepted.
7.3.4 Need for rehabilitation and training
None of the studies reporting the effect of thalamic DBS for MDMS discussed any
clinical problems that arose in the immediate post-operative period. However
problems with post-operative recovery were encountered in this cohort of patients.
Many patients in the post-operative period and were generally more fatigued and
slow to return to their pre-operative levels of mobility. This resulted in an average
length of stay in DCN for the 2 stages of the operation to be carried out of 15 days.
The length of stay in hospital for implantation of a thalamic DBS and the post¬
operative recovery time of patients with MS have not been reported in previous
studies. Shorter LOS (1 week) have been reported for the procedure when performed
in patients with Parkinson's disease and essential tremor but the study implied that
stages 1 and 2, of implanting the thalamic DBS electrode and the IPG respectively,
were performed at the same operation( Hariz et al. 1998.
A comprehensive, integrated, multidisciplinary rehabilitation programme was
required to support thalamic DBS insertion since some patients required general
rehabilitation to return to their pre-operative level of functional ability; the
stimulators needed programme adjustments; and some patients needed intensive
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physiotherapy and occupational therapy to relearn use of the target limb. The average
length of stay for the 9 patients who had a period of rehabilitation was 54 days. Three
patients had exceptionally long stays owing to the development of post-operative
haemorrhages resulting in transient (patients 5 and 15) and permanent (patients 7 and
8) reduced functional ability. The time spent in the rehabilitation units was reflected
by the total cost of the LOS for rehabilitation for each patient shown in Table 6-17
and was considerable in the cases of patients 5, 7 and 8. No study ofDBS for patients
with MDMS has to date highlighted this requirement for rehabilitation post¬
operatively although it has been argued that inevitably the degree of success of
thalamic DBS will depend on case selection, surgical technique and postoperative
physiotherapy, aimed at optimizing functional gain (Alusi et al. 1999a).
7.4 Problems With its Use
7.4.1 Turning the stimulator on and off.
Turning the thalamic DBS on and offwas not straightforward. It was important to be
aware of how the IPG had been positioned by the surgeon in the pectoral pouch in
the patient's chest. The IPG was rectangular in shape and the surgeon usually
implanted it with the longer side positioned horizontally; the base of the hand-held
magnet with which the patient was taught to 'swipe' the IPG was also rectangular in
shape and it was essential that the long side of the magnet was placed over the long
side of the IPG to successfully switch the stimulator on and off. There were
difficulties switching the IPG in one patient and this was because the IPG had been
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implanted vertically and the researcher was not aware of this and therefore did not
teach the patient to hold the magnet vertically.
Patients who underwent operation at the beginning of the study reported being
uncertain as to whether or not the DBS had been successfully switched on or off by
applying the hand held magnet over the IPG. This was because they often had
difficulties holding the magnet correctly to swipe the IPG owing to poor hand
function and poor co-ordination. It was therefore necessary to issue all the patients
with a small transistor radio with instructions of how to perform an AM radio test in
order to determine the state of the DBS (Appendix 31). This involved tuning the
radio to its lowest setting on the AM waveband (530 Hz) but not on to a station. The
volume was adjusted until a static noise was heard. The patient was instructed to pass
the radio over the skin covering the IPG and if the IPG was switched on a loud
interference noise was emitted from the radio.
Only 3 of the 10 patients who had DBS implanted were able themselves successfully
to switch the DBS on and off every day using the magnet. The people who cared for
the other patients at home and were responsible for getting them out of bed and
putting them back to bed at night therefore had to be taught how to perform this task.
This necessitated the researcher visiting the patients at home once they had been
discharged to instruct the appropriate person.
7.4.2 Setting the amplitude of the magnetic field in the IPG
Apart from the normally programmed amplitude setting (which was programmed
into the IPG before the patients were discharged from hospital) the IPG also had'-a
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magnet setting. The research team were not aware at the beginning of the study that
it was possible for the patient to switch the amplitude from one setting to another by
holding the magnet over the IPG for longer than 6 seconds. Patients were taught to
switch the DBS on and off by holding the magnet over the IPG for 2 seconds.
However, because of the difficulties the patients had in holding the magnet correctly,
they often inadvertently held the magnet over the IPG for too long. This caused a
problem with 2 patients before this feature of the IPG became known. The patients
accidentally switched to the magnet setting, which had not been programmed by the
researcher and therefore was not set to deliver a current. The patients both contacted
the researcher because the transistor radio was not emitting a buzzing noise when the
DBS was switched on and they therefore assumed that the IPG battery was depleted
and required replacement.
It was important that the magnetic field amplitude was set to be the same as the
normally programmed amplitude so that if the patient did accidentally switch the IPG
onto this mode it would deliver the same amplitude of stimulation. The researcher
also had to remember to update and change the amplitude of the magnetic field if any
alterations were made to the programming of the DBS at any stage.
7.4.3 Adjustment to the stimulator
During the course of this study readjustment of stimulator settings was undertaken in
the majority of patients. In most instances settings were altered to regain the degree
of benefit initially achieved particularly if the patient had experienced a
microthalamotomy effect which tended to wane in the first month after surgery, or to
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try to obtain a better effect. Some patients required many visits to achieve optimum
tremor suppression as time progressed. This was both time consuming and costly.
The mean number of visits for reprogramming was 4 (range 0-13).
This waning efficiency of the thalamic DBS was most often seen in the first month
after surgery. This phenomenon has been reported by others (Benabid et al. 1991;
Blond et al. 1992; Hubble et al. 1996) and may be due to loss ofmicrothalamotomy
effects post-operatively or to changes in impedence in the tissues associated with
tissue injury and healing related to the procedure.
Adjustment to the parameters of stimulation was required initially in the post¬
operative period and was a common need in the first 3 months after operation.
Thereafter most patients reached a stable situation or it was felt that the optimum
tremor suppression had been achieved. Sometimes the effect was clinically
disappointing despite extensive attempts at reprogramming the DBS. In some
patients there was a need for a late increase in the amplitude of stimulation which
may have been due to either the progression of MS or the development of escape or
tolerance phenomenon. In these patients DBS became less effective with time and an
increasing amplitude of stimulation was required to alleviate tremor. However a final
level was reached as the stimulation amplitude could no longer be increased owing to
adverse effects such as dysphasia and diplopia.
Tolerance has been reported by several authors (Benabid et al. 1996; Pollack et al.
1993) and could be due to a decreased biological response (habituation) of the
neuronal network which results in brain accommodation to the stimulation. Pollack
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reports that in his opinion tolerance phenomena occur more often in patients who
require relatively high amplitudes of stimulation immediately after operation. This
may occur in a patient with a sub-optimal electrode position in the ventolateral
nucleus of the thalamus. The general understanding of tolerance phenomena has
resulted in the strong recommendation to switch the stimulator off when not really
needed, for example during sleep, and patients in the present study were advised to
do this. Doing so will increase the battery life of the stimulator by 30% if the patient
has 8 hours of sleep per day.
7.4.4 Parameters for stimulation with the IPG
Using an external computer it was possible to modify the parameters of stimulation
and to test the efficacy of stimulation at each electrode contact in the thalamus. The
parameters were set on discharge from hospital and the stimulation was often
adjusted when the patients were evaluated at the 1, 3 6 and 12 month post-operative
assessments. Each session of adjustment lasted approximately an hour. The intensity
of stimulation was slowly increased until the patient complained of unpleasant
transient dysaesthesia or dysarthria or hand and face dystonia with stimulation. If the
tremor had not improved, another combination of electrodes was used or a change
was made to the frequency and/or pulse width of the stimulation.
There was a wide variation in the parameters for stimulation of the IPG both when
the patients were discharged from hospital after the implantation of the thalamic
DBS and 12 months after the operation. The mean amplitude, frequency and pulse
width which were clinically effective on discharge from hospital and at 12 months
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were 2.7V (range 1.8 - 2.9V), 120Hz (range 30 - 185Hz), 120ps (range 60 - 1 60jj.s)
and 3V (range 2.2 - 5V), 160Hz (range 130 - 185Hz), 11 Ops (range 60 - 150ps)
respectively. It appears therefore that some patients responded to low frequency
stimulation and others to high frequency stimulation in the early stages after
operation. This contrasts with the finding that DBS suppresses tremor only when the
frequency of stimulation is at least 100Hz (Benabid et al. 1996). The mechanism of
action of DBS is still unknown but it could be due to the alteration of a transcortical
reflex loop passing through the ventrolateral nucleus of the thalamus, in the same
manner as thalamotomy. Instead of the removal by thalamotomy of a central
oscillatory mechanism, electrical stimulation could inhibit this neuronal rhythmic
firing, at least if the stimulating frequency reaches a level of more than 100 Hz
(Benabid et al. 1991). If this hypothesis is accepted, low frequency stimulation used
in some of the patients in this study post-operatively should not have had an effect.
At 12 months the range in the frequencies (130 - 185 Hz) and pulse widths (60 -
150ps) of stimulation between patients were smaller than immediately after
operation (30 - 185Hz, 60 - 160ps) although the range of stimulation amplitudes
was larger (2.2V - 5V, 1.8 - 2.9V). This may have been because the researcher had
become more proficient at programming the parameters for stimulation. The patients
required higher amplitudes of stimulation at 12 months and in 8 of the 10 patients the
optimum effect was achieved by assigning a positive polarity to the IPG casing and a
negative polarity at the tip of the DBS electrode in the thalamus. The need for the
late increase in stimulus amplitude may have been due to the progression of MS or
the development of tolerance.
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7.4.5 Rebound effect
In some cases when stimulation was turned off movements of the affected limb
became very wild and in one patient (patient 2) were more severe than betore the
operation. These symptoms may be explained as rebound effects. Blond et al (Blond
et al. 1992) reported that discontinuation of thalamic DBS can result in transient
rebound tremor, a coarse tremor of greater intensity than the subject's baseline
tremor. Objective evidence of this phenomenon is lacking and a study involving 10
patients with DBS implanted found that no rebound tremor was present when
thalamic DBS was discontinued (Villagra et al. 1996). A recent study reporting the
effects of thalamic DBS on PD's and ET allowed 30 - 45 minutes to pass after
switching the stimulator off to avoid a rebound phenomenon (Hariz et al. 1998).
This was not done in the present study as it was not a problem in the majority of the
patients.
7.5 Findings of this Study
7.5.1 Reliability' and validity contribution of MFTRS
FTRS was devised with a focus on the assessment of disorders of movement
associated with Parkinson's disease and ET and it therefore required to be modified
for use specifically with patients with MDMS. Once the necessary modifications had
been made to the scale (MFTRS) there remained a need to examine the theoretical
links between the objective measurement of the severity of the disorders of
movement in patients referred for thalamic DBS and the MFTRS. A number "of
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studies were conducted to validate the measurement and reliability of the MFTRS in
the assessment of patients with MDMS.
The first of these was to determine the reliability of a slightly modified Fahn's
Tremor Rating Scale (MFTRS) when rating the severity of tremor in various parts of
the body in patients with disorders ofmovement due to MS. All the examiners found
the MFTRS simple to use when evaluating an edited video of the patients performing
ad hoc tasks. In general, the results demonstrated good inter-examiner and very good
examiner reliability although there were variations in examiner scores of tremor in
different body regions. Assessment of tremor in the trunk showed a lower examiner
and inter-examiner reliability although it still showed a satisfactory level of
agreement. This difficulty in scoring truncal tremor may have arisen because there
was less emphasis placed in the guidelines on how to assess tremor in the trunk than
tremor in the upper limbs. This was because movement disorders involving the upper
limbs were to be the main focus of attention for evaluating the effect of thalamic
DBS. In contrast and more importantly, scores for tremor on the upper limb tasks
showed good reliability. In particular, spirography provided a convenient
standardized and consistently graded measure of the disability caused by a movement
disorder.
The extent of examiner agreement in this study was a function not only of the
inherent qualities of the assessment scale but also of features of the background and
characteristics of the individual examiners. In this study the patients were assessed
using a standardized assessment protocol, using a specified scoring procedure, under
the same environmental conditions, with consistent directions. Differences in rating
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levels found amongst examiners and suggests that in clinical or research studies it is
advisable for either the same person or members of the same occupational group to
perform the ratings of tremor.
As discussed previously it is difficult clinically to define the boundaries of action,
intention and goal-related tremor, and to differentiate between these types of tremor
and dysmetria (Bain et al. 1993). Because of these difficulties in clinical practice, it
was decided that for the purposes of this study, kinetic and intention tremor should
be assessed together by asking the patient to perform the finger/nose test, a test that
is widely used for this purpose. Combining kinetic and intention tremor resulted in
acceptable levels of examiner and inter-examiner reliability for the rating of
kinetic/intention tremor. Goal-related tremor is tremor that occurs to any significant
extent during the pursuing of a goal and in this study was assessed by observing the
patient perform spirography, pouring and the subtests of the Jebsen Test of Hand
Function - and was also found to have good reliability.
The second aspect of the study was to evaluate the validity of the MFTRS. Validity
deals with whether or not a legitimate inference can be made from a scale of
measurement or a test. To do this the scale is compared to a criterion. However this
was not possible when measuring tremor as a 'gold standard' has not been defined.
Aspects of validity of the MFTRS were assessed by calculating the correlation
coefficients between the different component parts of the MFTRS and between them
and measurements of impairment, disability and handicap, and the score on the
Kurtzke scale for measurement of cerebellar function as scored by a neurologist. The
pattern of correlation suggested adequate validity.
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In conclusion, a composite of Fahn's TRS (MFTRS) provided a simple, concise, 24
item scale for evaluating movement disorders in MS. The measurement validity of
the MFTRS was established and inter-examiner and examiner reliability scores
obtained in this study using MFTRS show that it can be used with confidence in a
clinical setting. However it should be noted that examiners should be familiar with
the guidelines for using the scale and preferably should have experience in the field
/
of clinical neurology. It is preferable for research purposes that one examiner
performs the assessments.
7.5.2 Effect of thalamic DBS on impairment, disability, handicap and QOL
7.5.2 (i) Improved severity of tremor and its impact on ADL
Two previous studies, involving 26 patients with MDMS claimed that thalamic DBS
was effective in approximately 70% of cases (Geny et al. 1996; Siegfried 1993).
Geny's study reported that there was a significant reduction in upper extremity
tremor when the patients had their forefingers near their noses: measuring what was
referred to in the present study as postural b) tremor. Although Siegfried reported a
similar level of success in his study, severity of tremor and function were not
objectively quantified thus casting doubt on this claim.
In the present study, thalamic DBS reduced the severity of tremor amplitude of the
target limb in all 12 patients who had either the thalamic DBS system or the thalamic
DBS electrode implanted and the severity of tremor at all the postoperative
assessments when the DBS was switched on was significantly less compared with
the severity of tremor before operation.
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Despite the statistically significant improvement in ratings of the severity of tremor
and the scores for performance on the Jebsen subtests when the DBS was switched
on, patients did not show a major functional improvement. Most of the patients had
lost all use of the target upper limb preoperatively as a result of the severity of the
movement disorder. The operation enabled them to grasp more easily grasp an object
and manipulate it for simple tasks (eg. eating an apple) which was also a finding of
Geny et al (Geny et al. 1996) ,but the patients still required assistance in most
activities of daily living and there was no significant difference between scores on
the self-care section of the FIM (p = 0.67) or the Barthel Index (p = 0.67) when the
pre-operative scores were compared with the scores 12 months after implantation.
The severity of all types of tremor, particularly the postural components in the upper
limb, was reduced. The severity of postural b) tremor improved the most in
agreement with the findings of Geny et al (Geny et al. 1996). At the 6 month post¬
operative assessment 5 of 9 patients had no postural a) tremor (although 2 of these
patients had no postural a) tremor pre-operatively either) and 4 of the 9 patients had
no postural b) tremor. Kinetic/intention and goal-related tremor remained prominent
and disabling as was observed in the studies by Narabashi (Narabayashi 1986) and
Geny (Geny et al. 1996). In none of the 9 patients were these two types of tremor
absent 6 months after the operation.
In other words, surgery had the effect of damping down the tremor generally and
perhaps making life more tolerable for both the patients and their carers.
Unfortunately this did not have a dramatic effect on enabling patients to perform
activities of daily living with the target upper limb. Most patients had better postural"
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control of their heads and target upper limbs enabling them to be fed more easily by
their carers and pick up and eat small pieces of food such as biscuits, sweets and
pieces of fruit with the target upper limb. The persisting, although less severe
presence of kinetic/intention tremor was disabling and prevented the patients from
carrying out any skilled activities with the target upper limb such as feeding
themselves with a utensil or drinking from a cup held in the hand. Patients still
required the same amount of assistance with ADL from the people who looked after
them whether friends and relatives or social services. This supports Benabid's view
that:
'In MS the postural component of the tremor is usually well controlled but
there is little effect on the action component and the cerebellar dysmetria.'
(Benabid et al. 1993)
7.5.2 (ii) Patients' perception and handicap and QOL
Despite the fact that there was no significant change in the patients' ability to
perform ADL as measured by the self-care section of the FIM and the Barthel Index,
both the examiner and the patients perceived the patients' tremor related disability to
be less severe after surgery than before (see Figure 6-20 in Chapter 6). At every
assessment the patients' ratings of their tremor related disability tended to be
marginally less than the examiner's ratings.
When patients in whom either an electrode or a thalamic DBS was implanted were
asked about their opinions of the operation, most expressed some degree of
satisfaction but 5 patients were dissatisfied with the outcome. Of these, 3 represented
failures of the operative procedure and in the other 2, although implantation had been
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earned out the procedure was discontinued. One of these had suffered a thalamic
haematoma as a result of the operation.
Despite these findings there was no significant change in handicap as measured using
the London Handicap Scale and the Handicap Questionnaire. The scores at 12
months after the operation indicated that patients perceived themselves to be more
disadvantaged than before.
The aspects of QOL associated with MDMS that were studied showed little change.
The only significant change noted was in the anxiety score of the Hospital Anxiety
and Depression Scale. Patients perceived themselves to be less anxious 12 months
after operation compared with before; however the number of people assessed at 12
months was small. Patients reported that they felt less embarrassed because the
thalamic DBS had resulted in a beneficial cosmetic effect on the movement disorder
and as the movement disorders were generally not as noticeable the patients felt more
comfortable going out to public places with their friends and families.
There was no change in the fatigue experienced by patients despite the fact that it has
been stated that in patients with MS with large amplitude movement disorders and
complex tremor, reducing fatigue may be one of the objectives of thalamic DBS
(Nguyen et al. 1996). Also almost all of the 13 patients in Geny's study claimed that
the fatigue they experienced while performing some activities of daily living
decreased owing to the relief of the tremor but this was not measured objectively
(Geny et al. 1996) . Fatigue was however measured in the present study using the
268
FSS but a reduction of fatigue as a result of a reduction in the severity of the
movement disorders was not experienced by patients.
In summary, thalamic DBS had an effect on impairment (severity of tremor) but it
did not affect disability (ADL), handicap or aspects of QOL studied apart from
perhaps reducing anxiety in the patients who underwent implantation.
A recent study (Rothwell 1998) has shown that patients with MS are less concerned
than their clinicians about physical disability but more concerned with vitality and
well being. Clinical trials evalauting stereotactic treatment for MDMS should
therefore assess the effect of surgery on factors such as handicap and aspects ofQOL
The assessment, intervention and follow-up costs of this novel treatment are
considerable. The average cost per patient treated with thalamic DBS was around
£14,000. This is more than the cost of treating patients with MS with interferon beta-
lb for one year (£10,000 per year) (Swingler and Compston 1988). There were
similarities between the results of the study on interferon-lb and the present study in
that there was a high cost associated with the treatment which resulted in a modest
clinical effects.
The £4602 given as the official cost of a stereotactic operation may be an under¬
estimate of the cost of thalamic DBS. This was because the average length of stay in
the Western General Hospital was 15 days for these patients which is considerably
longer than the average length of stay (7 days) of patients admitted for a typical
which patients consider important.
7.5.3 Cost benefit of thalamic DBS
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stereotactic operation such as brain biopsy. The figure used as a price for thalamic
DBS did also not include any extra treatments or investigations such as drugs or CT
scans required in connection with DBS implantation.
Thalamic DBS produced some improvement in patients' perception of their tremor-
related disability but in this cohort of patients, because it did not achieve any
substantial improvement in function in regard to performing activities of daily living
with the target upper limb, it did not result in any economic benefits (savings in
future care costs).
7.5.4 Clinical significance of the results
7.5.4 (i) Difficulty in predicting who will benefit
On clinical and neuroradiological grounds it is impossible to predict which patients
may benefit from this treatment. Benabid observed that the efficacy of thalamic
stimulation seemed to be limited when tremor was particularly violent during
movement and when tremor was axial and predominated in the proximal parts of the
limbs (Benabid et al. 1991). Seventy five percent of the patients referred to this
study had axial tremor and had complex movement disorders with added ataxic and
dysmetric components. Thalamic DBS was performed to treat the target arm but
often the axial tremor continued to compromise the functional benefit on the
stimulated side.
All the MRI scans showed diffuse hemispherical and brainstem plaques with
distortion of the thalami and widening of the third ventricle. There was considerable
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variation in the amount and locality of demyelination, plaques and brain tissue
atrophy in both the pre-operative and post-operative images.
Not all patients referred and assessed were suitable candidates: 37 patients were
assessed but of those only 10 went on to have a DBS implanted. If the patient's
movement disorder predominately affected the upper limbs and the patient's target
arm was potentially functional ie. had good strength, normal sensation and muscle
tone he was regarded as being a good candidate. However if the patient had a
movement disorder with severe axial involvement ie. titubation and/or truncal ataxia
he was not regarded as good candidate. It was likely that such patients might require
bilateral thalamic DBS to affect the midline musculature and it was impossible to
assess their tremor during the operation as the head is fixed in the stereotactic frame.
Detailed pre-operative assessment was essential. Patients with MS may have a
movement disorder but they may also have other symptoms such as weakness,
reduced sensation, abnormal muscle tone which contribute to their movement
disorders and may in fact be the main reason for the limitations of function. These
patients were only likely to obtain a limited benefit from thalamic DBS. Nguyen
(Nguyen et al. 1996b) argued that better selection with the exclusion ofpatients with
severe associated neurological disorders should improve results.
Stereotactic treatment of tremor in patients with MS should probably be restricted to
patients with stable disease whose tremor does not have a severe ataxic component
and who have few other deficits (Schuurman et al. 2000). This is problematic in
reality for several reasons. First, because of the nature ofMS it is difficult to predict
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the future course of a patient's disease. Patients with a stable relapsing remitting
form ofMS are probably the best candidates but 50% of patients who have relapsing
remitting disease (70 % of patients with MS) will have converted to a secondary
progressive form within 10 years (Weinshenker et al. 1997)
Secondly movement disorders do not commonly occur early in the course of the
disease (Bauer 1978) and the early appearance of cerebellar ataxia indicates a poor
prognosis (Matthews 1988). The mean duration ofMS in this cohort was 13.3 years,
and the mean duration of the onset of the MD from the time of diagnosis of MS was
7.8 years. Therefore, by the time the patients presented with cerebellar dysfunction
and were referred for thalamic DBS, other neurological systems were affected. The
patients were debilitated not only by the movement disorder but also by associated
neurological dysfunction. This was reflected in the mean EDSS score of the patients
which was 6.9 and indicated that they were severely disabled and dependent upon a
wheelchair.
7.5.4 (ii) Progression ofMS may mask improvement
'With MS patients there is a great difficulty isolating long term effects of
the operation from changes due to the illness' (Haddow et al. 1997).
Thalamic DBS is a palliative treatment for tremor. MS is a progressive disease and
therefore patients are likely to deteriorate. The natural course of the MS may
therefore mask improvement gained as a result of the intervention. Thalamic DBS
did have an effect on the severity of tremor but it did not have an effect on the
progression of the disease. Kurtzke EDSS scores were similar or worse at the 12
month assessment (mean = 7.3) compared with pre-operatively (mean = 7). The
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scores of severity of tremor in the non-target arm were also compared to provide an
impression of the progression of the MS. The findings showed that there was a slight
progression in the disease over the course of the study in the patients who underwent
implantation of a thalamic DBS. They were generally more disabled, more
disadvantaged and had a reduced QOL 12 months after the operation.
7.5.4 (iii) Discrepancy between improvement in severity of tremor and performance of
ADL
In this series thalamic DBS was found to be effective in reducing the severity of
tremor and improving the performance of the Jebsen subtests. However these
symptomatic and functional changes did not translate into a significant improvement
in patients' performance in ADL or in patients' perceptions of overall gains in
measurements of handicap and aspects of QOL. It was clear that a good result ie.
improvement in severity of tremor and improved arm function measured by Jebsen
subtests had often been achieved. However these symptomatic and functional
changes did not translate into significant improvements in patient performance in
ADL and therefore the benefits of the operation were clinically limited. The results
of this study were therefore very relevant to future practice.
7.5.5 Consequences of continuing thalamic DBS forMS patients
7.5.5 (i) The benefit of thalamic DBS did not have significant impact on QOL/ADL
Despite the claims of previous studies that thalamic DBS is a safe procedure, the
findings of this study suggested that there are considerable risks associated with
implantation of a thalamic DBS in patients with MS. Permanent deficits due to
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accurately placed lesions may result and the long-term effect on the risk of provoking
MS relapses and accelerating the progression of the disease are still not known.
7.5.5 (ii) Are resources diverted from a more worthwhile use?
Thalamic DBS requires a considerable investment of time, personnel and resources.
The procedure was not straight forward in the cohort of patients in the present study.
Patients appeared to require longer stays in hospital to recover from the operation
and in many cases needed rehabilitation and retraining of the target arm after
implantation of the thalamic DBS. The costs of equipment were substantial and this
needs maintaining at a cost since regular adjustment of the parameters of stimulation
is necessary. Also at some stage the IPG battery must be replaced. There were
therefore considerable foreseen and unforeseen costs associated with the
implantation of a thalamic DBS. There was no reduction in resources (home care)
after the thalamic DBS was implanted.
The health related QOL of people with MS is much lower than that of the normal
population (Murphy et al. 1998) and age-matched controls of patients with other
diseases (Holmes et al. 1998) and indeed other neurological illnesses (Vickrey et al.
1997). Therefore interventions which improve the QOL of people with secondary
progressive MS more efficiently than thalamic DBS need to be identified.
Continuing thalamic DBS for patients with MDMS will result in resources being
diverted from more worthwhile use. It is possible that more benefit would be
obtained from directing funds into supportive services (physiotherapy etc) for these
patients as improvements in disability and handicap have been shown after in-patient
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rehabilitation in patients with progressive MS (Freeman et al. 1996; Jones et al.
1996).
7.5.5 (iii) Results of previous studies should be challenged
The results of previous studies of thalamic DBS for MDMS suggest improvement in
approximately 70% of patients although these results are based on short follow-up
time only 3 months after implantation (Geny et al. 1996; Siegfried 1993). Geny et al
acknowledged that there was a discrepancy between the clear decrease of amplitude
of the tremor and the poor improvement in ADL. The methods used in the present
study enabled the microthalamotomy effect to be objectively measured for the first
time and found that it was still present to a varying extent 12 months after the
operation in 66% of the patients. This suggested that in previous studies there has
probably been a gross underestimation of the influence of this effect on the final
outcome and that the true effect of the thalamic stimulation was probably less than
has been reported. Any future studies should be prospective and use comprehensive,
multi-dimentional measurements for assessment.
7.6 CONCLUSIONS
The tremor of MS is often a component of ataxia which frequently affects the upper
limbs, head and trunk. Ataxia and tremor commonly exist together and the
movement disorder often includes dysmetria. The movement disorders rarely occur
as isolated clinical signs and tend to present later in the course of the disease. The
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progressive and cumulative neurological deficits in MS account for increasing
disability, handicap and decline in QOL. For many patients with chronic incurable
diseases such as MS the main objective of an intervention may be to lessen the effect
of the disease by alleviating symptoms and maximizing the patient's ability to
participate in activities by reducing disability and handicap. In the present study, the
hypothesis that the treatment of disorders ofmovement in multiple sclerosis could be
improved by the use of thalamic DBS was proposed; and prerequisite validation of a
scale to assess such impairment was undertaken.
The work presented in this thesis had 3 main objectives. There was no validated scale
available for the assessment of MDMS. Therefore the first objective of this thesis
was to develop and validate a scale for measuring MDMS. The work carried out in
this thesis proved the MFTRS to be reliable and valid for measuring MDMS. The
potential use of the MFTRS is evidently great for both research purposes and for use
in clinical practice, as no other validated scale exists for measuring MDMS. Despite
the fact that there have been 7 studies that have reported outcome after thalamic DBS
implantation in patients with MDMS since 1980, this study was the first study to use
a tremor rating scale that had been validated specifically for use with patients with
MDMS to measure the outcome of the intervention.
One of the recommendations of this study for future researchers would be that they
should make a training video to assist in training examiners in the use of the MFTRS.
Standardized assessment is essential to permit comparisons between examiners and
between studies and this may be difficult to achieve if examiners are not familiar
with patients with MDMS.The video could be similar to the video included in--tHe
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Appendix showing patients with varying severity of tremor and movement disorders
affecting different areas of the body. It is anticipated that this would help the
examiners to assess different patients with variable presentations of movement
disorders.
The second objective of the study was to evaluate the long term effect of thalamic
DBS on impairment, disability, handicap and aspects of QOL relevant to patients
with MDMS undergoing implantation. Thalamic DBS significantly reduced the
severity of the tremor (measured using the MFTRS) and it significantly improved
performance of the target upper limb (measured using the JTHF) at 12 months
compared to before the operation. However the benefits in ADL due to these
symptomatic improvements in function were disappointing and unpredictable owing
to persistence of cerebellar dysmetria, the coexistence of other associated
neurological dysfunction that caused other disabling clinical features, post-operative
complications and the progression of the MS. These findings are in agreement with
those of previous studies although the follow-up time in the present study was
considerably longer than in any of the other studies. The results of this study
contrasted with those of previous studies by showing by showing that post-operative
complications can compromise the beneficial effect of thalamic DBS.
Severe disability as found in this cohort of patients with MDMS (mean pre-operative
EDSS score = 6.9) in whom thalamic DBS were implanted has been shown to be
accompanied by decrease in QOL. Thalamic DBS resulted in a significant reduction
in anxiety levels (measured using the anxiety section of the HAD) but did not have
an effect on other aspects of QOL measured in this study.
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The present study was the first study of thalamic DBS for MDMS which presented
data comparing evaluations with the DBS on and off at every post-operative
assessment. This showed that even when the DBS was switched off there was a
beneficial effect on the ratings of severity of tremor and the successful performance
of the Jebsen subtests when the scores were compared to the pre-operative (baseline)
scores. Although this effect was only significant one month after the operation it was
still evident in the majority of patients 12 months after the operation.
'Microthalamotomy' effect has been mentioned in previous studies but the
magnitude and the length of time for which the effect persists has not been measured
objectively. The results of this study suggest that the effect of microthalamotomy on
outcome has probably been underestimated and the beneficial effect that has been
attributed to the stimulation after implantation of a thalamic DBS may in fact be
partly due to the persisting beneficial microthalamotomy effect. It is therefore very
important that future studies should report data collected pre-operatively and data
collected at the post-operative assessments with the stimulator on and off to
determine if the reported benefit is due to the effect of the thalamic DBS, the
microthalamomy effect or a combination of the two.
The third objective was to estimate the costs associated with thalamic DBS. In the
NHS today there is increasing emphasis on evidence based practice. This study
therefore attempted to address the issue of the outcome of thalamic DBS in relation
to the cost of the intervention. The resources associated with the implantation of a
thalamic DBS were substantial and arose from assessment; purchase (£7,602 per set)
and implanting of the thalamic DBS; follow-up; comprehensive post-operative
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rehabilitation requirement; staff costs for reprogramming the DBS and providing
support. Results showed that a small benefit in terms of reduction of severity of
tremor, improved performance on the Jebsen subtests and reduced anxiety after the
operation was associated with high costs (approx £14,000 per patient implanted with
a thalamic DBS). The beneficial psychological effect which was apparent in patients
after the operation is probably far too modest to be considered cost effective for the
NHS. However, to patients with severe disabling tremor in whom a cost saving
intervention for MS is unlikely, they may not regard the improvement as 'modest'. If
given a choice between the anxiety resulting from untreated tremor and thalamic
DBS patients appear to be prepared to settle for small benefits which enhance this
particular aspect of their quality of life.
It is probably appropriate to allocate more funds to people with MDMS but the
resources used for thalamic DBS might have been better spent on identifying other
more efficient ways of improving the QOL in patients with secondary progressive
MS. Recent studies have shown interventions such as supportive and rehabilitation
services (physiotherapy, occupational therapy) can significantly improve disability,
handicap and QOL of people with MS and, realistically, far more benefit would be
obtained from directing funds into these interventions. Also in view of the limited
apparent benefit and high costs and risks of the procedure, it seems unlikely that a
large controlled trial could be justified.
In conclusion the present study evaluated the effect of thalamic DBS on MDMD and
in doing so highlighted important clinical, management and health implications
associated with the operation and also some of the problems associated with its-use
in this cohort of patients. The published paper in connection with the validation of
the MFTRS has contributed to developments within the field of the assessment of
MDMS. Evaluation of the complex movement disorders seen in patients with MS
can now be performed with confidence in the clinical setting and treatments for
disabling tremor in patients with MS can be properly evaluated.
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APPENDIX 4
MODIFIED FAHN'S TREMOR RATING SCALE










4. Enter time ofdav scored
5. Assessment Interval:
AM PM
□ Pre Implant □ 6 month □ Other, specify:
0 1 month □ 9 month





3. Right Upper Extremity
tremor
4. Left Upper Extremity
tremor
0 = None
1 = Slight. May be intermittent
2 = Moderate amplitude. May be intermittent
3 = Marked amplitude
4 = Severe amplitude
0 = None
1 = Slight. May be intermittent
2 = Moderate amplitude. May be intermittent
3 = Marked amplitude
4 = Severe amplitude
0 = None
1 = Slight. May be intermittent
2 = Moderate amplitude. May be intermittent
3 = Marked amplitude
4 = Severe amplitude
0 = None
1 = Slight. May be intermittent
2 = Moderate amplitude. May be intermittent
3 = Marked amplitude




























Date of Birth / /
month dav vcar
Date of Evaluation / /
month dav year
PART B
5 -7 Ask the patient to join both points of the
beginning with the dominant
Page 2
drawings without crossing the lines. Test each hand.
5. Drawing A 0 = Normal Right
1 = Slightly tremulous. May cross lines occasionally Left
2 = Moderately tremulous or crosses lines frequently
3 = Accomplishes the task with great difficulty. Many errors
4 = Unable to complete drawing
6 Drawing B 0 = Normal Right
1 = Slightly tremulous. May cross lines occasionally Left
2 = Moderately tremulous or crosses lines frequently
3 = Accomplishes the task with great difficulty. Many errors
4 = Unable to complete drawing
Pouring (use firm plastic
cups, about 8cm tall, filled
with water to 1cm from top.
Ask patient to pour water
from one cup to another.
Test each hand separately).
0 = Normal
1 = More careful than a person without tremor, but no water
is spilled
2 = Spills a small amount ofwater (up to 10% of total amount)
3 = Spills a considerable amount ofwater (> 10-50%)




Oate of Birth / /
mCntx cay




Drawings A, B and C are made with the Left Hard
Right Hand





Drawings A, B and C are made with the Led Hand
F.igr.t Hard
CHAWING A DRAWING =
Patient Identifier
Date ofBirth / /
month dav year
Date of Evaluation / /
month dav year Page 5
PART C To be completed ONLY after referring to the guidelines.Scores are provided by patients (with the exception of
speaking). Patients are asks to evaluate their ability to carry out these tasks using the target arm or both arms (if a
bilateral activity) using the definitions provided.
8. Speaking 0 = Normal I j
1 = Mild dysarthria when "nervous" only 1
2 = Mild dysarthria, constant
3 = Moderate dysarthria
4 = Severe dysarthria. Some words difficult to understand.
9. Feeding other than liquids 0 = Normal
1 = Mildly abnormal. Can bring all solids to mouth, spilling only rarely
2 = Moderately abnormal. Frequent spills of peas and similar foods.
May bring head at least halfway to meet food.
3 = Markedly abnormal. Unable to cut or uses two hands to feed.
4 = Severely abnormal. Needs help to feed.
10. Bringing liquids to mouth 0 = Normal
1 = Mildly abnormal. Can still use a spoon, but not if it is completely full. '
2 = Markedly abnormal. Unable to use spoon; uses cup or glass
3 = Markedly abnormal. Can drink from cup or glass, but needs two hands.
4 = Severely abnormal. Must use a straw.
0 = Normal
1 = Mildly abnormal. Able to do everything, but is more careful than <
the average person.
2 = Moderately abnormal. Able to do everything, but with errors; uses
electric razor because of tremor.
3 = Markedly abnormal. Unable to do most fine tasks, such as putting on
lipstick or shaving (even with electric shaver), unless using two hands.
4 = Severely abnormal. Unable to do any fine-movement tasks.
0 = Normal
1 = Mildly abnormal. Able to do everything, but is more careful than the 1 I
average person.
2 = Moderately abnormal. Able to do everything, but with errors.
3 = Markedly abnormal. Needs some assistance with buttoning or other
activities, such as tying shoelaces.
4 = Severely abnormal. Requires assistance even for gross motor activities.
0 = Normal ,
1 = Mildly abnormal. Legible. Continues to write letters. ; i
2 = Moderately abnormal. Legible, but no longer writes letters.
3 = Markedly abnormal. Illegible.
4 = Severely abnormal. Unable to sign checks or other documents requiring a
signature.
14. Working 0 = Tremor does not interfere with job
1 = Able to work, but needs to be more careful than the average person.
2 = Able to do everything, but with errors. Poorer than usual performance
because of tremor.
3 = Unable to do regular job. May have changed to a different job
because of tremor. Tremor limits housework, such as ironing.












Based on assessment of tremor related disability which is calculated according to the percent of impairment in carrying
out all activities of daily living and the cosmetic effect of the tremor.
GLOBAL ASSESSMENT BY EXAMINER (Circle one of the 5 levels)
0 = No functional disability
1 = Mild disability
2 = Moderate disability
3 = Marked disability





GLOBAL ASSESSMENT BY PATTENT (Circle one of the 5 levels)
0 = No functional disability
1 = Mild disability 1-24% impaired
2 = Moderate disability 25-19% impaired
3 = Marked disability 50-74% impaired
4 = Severe disability 75-100% impaired
SUBJECTIVE ASSESSMENT BY PATIENT COMPARED TO LAST VISIT (Circle one of the 7 levels)
+3 = Marked improvement
+2 = Moderate improvement
+1 = Mild improvement
0 = Unchanged
-1 = Mild worsening
-2 = Moderate to marked worsening








MODIFIED FAHN'S TREMOR RATING SCALE
GUIDELINES FOR COMPEETING THE FORM
The rating scale is divided into 3 parts (A, B & C).
PART A
Part A (Scores 1-4) quantifies the tremor at test, with posture holding, and with
action and intention manoeuvres, for 4 parts of the body.
Severity of tremor in each of the four body parts is rated by amplitude. Whether the
tremor is intermittent or always present is not a factor in the severity score.
The definitions for tremor severity are:-
0 = None
1 = Slight, barely perceivable, maximal amplitude < 1cm, may be intermittent
2 = Moderate, amplitude 1 - 5cm, may be intermittent
3 = Marked, amplitude 5 - 10cm
4 = Severe, amplitude> 10 cm
The definitions indicate that tremors rated 1 and 2 could be either intermittent or
continuous. Since larger amplitude tremors are less likely to be intermittent, the
definitions for 3 and 4 severities do not list the choice for intermittence.
Tremor severity in Part A is rated for four situations: rest, maintaining a posture,
performing a movement and performing a motor goal. Definitions for these 3
situations are provided for the head, trunk and limbs as follows.
Tremor:
1. at REST (in repose)
Observe the head and trunk, when the patient is lying supine or with the head and
trunk fully supported by head rests and back rests in the wheelchair. Observe the
upper limbs, with the forearms resting on the thighs.
NB some individuals may not be able to relax their muscles when they are
positioned up against gravity even though they are supported in a wheelchair.
Consequently even though they are at rest their tremor may still be evident. In
this instance, one might have to assess for rest tremor with the patient supine. It
is also important to allow some time to elapse for relaxation to occur
(approximately 10 seconds).
2. with posture holding
Observe the trunk
Observe the head - patient sitting in chair/wheelchair with back supported but
no head support.
patient attempting to sit unsupported (i.e. sitting
balance test). If
the patient does not have static sitting balance ie.
posture, write unable to score next tocannot hold a
this.
Observe the UE a) arms outstretched, wrists mildly extended, fingers
spread apart.
b) arms held with elbows flexed, shoulders abducted and
fingers spread apart. Winged posture to look for "wing
beating" tremor.
3. with ACTION & INTENTION
Observe the head - Whilst the patient moves their head from side to side and
looks up.
Observe the trunk - Whilst the patient attempt standing and walking. If patient
is unable due to lower limb involvement then observe the
trunk whilst patient attempts sitting.
Observe the UE - Whilst the patient performs the finger to nose test 3x.
NB Action and intention tremor are given a single score.
4. with GOAL - related
Observe the head
Observe the trunk
Observe the UL's -
Whilst the patient performs the tasks in Sec B, handwriting
and card turning. Also observe them attempting to drink
from a straw in a cup held by the examiner.
Whilst the patient moves from sitting to standing or if
unable due to lower limb weakness observe the trunk
whilst they perform the upper limb function tasks in Sec B
and the subtests of the JTHF.
Whilst the patient performs the upper limb function tasks
in Sec B and the subtests of the JTHF.
N.B. Since action/intention and goal related tremor may be superimposed on top of
postural tremor it is important to determine if the activity results in a greater tremor
amplitude than that seen with posture holding alone.
PART B
Part B (Scores 5 to 7) relates to action/intention and goal-related tremors of the upper
limbs. Severity is determined by watching the patient draw spirals and pour water.
The patient is allowed to rest their target arm on the table while they perform the
tests.
Spirometry is evaluated by having the patient carry out the activities on the scoring
form. Space is available for assessing each hand.
Task A }
} are the drawing of an Archimede's spiral.
Task B }
The quantification of these tasks is based on the crossing of the lines in the figure.
There is less space available between the lines in task B, making the task more
difficult.
Pouring water from one cup to another is also quantified. Cup size and the amount of
water used in the test are specified to ensure consistency between examination events
and among clinicians. The amount of water spilled is the basis for the severity
grading.
PART C
Part C assesses functional ability. Its items evaluate the severity of tremor with:
• speaking
• eating (feeding)
• bringing liquids to the mouth
• hygienic care
• dressing
• working (this classification includes homemaking, as well as other jobs)
These scores with the exception of speaking, are provided by patients, who are asked
to evaluate their ability to carry out these tasks by using the definitions provided.
Speaking can also be evaluated by the examiner and is a global evaluation ofwhether
the patient appears to have any difficulties with speech eg. obvious dysarthria. This
is purely an observation made by the researcher and not an attempt to diagnose the
cause of the speech impairement.
Unilateral upper limb activities in Part C are assessing the target extremity except
for writing which evaluates the dominant hand. The bilateral activities are a global
assessment of the ability to perform the task with both arms taking into consideration
the functioning of the unaffected or less affected arm.
The definitions for evaluating and scoring tremor, drawing, pouring and functional
ability (Parts A, B and C) are provided in Appendix 6 (Definitions for scoring the
MFTRS).
Global Assessment
In addition to the quantitation of tremor through Parts A, B & C, the scoring form
allows assessment of overall severity by both the patient and the examiner. This
subjective global severity is based on the assessment of tremor-related disability,
which is calculated according to the percent of impairment in carrying out all
activities of daily living and the cosmetic effect of the tremor, which can be
psychologically damaging.
Comparison Assessment
The scores obtained in Parts A, B & C and the global assessments will provide the
major input of a comparison before and after implantation of DBS. However, it is
also useful to obtain subjective evaluations by the patient as to the effectiveness of
the stimulator. The scoring form provides definitions for the patient to carry out such
a self-evaluation (see Definitions for Fahn's TRS,p- of Appendix). Patients are not
permitted to refer to old scores when making a new judgement at a later assessment.
Scoring System
1. To obtain information relating to tremor in different areas of the body : the
total score for each of the body areas in Part A is calculated by amalgamating the
scores for the different components of tremor in each body area.
2. To obtain a specific evaluation ofthe target upper limb: the subtotal score for
the target upper limb in Part A (out of a possible 20) plus a subtotal score for the
target upper limb's performance of the tasks in Part B (out of a possible 12) plus
the total score for Part C (out of a possible 28) are amalgamated giving a total
possible score out of 60 for a very severely tremorous patient with no functional
use of the target upper limb.
3. The % severity ofdisability can then be calculatedfor the target upper limb:
the total score is expressed as a percentage
ie. % severity = total score x 100
60 1
APPENDIX 6
DEFINITIONS FOR THE CLINICAL GRADING OF THE
VARIOUS COMPONENTS OF TREMOR USING THE
MODIFIFTED FAHN'S TRS
PART A (scores 1 -4)
Rating Tremor = Rate tremor amplitude
1) at REST (in repose)
For head and trunk: when fully supported in wheelchair or lying down
For UE: with forearms resting on thighs
For LE: sitting in chair
2) with POSTure holding
For head: with patient sitting with no head support.
For trunk: with patient sitting trying to achieve sitting balance with no
trunk support
ForUE:a) arms outstretched, wrists mildly extended, fingers spread
apart
b) arms held with elbows flexed, shoulders abducted and
fingers spread apart
3) with ACTion and INTention
For head Observe the head whilst the patient moves their
head from side to side and looks up.
For trunk Observe the trunk whilst the patient attempt
standing and walking. If patient is unable due
to lower limb involvement then observe the
trunk whilst patient attempts sitting.
For UE: Finger to nose test 3x and other actions, ie pouring water,
drinking from a cup, the Jebsen.
4) with GOAL related
For head: observe the head whilst the patient drinks water
using a straw from a beaker held in front of the patient by
the examiner and also while the patient performs the upper
limb functional tasks in Sec B and the subtests of the
JTHF.
For trunk: observe the trunk whilst the patient moves from
sitting to standing or if unable due to lower limb weakness
observe the trunk whilst they perform the upper limb
function tasks in Sec B and the subtests of the JTHF.
For UE: observe the head whilst the patient performs the
upper limb functional tasks in Sec B and the subtests of
the JTHF.
0 = None
1 = Slight, barely perceivable, maximal amplitude<l
cm, may be intermittent.
2 = Moderate, amplitude 1 - 5cm, may be intermittent.
3 = Marked, amplitude 5 - 10cm.
4 = Severe, amplitude >10cm.
PART B (scores 5-7)
Drawings (A, B): Ask the patient to join both points of the spirals
without crossing the lines. Test each hand, beginning with the lesser involved
hand
0 = Normal
1 = Slightly tremulous. May cross lines occasionally.
2 = Moderately tremulous or crosses lines frequently.
3 = Accomplishes the task with great difficulty. Many errors.
4 = Unable to complete drawing.
Pouring: Use firm plastic cups (8cm tall), filled with water to 1cm
from top. Ask patient to pour water from one cup to another.
Test each hand separately.
0 = Normal
1 = More careful than a person without tremor, but no water spilled.
2 = Spills a small amount ofwater (up to 10% of total amount).
3 = Spills a considerable amount ofwater (> 10 - 50%).
4 " Unable to pour water without spilling most of the water.
PART C (scores 8-14) Scores are provided by patients with the exception of
speaking.
8. Speaking 0 = Normal
1 = Mild dysarthria when "nervous" only
2 = Mild dysarthria
3 = Moderate dysarthria
4 = Severe dysarthria. Some words difficult to understand.
9. Feeding other than liquids 0 = Normal
1 = Mildly abnormal. Can bring all solids to mouth, spilling
only rarely
2 = Moderately abnormal. Frequent spills of peas and similar
foods.
May bring head at least halfway to meet food.
3 = Markedly abnormal. Unable to cut or uses two hands to
feed.
4 = Severely abnormal. Needs help to feed.
10. Bringing liquids to mouth 0 = Normal
1 = Mildly abnormal. Can still use a spoon, but not if it is
completely full.
2 = Markedly abnormal. Unable to use spoon; uses cup or glass
3 = Markedly abnormal. Can drink from cup or glass, but
needs two hands.
4 = Severely abnormal. Must use a straw.
11. Hygiene 0 = Normal
1 = Mildly abnormal. Able to do everything, but is more
careful than the average person.
2 = Moderately abnormal. Able to do everything, but with
errors; uses
electric razor because of tremor.
3 = Markedly abnormal. Unable to do most fine tasks, such as
putting on
lipstick or shaving (even with electric shaver), unless using
two hands.
4 = Severely abnormal. Unable to do any fine-movement tasks.
12. Dressing 0 = Normal
1 = Mildly abnormal. Able to do everything, but is more careful
than the average person.
2 = Moderately abnormal. Able to do everything, but with
errors.
3 = Markedly abnormal. Needs some assistance with buttoning
or other
activities, such as tying shoelaces.
4 = Severely abnormal. Requires assistance even for gross
motor activities.
3. Writing 0 = Normal
1 = Mildly abnormal. Legible. Continues to write letters.
2 = Moderately abnormal. Legible, but no longer writes letters.
3 = Markedly abnormal. Illegible.
4 = Severely abnormal. Unable to sign checks or other
documents requiring a signature.
14. Working 0 = Tremor does not interfere with job
1 = Able to work, but needs to be more careful than the
average person.
2 = Able to do everything, but with errors. Poorer than usual
performance because of tremor.
3 = Unable to do regular job. May have changed to a different
job
because of tremor. Tremor limits housework, such as
ironing.
4 = Unable to do any outside job; housework very limited.
Based on assessment of tremor related disability which is calculated according to the percent of
impairment in carrying out all activities of daily living and the cosmetic effect of the tremor.
GLOBAL ASSESSMENT BY EXAMINER (Circle one of the 5 levels)
0 = No functional disability
1 = Mild disability 1-24% impaired
2 = Moderate disability 25-49% impaired
3 = Marked disability 50-74% impaired
4 = Severe disability 75-100%impaired
GLOBAL ASSESSMENT BY PATIENT (Circle one of the 5 levels)
0 = No functional disability
1 = Mild disability 1 -24% impaired
2 = Moderate disability 25-49% impaired
3 = Marked disability 50-74% impaired
4 = Severe disability 75-100% impaired
SUBJECTIVE ASSESSMENT BY PATIENT COMPARED TO LAST VISIT (Circle one of the 7
levels)
+3 = Marked improvement (50-100% improved)
+2 = Moderate improvement (25-49% improved)
+1 = Mild improvement (10-24% improved)
0 = Unchanged
-1 = Mild worsening (10-24% worse)
-2 = Moderate to marked worsening (25-49% worse)
-3 = Marked worsening (50-100% worse)
APPENDIX 7
APPENDIX 8
JEBSEN TEST OF HAND FUNCTION
GUIDELINES FOR PERFORMING THE TEST
BATTERY
Specifications for placement of test equipment and subject:
If the right hand is being assessed the perspex board (See Appendix 9 for
description) should be positioned on the right hand side of the table before
commencing the subtests to establish the position of the central reference point. To
do this the right hand edge of the perspex board should be placed in line with the
right hand edge of the table and a marker should be placed on the front edge of the
table, in line with the central marker on the front edge of the board. This is the
central reference point from which the distance to all markers placed on the table
should be measured ie. markers for cards, small objects coffee jar and the perspex
board.
The subject should be seated as close to the table as possible with their
midline positioned inline with the central reference point on the table. Ideally the
patient should be sitting on a dining chair with no arms so that they are close to the
table. If they are wheelchair bound where possible the arms of the wheelchair should
be removed but this will only be possible in those patients who have adequate trunk
control to sit without lateral support.
Equipment required:
Clip-board, plain A4 paper, black rollerball pen, nine 5 inch by 3 inch cards, 1 pound
coffee jar, 2 X 1 inch paper clips, 2 regular sized bottle tops(about 1 inch in
diameter), 2 one pence pennies, 5 kidney beans, a teaspoon, 4 checkers, 5 empty
baked bean cans, 5 full baked bean cans, 2 crocodile clips, a packet of self adhesive
markers, a ruler and the perspex board.
Standardised procedures and instructions:
The subtest descriptions below have been written for a right-handed subject. The
subtests were always presented in the same sequence and were always performed
with the dominant hand first.
SUBTEST 1: WRITING
Procedure:- The subject is given a black rollerball pen and a sheet ofA4 blank,
unruled white paper fastened to a clip board. The sentence to be copied has 24 letters
and is of third-grade reading difficulty.* The sentence is typed in capital letters and
centred on a 3 by 5 inch index card. The card is presented with the typed side faced
down on the table. After the articles have been arranged to the comfort of the subject
(See Instructions), the card is turned over by the researcher with an immediate
command to begin. The item is timed from the word "go" until the pen is lifted from
the page at the end of the sentence. The item is repeated with the non dominant hand
using a new sentence.
Instructions:- "Do you require glasses for reading? If so, put them on. Take this pen
in your right hand and arrange everything so that it is comfortable for you to write
with your right hand. On the other side of this card(indicate) is a sentence . When I
turn the card over and say 'Go' write or print the sentence as quickly and as clearly
as you can using your right hand. Do you understand? Ready? Go."
• Different sentences were used when subsequent sub tests were given to an
individual. Available sentences were: (1) The old man seemed to be tired. (2)
John saw the red truck coming. (3) Whales live in the blue ocean. (4) Fish take air
out of the water.
SUBTEST 2: CARD TURNING (simulated page turning)
Procedure:- Five 3 by 5 inch index cards, with a cross on one side only were placed
in a horizontal row 2 inches apart on the table in front of the patient. Each card is
oriented vertically, 5 inches from the front edge of the table. This distance is
indicated on the table with a small marker stuck to the table (Fig 1A). Timing was
from the word "Go" until the last card is turned over. No accuracy of placement after
turning is necessary. The item was repeated with the non-dominant hand.
Instructions:- " Place your right hand on the table please. When I say 'Go' use your
right hand to turn these cards over one at a time as quickly as you can beginning with
this one (indicate card to extreme left). You may turn them over in any way that you
wish and they need not be in a neat pattern when you finish. Do you understand?
Ready? Go"
Non Dominant hand:- "Now the same thing with the left hand beginning with this
one(indicate extreme right card). Ready? Go."
SUBTEST 3: SMALL COMMON OBJECTS
Procedure:- An empty 1-pound coffee can is placed directly in front of the subject, 5
inches from the front edge of the desk. Two 1-inch paper clips (oriented vertically);-
two regular sized bottle tops(each one inch in diameter, placed with the inside of the
cap facing up) and two one pence pennies are placed in a horizontal row to the right
of the can. The paper clips are to the extreme right and the pennies nearest the can.
The objects are 2 inches apart and there placement is indicated by markers stuck to
the table (See Fig IB). Timing is from the word "Go" until the sound of the last
object striking the inside of the can is heard. The item is repeated with the non-
dominant hand. The layout for the non dominant hand is amirror image of the one
described, with the objects to the left of the can.
Instructions:- " Place your left hand on the table please. When I say "Go' use you
right hand to pick up these objects one at a time and place them in the can as fast as
you can beginning with this one (indicate paper clip on the extreme right) Do you
understand? Ready? Go"
SUBTEST 4: SIMULATED FEEDING
Procedure:- Five kidney beans of approximately 5/8-inch are placed on the perspex
board clamped to the table in front of the subject, 5 inches from the front edge of the
table. The beans are orientated to the right of centre, parallel to and touching the
upright of the board 2 inches apart. An empty one pound coffee can is placed
centrally in front of the board. A regular teaspoon is provided (Fig 1C). Timing is
from the word "Go" until the last bean is heard hitting the bottom of the can. The
item is repeated with the non-dominant hand, the beans being placed to the left of
centre.
Instructionstake the teaspoon in your right hand please. When I say 'Go' use
your right hand to pick up the beans one at a time with the teaspoon and place them
in the can as fast as you can beginning with this one (indicate bean on the extreme
right). Do you understand? Ready? Go"
Non Dominant hand:- "Now the same thing with the left hand( indicate bean on the
extreme left). Ready? Go."
SUBTEST 5: CHECKERS
Procedue:- Four standard sized (one and a 1/4 inch diameter) checkers are placed in
front of and touching the perspex board clamped to the table in front of the subject,
5 inches from the front edge of the table. The checkers are orientated two on either
side of the centre in a 0000 configuration (Fig ID). Timing is from the word "Go"
until the fourth checker makes contact with the third checker. The fourth checker has
to stay in place stacked on top of the other checkers. The item is repeated with the
non-dominant hand.
Instructions:- Place your left hand on the table please. When I say "Go" use your
right hand to stack your checkers on the board in front of you as fast as you can like
this, one on top of the other (demonstrate). You may begin with any checker. Do you
understand? Ready? Go"
SUBTEST 6: LARGE LIGHT OBJECTS
Procedure:-Five empty food cans (baked beans) are placed in front of the perspex
board clamped to the table in front of the subject 5 inches from the front edge of the
table. The cans are spaced 2 inches apart with the open end of the can facing down
(figIE). Timing is from the word "Go" until the fifth can has been released. The item
is repeated with the non-dominant hand.
Instructions:- "Place your right hand on the table please. When I say "Go" use your
right hand to stand these cans on the board in front of you, like this (demonstrate).
Begin with this one (indicate the can on the extreme left). Do you understand?
Ready? Go."
SUBTEST 7: LARGE HEAVY CANS
Procedure:- Five full( 1 pound) cans are placed in front of the perspex board
clamped to table in front of the subject, 5 inches from the front edge of the desk. The
cans are spaced 2 inches apart (Fig IE). Timing is from the word "Go" until the fifth
can has been released. The item is repeated with the non-dominant hand.
Instructions:- "Now do the same thing with these heavier cans. Place your right
hand on the table. When I say "Go" use your right hand to stand these cans on the
board as fast as you can. Begin here (indicate can on extreme right). Do you
understand? Ready? Go."
Non Dominant Hand:- " Now the same thing with your left hand beginning here
(indicate can on far left). Ready? Go."
Figure IA: placement ofequipmentfor subtest 2 - card turning
Figure 1C: placement ofequipment for subtest 4 - simulatedfeeding
Figure IE: placement ofequipmentfor subtests 6 and 7- moving large objects
(empty orfull cans)
APPENDIX 9
DIMENSIONS OF THE JEBSEN BOARD
Dimensions of the Jebsen board:
A perspex board 100cm long, 30cm wide and 14mm thick was secured to the table
with 2 crocodile clips. The front edge (14mm thickness) of the board was marked
with 5 markers at 5 inch intervals, the middle marker placed centrally on the front
edge, to assist with reference when placing objects. A centrepiece of perspex, 51cm
long, 5cm high and 10mm thick was glued to the centre of the board 6 inches from
the front edge of the board. The front of the centre upright was marked with 10
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Thank you for agreeing to be one of the examiners of tremor severity in patients with multiple
sclerosis.
The tremor rating scale (TRS) was devised by Fahn originally for Parkinson's Disease patients and
patients with essential tremor. It has not been validated in MS patients.
The patients in the Deep Brain Stimulation (DBS) study have a movement disorder resulting from MS
namely ataxia and tremor affecting their upper limbs and/or trunk. The scale has therefore been
modified very slightly for use on this group ofpatients.
The main reason for carrying out an inter-examiner reliability study is to determine the level of
agreement between examiners in:
a) the subjective rating of tremor (Part A)
b) the spiral tests and pouring test (Part B)
I have enclosed the following:-
1) a video tape showing the standardised assessments of 10 patients
2) a copy of the video protocol
3) information on the TRS
a) Guidelines
b) Definitions of tremor
c) Instructions for raters
4) Rating Scale Forms (one set for each patient A —» J. Attached are copies of the patient's
spiral drawings and handwriting).
Please read through the guidelines, definitions and instructions carefully before you begin.
I would be grateful if you could return the videotapes and completed TRS forms to me by Tuesday
4th February.
Many thanks in anticipation.
Yours sincerely,




TREMOR RATING SCALE TRS
PART A
1. Head tremor 0 = None REST
1 = Slight. May be intermittent POST
2 = Moderate amplitude. May be intermittent ACT/INT
3 = Marked amplitude GOAL
4 = Severe amplitude
2. Trunk tremor 0 = None REST
1 = Slight. May be intermittent POST
2 = Moderate amplitude. May be intermittent ACT/INT
3 = Marked amplitude GOAL
4 = Severe amplitude
3. Right Upper Extremity
tremor
0 = None
1 = Slight. May be intermittent
2 = Moderate amplitude. May be intermittent
3 = Marked amplitude







4. Left Upper Extremity 0 = None REST
tremor 1 = Slight. May be intermittent POST a)
2 = Moderate amplitude. May be intermittent b )j
3 = Marked amplitude ACT/INT
4 = Severe amplitude GOAL ;
PART B








7. Pouring (use firm plastic
Right
cups, about 8cm tall, filled
Left
with water to 1 cm from top.
Ask patient to pour water
from one cup to another.
Test each hand separately).
0 = Normal
1 = Slightly tremulous. May cross lines occasionally
2 = Moderately tremulous or crosses lines frequently
3 = Accomplishes the task with great difficulty. Many errors
4 = Unable to complete drawing
0 = Normal
1 = Slightly tremulous. May cross lines occasionally
2 = Moderately tremulous or crosses lines frequently
3 = Accomplishes the task with great difficulty. Many errors
4 = Unable to complete drawing
0 = Normal
1 = More careful than a person without tremor, but no water
is spilled
2 = Spills a small amount ofwater (up to 10% of total amount)
3 = Spills a considerable amount ofwater (> 10-50%)
4 = Unable to pour water without spilling most of the water
APPENDIX 14
INSTRUCTIONS FOR RATERS
The video shows a standardised assessment of tremor being carried out on ten
patients. The tape runs for 2 hours 45 mins in total. The patient is filmed carrying
out the activities listed on the video protocol (see attached). The order of these
activities may vary slightly.
The conversation between the researcher and the patients is included, i.e. the sound,
as it makes the video tape more meaningful. However, examiners are free to agree or
disagree with any comments made.
Assessments may not always appear to be straightforward. For example, it is
difficult to assess postural tremor in the trunk if a patient is unable to maintain a
posture or sit unsupported. However, please remember that one is assessing whether
tremor is present and the degree to which it is occurring in a body part when the
patient is attempting to achieve a certain position.
When a patient is moving a body part it is often difficult to differentiate between
action tremor (occurring during the movement) and intention tremor (occurring at the
end of the movement). They are therefore, grouped together for this reason.
When rating goal-related tremor please observe the video of the patient performing
the spiral tests, the pouring test, the handwriting and card turning tests and rate the
tremor in different parts of the body. Tremor may vary depending on the worst
tremor observed when the patient performs these tasks.
Please watch the tape of all 10 patients (A -» J). Starting at the beginning of the tape
with patient A.
PART A -Whilst you watch the tape of each patient, rate their tremor (rest, postural,
action/intention, goal related) for the:
- head
- trunk
- right upper limb
- left upper limb
Write a number (0 - 4) in the boxes provided.
PART B - Look at the photocopies of the patient's spiral drawings and hand writing
(attached to the rating forms). Rate the spiral drawings and the pouring
tests only, by writing a number in the appropriate box, as you observe
them performing these tasks on the video.
Please read the guidelines and definitions of tremor before you begin and refer to
these when making your judgements.
APPENDIX 15
FUNCTIONAL INDEPENDENCE MEASURE
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30. Follow-up Living Setting
I-Home 2-BoatO and Care 3-Transkronal Lwng
4-lntem>edate Care 5-Skil*d Nurarg Facktfy
6-Acuta unit of own facility 7-Acuta unit anotftar facility
8-Chronic Hospital 9-Rertabilitabon Facility 10-Otfier
II-Oied 12-AJtemate Level o( Care
31. Follow-up Living Wth
(Comptete onfy tf Mom 301% codrtl 1-Home.)
1Alone 2-Familyff7etatives 3-Fnends
a Attendant 5-Othai
32. Follow-up Vocational Category
1Employed 2-Snetered 3-Student 4-Honwmiker
5-NotWortong 6Aatred-»ge 7-Retred-disab*y
33. Follow-up Vocational Effort
(Complete ordy if Mom 32 is coded 1.2.3 or 4 )


































34. Foliow-up Information Source
1-Pibent 2-F«mrfy 3-Other
35. Follow-up Method
1 -In person 2-Telephone 3-Maded questionnaire
36. Follow-up Health Maintenance
1-Own care
2-Unpaid person or famiy



















































4 (Subject = 75 % +)
Maximal Assistance
(Subject = 25 % +)
Total Assistance
(Subject = 0 % +)
(NOTE: Leave no blanks;
enter 1 if not testable
due to risk)











1. 1 minute 'static' sitting balance
A period of unsupported sitting without a back rest in excess of one minute. Hips, knees and
ankles should be positioned at 90 degrees, with both feet flat on the floor. Independent sitting
balance was defined as sitting unsupported on abed with head erect, eyes looking forward,
trunk erect and not slumped with minimal flattening of the lumbar spine, thighs to remain in
contact with the bed and no hand or arm support on bed. Weight should be distributed evenly
between the ischial tuberosities and the head should adopt a midline position. The upper limbs
should rest passively in the lap and should not resort to fixing with their hands.
2. 10 second standing balance
A period of unsupported standing in excess of 10 seconds. The weight should be evenly
distributed between both feet in both coronal and sagital planes. Physical help is permissible in
making the transition from sitting to standing, but during the timing period no help should be
given.
3. 10 metre walk
A timed walk over a measured distance of 10 metres in a straight line using a hand-held
stopwatch. The patient should commence the walk from a standing start, from a predetermined
spot and be instructed to walk to a point distant to the end of the walkway. Timing should start
at the beginning of the first step and finish as the patient crosses the mark indicating the end of
the walkway. The assessor should walk beside the patient on the tremorous side both for
reasons of security and to allow the most accurate judgement of the termination of the walking
episode.
Verbal instructions should be standardised to "I would like you to walk to the far end of this
room at a speed which is comfortable foryou, but I will time how long it takes
If appropriate a walking aid may be used but verbal cueing should be avoided. v
APPENDIX 17
THE LONDON HANDICAP SCALE QUESTIONNAIRE
Your health and your life
This questionnaire is about the wayyour health affects your everyday life. Please read the instructions for each question and then answe
by ticking the box next to the sentence which deschbes you best.
When answenng the questions, it may help to think about the things you have done over the last week and compare yourself witt
someone like you who is in good health Mobility
Getting Around
Think about how you get from one place to another, using any help, aids or means of transport that you normally have available
1. DOES YOUR HEALTH STOP YOU FROM GETTING AROUND? Please tick one box only Q
NOT AT ALL You go everwhere you want to no matter how far away.
VERY SLIGHTLY You go most places you want but not all.
QUITE A LOT You get out of the house, but not far away from it.
VERY MUCH You don't go outside, but you can move around from room to room indoors
ALMOST COMPLETELY You are confined to a single room, but you can move around in it







Think about things like housework, shopping, looking aftermoney, cooking, laundry, getting dressed, washing shaving and using the toilet







You do everything to look after yourself.
You need a little help now and again.
You need help with some tasks (such as heavy housework or shopping) but no more than once a day
You do some things for yourself, but you need help more than once a day. You can be left alone safely for
a few hours
You need help to be available all the time. You cannot be left alone safely. G
You need helpwith everything. You need constant attention, day and night Q
Occupation
Work and leisure
Think about things like work (paid or not), housework, gardening, sports, hobbies, going outwith friends, travelling, reading
looking after the children, watching television and going on holiday
_







You do everything you want to do.
You do almost all the things you want to do.
You find something to do almost all the time, but you cannot do some things for as long as you would like
You are unable to do a lot of things, but you can find something to do most of the time.
You are unable to do most things, but you can find something to do some of the time.






Getting on with people
Think about family, friends and the people you might meet during a normal day







You get on well with people, see everyone you want to see. and meet new people
You get on well with people, but your social life is slightly limited
You are fine with people you know well, but you feel uncomfortable with strangers
You are fine with people you know well, but you have few friends and little contact with
neighbours. Dealing with strangers is very hard
Apart from the people who look after you. you see noone. You have no friends and no visitors
You don't get on with anyone, not even people who look after you
Orientation
Awareness of your surroundings
Think about taking in and understanding the world about you, and finding yourway around in it Please tick one box only







You fully understand the world around you. You see. hear, speak and think clearly, and your memory is good
You have problems with hearing, speaking, seem or your memory, but these do not stop you doing most things
You have problems with heanng, speaking, seeing or your memory, which make life difficult a lot of the
time. But you understand what is going on.
You have (he/she has) great difficulty understanding what is going on
He/she ts unable to tell where he/she is orwhat day it is. He/she cannot look after him/herself at all




Afford the things you need
Think about whether health problems have led to any extra expenses, or have cause you to earn less than you would if you were healthy.







You can afford everything you need. You have easily enough money to buy modem labour saving devices and
anything you need because of ill health
You have just about enough money. It is fairly easy to cope with expenses caused by ill health
You are less well off than other people like you: however, with sacnfices you can get by without help
You only have enough money to meet your basic needs. You are dependent on state benefits kx extra expenses
You are dependent on state benefits, or money from other people or chanties. You cannot afford the things you need
You have no money at all and no state benefits. You are totally dependent on chanty for yourmost basic needs
□
□
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APPENDIX 18
SPSS PROGRAMME FOR CALCULATING OVERALL LONDON
HANDICAP SCORE
Box: SPSS programme for calculating overall handicap score
get/file ' c \....\lha.sav'.
title "LONDON HANDICAP SCALE*
if (raobil • 1) um - 6.8.
if (mobil -2) ua - 2.5.
if (mobil -3) ua - -0.3.
if (mobil -4) ua - -3.2.
if (mobil •5) ca ■ a* b*
if (mobil -6) ua » -9.0.
if (occup -1) uoc ■ 6.5.
if (occup -2) uoc - l.l.
if (occup -3) uoc - 0.4.
if (occup -4) uoc • -0.2.
if (occup -5) uoc - -0.9.
if (occup -6) uoc - -6.8.
if (physind -1) upi - 9.6.
if (physind -2) upi - 0.8.
if (phyaind -3) upi ■ -0.7.
if (phyaind -4) upi • -2.2.
if (phyaind >5) upi - -5.2.
if (phyaind -6) upi . -8.2
if (social -1) usi . 8.0.
if (social -2) usi - 5.3.
if (social -3) usi - 2.4 .
if (social -4 J usi - -1.0.
if (social -5) uai - -3.7.
if (social -6) usi " -6.8.
if (orient -I) uor . 9.4.
if (orient -2) uor - 1.8.
if (orient -3) uor - -3.4.
if (orient -4) uor - -S.8.
if (orient -5) uor - -7.7.
if (orient -6) uor - -9.9.
if (econ -1) ueaa ■ 9.2.
if (econ *2) ueaa - 6.1.
if (econ >3) ueaa - 2.9.
if (econ -4) ueaa - -2.2.
if (econ *5) ueaa - -6.1.
if (econ -6) ueaa • -9.9.
compute lha - 50.5+um*uoc+upi+usi+uor+uesa.





Assessment ofHandicap self- questionnaire
Please answer the following questions by putting a circle around the
appropriate letter.
Has your tremor stopped you
1. working? A B C D
2. applying for a job or promotion? A B C D
3. shopping by yourself ? A B C D
4. doing a favourite hobby or sport ? A B C D
5. travelling by public transport? A B C D
6. driving a car? A B C D
7. eating out? A B C D
8. going on holiday? A B C D
9. accepting a party invitation? A B C D
Key:
• A no
• B yes because you are embarrassed by the tremor
• C yes because of the physical difficulties produced by the tremor _
































Clinicians are aware that emotions play an important part in most illnesses. If your
clinician knows about these feelings he or she will be able to help you more.
This questionnaire is designed to help your clinician to know how you feel. Read each
item below and underline the reply which comes closest to how you have been feeling
in the past week. Ignore the numbers printed at the edge of the questionnaire.
Don't take too long over your replies, your immediate reaction to each item will p£










I feel tense or 'wound up'
Most of the time
A lot of the time
From time to time, occasionally
Not at all
I still enjoy the things I used to enjoy
Definitely as much
Not quite so much
Only a little
Hardly at all
I get a sort of frightened feeling as if
something awful is about to happen
Very definitely and quite badly
Yes. but not too badly
A little, but it doesn't worry me
Not at all
I can laugh and see the funny side of things
As much as I always could
Not quite so much now
Definitely not so much now
Not at ail
Worrying thoughts go through my mind
A great deal of the time







Most of the time





I feel as if I am slowed down




I get a sort of frightened feeling like





I have lost interest in my appearance
Definitely
I don't take as much care as I should
I may not take quite as much care
I take just as much care as ever






I look forward with enjoyment to things
As much as I ever did
Rather less than i used to
Definitely less than I used to
Hardly at all
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1. My motivation is lower when I am fatigued.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
2. Exercise brings on my fatigue.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
3. I am easily tired.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
4. Fatigue interferes with my physical functioning.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
5. Fatigue causes frequent problems for me.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
6. My fatigue prevents sustained physical functioning.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
7. Fatigue interferes with carrying out certain duties and responsibilities.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
8. Fatigue is among my three most disabling symptoms.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree
1 2 3 4 5 6 7
9. Fatigue interferes with my work, family, or social life.
Choose a number from 1 to 7 that indicates your degree of agreement with this
statement and mark it on the line below.
Strongly disagree Strongly agree





PATIENT'S OPINION OF THE OPERATION







Please circle the appropriate description of how vou feel.
APPENDIX 23
DETAILED PATIENT INFORMATION SHEET ABOUT STUDY
OF THALAMIC STIMULATION FOR MOVEMENT
DISORDERS IN MULTIPLE SCLEROSIS.
You are being asked to participate in a research study to demonstrate the safety,
reliability, and effectiveness of deep brain stimulation (DBS) for the suppression of
movement disorders caused by Multiple Sclerosis. If you choose to participate, you
will be one of 15 individuals participating in this clinical investigation and the
duration of your participation is expected to last 12 months. The following document
briefly describes the device to be used and possible complications which might
occur.
BACKGROUND
Electrical stimulation has been used for over 20 years to treat hundreds of patients
suffering from chronic pain. Recent European studies have shown that DBS may
suppress tremor associated with Parkinson's disease and essential tremor when an
area of the brain called the VIM of the thalamus is stimulated. A destructive lesion,
or thalamotomy, of this area can also control tremor, but may have permanent side
effects. The effectiveness and safety of deep brain stimulation for controlling tremor
in patients with MS. is currently not known.
The DBS system consists of:
*a lead which consists of insulated wires with four electrodes at the end.
*an extension wire which connects the lead to the power source
*an Implanted Pulse Generator (IPG) which is the power source
The IPG is a metal "can" about two inches in diameter and about 1/2 inch thick. It
contains a small battery and produces the electrical pulses needed for stimulation.
The battery cannot be replaced without replacing the entire IPG. Replacing the IPG
involves minor surgery. Battery life varies for each patient depending on the type and
intensity of stimulation needed for good tremor relief. For patients using DBS to
treat chronic pain, battery life has been typically been three to five years.
IMPLANTATION PROCEDURES
The implantation usually takes place in two stages. During the first stage you will
have an MRI or CT Scan to determine the proper location for the lead within you our
brain. The leads are then carefully placed in the brain using a procedure called
stereotactic neurosurgery. This procedure has been used in brain surgery for
movement disorders such as Parkinson's disease and multiple sclerosis for at least 40
years. The lead is implanted through a small opening (1/2 inch) in the skull using
local anaesthetic and mild sedation. A small area of your hair must be shaved to
avoid the risk of serious contamination from bacteria.
During the procedure your doctor may ask a number of questions about what you
feel and how your tremor feels. He is doing this to make sure the lead is in exactly
the right place in the brain. Your doctor will test the DBS system to see if your
tremor is reduced adequately. The lead may be connected to wires which run through
the skin to a temporary external stimulator.
If you receive good tremor relief, that is sustained over a few days the second stage
of the implantation takes place. During the second stage, a permanent extension wire
is passed under the skin of the neck and attached to the IPG. The IPG is also placed
under the skin, usually just below the collar bone.
If you do not receive adequate relief of tremor, you will not have the complete DBS
System implanted. In this case, you will return to your physician at one month and
six months for follow-up assessments.
BENEFITS
You may gain substantial control over your medically refractory movement disorder
due to multiple sclerosis.
This may improve your quality of life and allow you to participate more fully in
some activities of daily living.
The ITREL* II IPG is programmable and permits you and the researcher to choose
the parameters which provide maximum reliefwith minimal side effects. The
researcher can adjust the stimulation many different ways to provide you with the
best comfort and tremor relief. In addition y our will be provided with a magnet so
you can turn the stimulation off and on.
RISKS
Every effort is made to minimise the risks of the surgery and of brain stimulation,
however, complications may occur. Besides the general surgery and anaesthesia risks
your doctor has explained to you, the following complications due to implantation of
this device may occur:
• Bleeding (haemorrhage) inside the brain, which could lead to a stroke, causing
severe neurological damage, such as weakness, paralysis, or speech problems, or
even death. The risk of stroke increases with age. If you have high blood pressure
or are over 60 years old, the risk is about 5%. If you are under 40 the risk is about
1%.
Much less common complications include:
• Weakness ofmovement, double vision or other vision problems, loss of
sensation or mental impairment.
• Infection, in which case the lead may need to be removed and/or antibiotic
therapy may be necessary. Some infections, such as meningitis and brain
abscesses, may be serious enough to cause death.
• Seizures
• Leaking of the fluid which surrounds the brain.
Problems which occur after the lead and IPG are implanted
• Mechanical or electrical problems, leading to failure of the DBS system. For
example the lead or extension wires may fracture or components may need to be
replaced. This may require further surgery.
• Persistent pain or fluid accumulation (seroma) at the IPG site for around the
system components. The components may change position or erode through the
skin, leading to infection and scarring. This may necessitate removal of the DBS
system
• Allergic reaction or rejection of the implanted system
• Migration ofmovement of the lead out of the brain.
Problems which may occur with stimulation
• Effectiveness or comfort of stimulation changing over time.
• Persistent paraesthesia (tingling) in the limbs or in the face.
• Speech problems, such as dysphasia (loss of ability to use or understand
language) or dysarthria (difficulty in speaking words)
• Disequilibrium (dizziness/light headedness)
• Movement problems such as dyspraxia (incoordination), dystonia (altered muscle
tone) facial and limb muscle weakness or partial paralysis and abnormal
voluntary movements.
• Paraesthesis (decreased sensory ability or numbness)
• Attention and cognitive deficits.
• Temporary worsening of the tremor when stimulation is stopped or "rebound"
• Most of the stimulation side effects can be avoided by reprogramming the IPG or
turning the IPGH off. Other side effects or complications may occur which are
more unusual or are not yet known and cannot be predicted at this time.
METHODS TO MINIMISE RISKS
Your doctor will ask for your medical history, and you will have a full physical and
neurological examination to determine if it is appropriate for you to participate in
this DBS study. To reduce the risks during surgery, careful surgical and sterile
operating methods are used. All the parts of the system are carefully manufactured
and the implantable parts are supplied sterile. The neurological risks are reduced by
careful lead placement for proper location and avoiding critical areas of the brain.
Test stimulation may determine if there are any undesirable side effects from the
stimulation. If there are undesirable side effects, the system can be removed.
After surgery, regular visits to y our doctor will help to detect any complications
with the system and allow treatment to begin as soon as possible. Many side effects
and complications can be avoided or treated by reprogramming parameters of
stimulation or discontinuing stimulation. You may have to compromise between side
effects and tremor control.
You should contact your physician if you incur any injuries, complications, or
adverse effects associated with this therapy.
ALTERNATIVES
The main alternative therapy is thalamotomy, which is a destructive lesion in the
brain. Your physician can explain the risk and benefits associated with this type of
therapy.
»
RIGHTS TO INFORMATION AND CONFIDENTIALITY
Your involvement in this study is confidential and y our rights are protected by
national and local laws. You will not be identified by name in any published reports
about this study, however, the records of this study may be inspected by your doctor
and hospital.
CHOOSING TO PARTICIPATE
Participation in this study is entirely up to you. You may refuse to participate or may
choose to stop participating at any time without penalty or loss of benefits you would
normally be entitled to without the study. If you choose not to participate, your
doctor will provide information on any other procedures that might help you instead.
If you choose to participate in the study, you will need to return to this study centre
for several follow-up visits (at one, three, six and 12 months). You will be required to
help the researcher complete a number of questionnaires concerning your DBS for
tremor treatment both before and after the surgery. You will also be required to be
videotaped a number of times with y our stimulator ON and OFF to measure the
results of your stimulation. You will not receive any payment for participation in this
study.
The DBS system is considered by your doctor to be ofpotential benefit for relieving
your tremor. Your doctor knows about the risks of implanting this DBS system and
has determined that the benefits which you may get from the implant outweigh the
risks.
APPENDIX 24
Does Thalamic Stimulation Decrease Tremor Associated with Multiple Sclerosis
CONSENT FORM
Patient's Name:
Have you read the information sheet? Yes / No
Have you asked further questions about the study? Yes / No
Who has explained the study to you?
Have you had sufficient time to consider your reply? Yes / No
Do you agree to take part? Yes / No
Are you aware that you can ask to withdraw
from the study at any time, without needing
to give a reason, and with no effect on your
care in other respects? Yes / No
Have you been told that impartial advice
is available if you are still concerned about
participating? Yes / No
If you are willing take part, please sign,
Signature Date
Signature of Investigator Date
Copies:
1) Investigator
2) To be retained by patient/subject
3) To patients GP
4) File case notes
patients with Multiple Sclerosis. I agree to the use of videotaping equipment during
the assessment sessions. I give my consent for the videotape of me to be studied by
medical staff involved in the research project evaluating the effect of thalamic deep
brain stimulation on movement disorders in multiple sclerosis.
I am aware that I can withdraw my consent at any time during the assessment
and that the information will be used for research purposes only.
Signed
Dated
2. The use of videotapes for teaching session
I give my consent for the videotape ofme to be used for the teaching and education
of staff and students in medical, paramedical and nursing professions. I am aware
that I can withdraw consent for the use of the videotape for teaching purposes at any
time, either during testing or at a later date.
Signed,
APPENDIX 26
THALAMIC STIMULATION FOR THE
TREATMENT OF TREMOR
ENTRY NOTE
Pltasc print or tvpt Form 1
1. Patient Identifier
2. Date ofBirth / /
month day year
3. Neurologist
4. Date of Evaluation / /
5. Has patient provided signed informed consent? □ Yes □ No Stop*
6. Has patient been diagnosed with Multiple Sclerosis
where tremor constitutes a significant function disability? □ Yes □ No Stop*
7. Has tremor been consistently disabling in
the target extremity for at least three months prior to
enrolment? □ Yes □ No Stop*
8. Is patient available for follow-up for the duration of the study? □ Yes □ No Stop*
9 If patient has Multiple Sclerosis, have medications been held
constant for at least 1 month prior to enrolment? □ Yes □ No Stop*
10. If patient has Multiple Sclerosis, are fluctuations predictable? □ Yes □ No Stop*
11. Is patient a surgical candidate? □ Yes □ No Stop*
12. Is patient between the ages of 18 and 80 years old. inclusive? □ Yes □ No Stop*
13. Was tremor adequately controlled by medications during the 3
months prior to enrolment? □ Yes Stop* □ No
14 Has patient undergone a thalamotomy procedure'.' □ Yes □ No
15 Does patient have other clinically or medically significant
disease? □ Yes No
16. Does patient have a history of dementia that would interfere
with the ability to participate in this study? □ Yes I. No
17. Does patient have history of alcohol or drug abuse? □ Yes □No
*Do NOT Enrol Patient
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DEEP BRAIN STIMULATION STUDY






Thank you for agreeing to help with this study, which involves two functional
assessments of the patient, one with the stimulator switched on, the other with it off.
So that we can remove learning and fatigue effects, we would like to have some
patients perform the assessments in the order Off-ON, and some in the order ON-
OFF. Also, in order to allow an objective assessment of the effectiveness of the
stimulator, the assessor (Julie Hooper) should not know whether or not the devise is
switched on. Please could you ensure that the stimulator is set to the correct
operation for each assessment, as given below, without telling Julie Hooper which
state the patient is in.
After setting the stimulator for the second assessment period, please put this sheet of
paper into the envelope provided, seal it, and give it to Julie Hooper.
Thank you very much for your help.
First Assessment Stimulator OFF
Second Assessment Stimulator ON
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Turning the stimulator on/off using the console
1. Hold the console programming head over the patient's scar (under their clavicle).
2.Press the REVIEW key on the programming head.
3.Then look at the top row of parameters on the console. Read along until you come
to IPG output. Does it say on or off? What setting do you want?
- if it's set on the setting that you want then leave things as they are and turn the
console off.
- if you want to change it to the opposite mode then
a) first press the IPG output button on the programming console.
b) then press EITHER the orange ON or the orange OFF switch on the console.
c) THEN PRESS THE PROGRAM KEY ON THE PROGRAMMING HEAD SO
THAT THE STIMULATOR IS CHANGED TO THE APPROPRIATE MODE.
4. To double check that the stimulator is set on the correct mode look along the top
row of programmable parameters on the console until you come to IPG output and
this should confirm the mode that you have set the stimulator to.
PLEASE NOTE
It is very important that the stimulator is set to the correct on or off setting as stated
in the sealed envelope and that the research physiotherapist is not aware of these
settings. If you have any difficulties in setting the stimulator to the desired mode
please ask the research physiotherapist to show you how to set the stimulator again.
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THALAMIC STIMULATION FOR THE
TREATMENT OF TREMOR
Please print or type LEAD IMPLANT Form 3
1. Patient Identifier





5. Date of Procedure / /
month day vear
6. Lot Number of Lead:
7. Target VIM: □ Left □ Right




9. Technique for target localization PRIOR to lead implant (check all that apply):
□ Ventriculography □ CT □ MRI □ Other.specifv
10. Stereotactic frame used:
□ Leksell D CRW □ BRW □ Other.specifV
11. How many times was a mapping electrode passed?
12. Optimum effect stimulating
with mapping electrode
13. Optimum effect stimulating
with 3382 DBS Lead:
14. Optimum effect WITHOUT
stimulating with 3382 DBS Lead:
□ No suppression of tremor
□ Mild suppression of tremor
□ Moderate suppression of tremor
u Complete suppression of tremor
□ No suppression of tremor
□ Mild suppression of tremor
□ Moderate suppression of tremor
□ Complete suppression of tremor
15. Device used for electrical stimuation: □ Medtronic Model 3625 Screener
□ No suppression of tremor
□ Mild suppression of tremor
□ Moderate suppression of tremor
□ Complete suppression of tremor
□ Other,specify
16. Was the 3382 DBS Lead implanted?
IfNo. why wasn't the lead implanted?
□ Yes □ No
□ No tremor suppression □ Other,specify_
17. Technique for target verification AFTER lead placement (check all that apply):
□ Ventriculography □ CT □ X-ray □ Other,specify
18. Final 3382 DBS Lead coordinates (O-electrode in relation to AC-PC line):
mm lateral to AC-PC Line; mm from PC along AC-PC Line; mm above (+) or beiow (-) AC-PC Line
19. Was the 3382 DBS Lead implanted in the longitudinal axis of VIM? □ Yes
20. Were there complications during lead implant: □ Yes □ No




THALAMIC STIMULATION FOR THE
TREATMENT OF TREMOR
IPG INTERNALISATION
Please print or type Form 4
1. Patient Identifier




5. Date of IPG internalisation procedure: / /
6. Was the IPG internalised?
□ Yes □ No
7. Were there any complications during IPG internalisation?
C Yes □ No
If yes. complete Complication Form 7 or 8.
8. Location of Itrel®II IPG: C Left subclavicular pocket
C Rich subclavicular pocket
□ Other.specify
9. Location of connector: D Head 0 Neck □ Other,specify
10. Serial numbger of Itrel®II IPG:
11. Serial number of extension
12. Length of extension cable: cm
INVESTIGATOR SIGNATURE DATE
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THALAMIC STIMULATION FOR THE
TREATMENT OF TREMOR
STIMULATION (IPG) PARAMETERS
Please print or type Form 5
1. Patient Identifier
2. Date of Birth / /
month day year
3. Neurologist
4. Date of ev aluation / /
month day year
5. Assessment Interval: 0 Discharge □ 6 month □ Other.specify:
□ 1 month □ 9 month
□ 3 month □ 12 month
















8. Instructions for patient to:
Continuously stimulate
Turn OFF at night
Use as needed
Other, specify:
If any current complications or side effects, or any since last follow-up visit, complete Form 7 and/or 8.
INVESTIGATOR SIGNATURE DATE
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Information about Jacqueline's stimulator
Jacqueline has a rectangular shaped stimulator implanted under the skin on the left
side of her chest under the collar bone (she has a 3inch scar over the stimulator site).
The stimulator needs to be turned on in the morning and off at night to conserve the
battery. Jacqueline may find this difficult to do particularly if her stimulator is
switched off as one needs a fairly steady hand. The stimulator is turned on and off by
holding a small blue magnet over the stimulator for 2 seconds, which effectively
works like a switch. It is possible to check whether or not the stimulator has been
turned on or off successfully with the magnet by holding a transistor radio over the
stimulator. The radio should be tuned on AM and should be set at the lower end of
the waveband at 530 KHz and turned on. If the stimulator is on you will hear a
buzzing/ interference sound when you hold the radio over the stimulator. If it is off
you will only hear the faint hissing noise of the volume.
How to turn Jacqueline's stimulator on/off
1. Stand on Jacqueline's left hand side. Hold the blue magnet in your left hand and
palpate the stimulator box in Jacqueline's chest with your right hand.
2. Hold the magnet at arms length and bring the magnet in on top of the stimulator
holding it horizontally. Hold it there for 2 seconds and then remove it. This should
switch the stimulator either on or off depending on what mode it was in when you
started.
3. To check which mode it is in USE THE RADIO.
Turn it on and turn the volume control up until you can hear a faint hissing sound
coming from the radio. Hold the radio with the wavelength band facing upwards and
over Jaqueline's stimulator. You should hear some buzzing/interference if it is on
and only the hissing sound of the volume if it is off. You may have to move it very
slightly around the stimulator area.
Any problems please contact the research physiotherapist-Mrs Julie Hooper on 0131
537 2414 (work- mornings only) or at home on 0131 556 1923 (ansa phone)
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THALAMIC STIMULATION FOR THE
TREATMENT OF TREMOR
FOLLOW-UP
Please print or type Form 6
1. Patient Identifier
2. Date of Birth / /
month day year
3. Neurologist
4. Date of evaluation / /
month day year
5. Follow-up Internal: □ 1 month D6 month 0 12 month
□ 3 month □ 9 month □ Other, specif.':
6. Device Status: □ In Use □ Stimulation Discontinued, complete Adverse Event Form 7 or Complication Form 8
7 Have any components been explanted since last follow-up?
I YES, complete Complication Form 8. G NO
8 Have there been any side effects or complications since last follow-up?
G YES, complete Adverse Event Form 7 or Complication Form 8 G NO
9 Stimulator use since last follow-up:
a. Use: □ Day Only □ Night Only □ Night and Day □ Not Used
b. Pattern: G Continuously □ Intermittently, as needed C Not Used
10. Average number of hours per day stimulation is on: Hours
11. When stimulation is turned off, does tremor amplitude appear to decrease over time before stabilising? □ Yes C No
If YES, enter the number of minutes from the time the stimulator is turned off until tremor stabilises: Minutes
12. Instructions to patient regarding future use.
a. Use: G Day Only □ Night Only □ Night and Day G Not Used
b. Pattern: □ Continuously □ Intermittently, as needed G Not Used
INVESTIGATOR SIGNATURE DATE
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THALAMIC STIMULLATOR FOR THE
TREATMENT OF TREMOR
THERAPY ADVERSE EVENTS
Please print or type Form 7
1. Patient Identifier
2. Date ofBirth / /
month day year
3. Neurologist
4. Date of evaluation / /
month day year
5. Date of event: / /
month day year
6. Enter appropriate codes from the lists below (complete a separate form for each event).
Adverse Event: Severity: Status: Date Resolved: / /
month day year
Etiology: Casualty: Interventions: . .
Relationship to Stimulation:
REPORT DEATH ON FORM #16: STUDY TERMINATION
Adverse Event: Severity: Etiology: Interventions:
1. Paresis; Extremity Weakness 1. Mild 1 Stimulation 1. No Intervention
2. Paralysis 2. Moderate 2. Concomitant Drugs 2. Patient Education
3 Double Vision 3. Serious 3. Disease Progression 3. Stimulation Parameters Changed
4. Headaches 4. System Components 4. Stimulation Discontinued
5. Eye Movement Disorders 5 Patient Related Condition 5. Concomitant Drug Reduced
6. Dysphasia 6. Unknown 6 Concomitant Drug Discontinued
7. Dysarthria 7. Other, specify: 7. Components Explanted
8. Disequilibrium (Complete Complication Form 8)





14. Attention or Cognitive Deficits Status: Casualty of Relationship to Stimulation:
15, Sensory Deficits 1 Resolved Etiology to Event: 1. Present Only with Stimulation
16. Gait Disorders 2. Ongoing 1. Remote 2. Present Only without Stimulation
17. Rebound 2. Possible 3. Present Both with and without
18. Intracranial haemorrhage 3. Probable Stimulation







THALAMIC STIMULATION FOR THE
TREATMENT OF TREMOR
SYSTEM COMPLICATIONS
Please print or tvpt Form 8
1. Patient Identifier
2. Date ofBirth / /
month day year
3. Neurologist
4. Date of evaluation / /
month day year
5. Date ofComplication / /
month day year
6. Enter appropriate codes from the lists below (complete a separate form for each complication).
Complication: Severity: Status: Date Resolved: / /
month day year
Etiology: Casualty: Interventions: • •
REPORT DEATH ON FORM H 16: STUDY TERMINATION
System Complications: Severity: Etiology: Interventions:
1. Seroma 1. Mild 1. Lead 1. No intervention
2. Hematoma 2. Moderate 2. IPG 2. Patient Education
3. Erosion 3. Serious 3. Extension 3. Lead Explanted
4. Infection 4. Burr Hole Ring & Cap 4. Lead Repositioned
5. CSF Leak 5. IPG-Extension Connection 5. Lead Replaced
6. Intracranial Haemorrhage 6. Lead-Extension Connection 6. Burr Hole Ring & Cap Replaced
7. No Stimulation 7. Surgical Procedure 7. Burr Hole Ring & Cap
8. Intermittent Stimulation 8. Patient Related Condition Repositioned
9. Loss of Effect 9. Patient Activity 8. Extension Explanted
10. Lead Migration 10. Phvsician/Staff Related 9. Extension Replaced
11. Lead Dislodgement 11. Unknown 10. IPG Explanted
12. Lead Fracture 12. Other, specify: 11. IPG Replaced
13. Burr Hole Ring & Cap 12. IPG ReprogTammed
Failure 13. Aspiration
14. IPG Malfunction 14. Antibiotic Therapy
15. Extension Fracture Status: Casualty of 15. Local Therapy
16. Extension Malfunction 1. Resolved Etiology to Complication: 16. Programmer Replaced/Repaired
17. Telemetry Failure 2. Ongoing 1. Remote 17. Surgical Exploration/
18 Programmer Malfunction 2. Possible Local Anaesthetic
19. Printer Malfunction 3. Probable 18. Surgical Exploration/
20. Therapy Side Effects 4. Definite General Anaesthetic








Is the patient able to turn the stimulator
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Table showing descriptive data of the total tremor scores
for the target arm
The components of tremor (postural a), postural b), kinetic/intention and goal-
related) were scored on a 5 point scale (0 - 4), with a higher score indicating
increased severity of tremor. The scores for the different components were summed





N Median Mean S.D. Minimum Maximum
Pre-op 12 12 11.5 2.35 7 15
1 month OFF 11 7 7.36 4.37 1 15
1 month ON 9 5 4.56 1.81 2 8
3 months OFF 8 8.5 9.38 4.24 4 16
3 months ON 8 5.5 5.50 2.20 3 9
6 months OFF 9 8 8.22 4.52 2 16
6 months ON 9 5 6.44 4.13 2 16
12 months OFF 8 9 9.13 4.02 3 16
12 months ON 7 5 5.14 2.41 3 10
APPENDIX 38
Table showing descriptive data of the total number of
successful Jebsen subtests with the target arm
The Jebsen Test ofHand Function included 7 subtests ofupper limb performance.
The test was scored by counting the number of successful subtests performed by the
patient: allocating 1 for a pass and 0 for a fail. The higher the score the better the
performance on the subtests (best score = 7, worst score = 0).
Time of
Assessment
Total number of successful Jebsen subtests
N Median Mean S.D. Minimu
m
Maximum
Pre-op 12 1.5 1.33 0.98 0 3
1 month OFF 11 2 2.82 1.72 1 6
1 month ON 9 5 1.56 2 7
3 months OFF 8 1.5 3 2.56 1 7
3 months ON 8 4.5 4.5 2.33 2 7
6 months OFF 9 2 2.67 2.65 0 7
6 months ON 9 4 3.67 2.45 0 7
12 months OFF 8 2 2.50 2.45 0 7
12 months ON 7 5 4.43 2.15 1 7
APPENDIX 39
Video to supplement written work of thesis showing
patients with movement disorders due to MS in whom
thalamic DBS were implanted in the study
The video shows clips of patients being assessed using the Modified Fahn's Tremor
Rating Scale to rate severity of tremor amplitude and the Jebsen Test of Hand
Function to measure the successful performance of Jebsen subtests with the target
arm. It shows patients in whom the movement disorder predominately affects the
upper limbs and patients in whom the movement disorder affects the head, and the
trunk as well as the upper limbs.
One patient is shown demonstrating a beneficial microthalamotomy effect after the
operation, the beneficial symptomatic and functional effect of thalamic DBS 12
months after operation can be seen in 2 patients. The last patient shown on the video
demonstrates the functional limitations in performing activities of daily living after
the operation due to the persistence of intention tremor and dysmetria.
APPENDIX 40
PUBLISHED WORK
Whittle IR, Hooper J, Mumford C, Pentland B., Taylor R. Derivation of a test battery
to evaluate the effects of thalamic DBS in patients with MS. Acta Neurochir (Wien)
138; 644-5, 1996.
Hooper J, Mumford C, Pentland B, Signorini D, Taylor R, Whittle IR. Validation of a
tremor rating scale to determine effects of thalamic deep brain stimulation for
movement disorders in patients with multiple sclerosis. J Neurol Neurosurg Psychiat
63; 130, 1997.
Hooper J, Taylor,R, Pentland B, Whittle IR. Rater reliability of Fahn's Tremor
Rating Scale in patients with multiple sclerosis. Arch Phys Med Rehabil 79; 1076-
1079, 1998.
Whittle IR, Hooper J, Pentland B. Thalamic deep brain stimulation for movement
disorders in multiple sclerosis. Lancet 351; 109-110, 1998.
Hooper J, Whittle IR. Long-term outcome after thalamotomy for movement
disorders in multiple sclerosis. Lancet 352; 1984, 1998.
Hooper J, Pentland B, Whittle ER. Problems associated with thalamic deep brain
stimulation for movement disorders due to multiple sclerosis. Multiple Sclerosis 4
(Supp 1);S7, 1998.
Whittle ER, Hooper J. Thalamic DBS for non-Parkinsonian movement disorders. Brit J
Neurosurg 13; 539, 1999
Yau Y-H, Hooper J, Whittle ER. Long term outcome following thalamotomy for
movement disorders. Brit J Neurosurg 13; 539, 1999
RESEARCH LETTERS
and in-vitro immune function, and immunity against
opportunistic infections in complete DGA. Potential future
uses of lymphocyte transplantation may include immune
constitution of children with other T-cell deficiencies, as
well as of functionally athymic adults after bone-marrow
transplants.
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Long-term outcome after
thalamotomy for movement
disorders in multiple sclerosis
Julie Hooper. Ian R Whittle
Sterotactic thalamotomy is an effective treatment for
tremor in Parkinson's disease with long-term benefits.
After thalamotomy for tremor due to multiple sclerosis
(MS), 90% of patients show immediate improvement,
which remains in 70% of patients at 1 year, but ionger-term
outcome is not well known.: This issue is important since
thalamic deep brain stimulation (DBS) is being
investigated as an alternative treatment to thalamotomy for
management of MS-related movement disorders.'' Since
the profile of patients with MS chosen for either
thalamotomy or thalamic DBS is probably similar, and
there are important clinical, management, and heaith
economic implications to DBS,'-4 we reassessed the clinical
status and functional outcomes of ten patients with MS
who underwent thalamotomy between December. 1989,
and October, 1994. We aimed to find out outcomes after 1
year in movement disorders, after thalamotomy and to
ascertain the general clinical status of the patients.
All ten patients had a form of cerebellar tremor that w;
distinguished clinically into rubral tremor, characterised t
severe postural tremor affecting the head, trunk, and upp>
limbs with a supradded action/intention component th
was present during volitional limb movements, or i
isoiated action intention tremor. All patients were severe
disabled by the movement disorders and had no function
use of their affected upper limb. After compute
tomography-guided ventrolateral thalamotomy, brachi
tremor was decreased in nine patients immediately after tf
operation.' In patients with severe rubral tremor, none ha
complete abolition of their movement disorder, an
although it decreased in most tremor remained disabiir
because of the unmasking or persistence of cerebelh
disease. At 1 year follow-up, only three patients, who ha
the best preoperative Barrel scores, had improved functio
(patients 4, 5, and 10). At final follow-up median 5
months after surgery) only six patients remained alive, an
one (patient 10) still had improved function (table).
These findings strongly suggest that in many patient:
onset of severe movement disorders is followed by
progressive functional decline, and even death, due to MS
Also, although stereotactic surgery might be temporarii
beneficial, a long-term impact is unlikely, mainly becaus
of additional damage to the central nervous systerr
Adequate assessment of thalamic DBS in patients wit
MS-associated movement disorders will require long-ten
follow up. Thalamic DBS, which is a more flexible an
non-lesional therapy than thalamotomy, will, howeve:
have only temporary effects if systemic functional declin
due to MS is as seen in our patients.
This work was funded by the Multiple Scierosis Society of United
Kingdom and Northern Ireland.
1 Kelly P, Gillingham FJ. The long-term results of stereotaxic surgery
and L-dopa therapy in patients with Parkinson's disease. J Xeurosur<
1980; 53: 332-37'.'
2 Haddow LJ, Mumford C, Whittle IR. Sterotactic treatment of
tremor due to muinpie scierosis. Xeurosurg Q 1997; 7: 23-34.
3 Genv C, Nygen J-P, Pollin B, et ai. Improvement of severe posturai
cerebellar tremor m multiple sclerosis by chronic thalamic
stimulation. Mov Disord 1996; 11: 489-94.
4 Whittle IR. Hooper J, Pentlana B. Thalamic deep brain stimulation
for movement disorders due to multiple sclerosis. Lance: 1998; 351:
109-10.
5 Whittle IR, Haddow LJ. CT guided thalamotomy for movement
disorders in muinpie scierosis: problems and paradoxes.
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Sublingual oestrogen treatment of postnatal depression
Antti J Ahokas, Saija Turtiainen. Marjatta Aito
Research Letters
Postnatal depression has been estimated to affect over 10% of
women with sequelae for the mother, marital relationship, and
infant's psychological development.' Depression can be severe
and resistant to psychotherapy and antidepressant drugs.
Therefore, safe and rapidly effective therapies are needed,-
with likely association to the cause of depression. Oestrogen
has been shown to be effective in the treatment of postnatal
depression.' We report two consecutive cases fulfilling the
ICD-10 criteria of depression with postpartum onset admitted
to the psychiatric duty outpatient unit who responded
successfully to sublingual 17-(3 oestradiol monotherapy. We
measured serum oestradiol by radioimmunoassay at baseline
and weekly during follow-up. The treatment effect was
evaluated by the 10-item Montgomery-Asberg Depression
Rating Scale (MADRS), scores 0-6.
A 30-year-old woman (case 1) had no personal or family
history of mood disorders, and the relationship with her
husband was stable. During the second week after delivery of
her first baby she reported anxiety and sleep disturbances.
Over the subsequent weeks she became more depressed, and
reported inner tension, irritability, broken sleep, reduced
appetite, and concern about her baby. Her family physician
prescribed oxazepam 15-30 mg and counselling support was
given with only temporary help. 2 months after delivery, the
symptoms increased until she felt almost chaotic and came
to the psychiatric duty outpatient unit, where severe post¬
natal depression was diagnosed (MADRS total score 43).
Her serum concentration of oestradiol was 140 pmol/L, but
other routine blood tests including thyroid function were
within normal limits. With ethical committee approval and
informed consent, she was given 17-P oestradiol (Estrofem,
Novo Nordisk, Bagsvaerd, Denmark) 1 mg sublinguallv four
times daily during the first week and 1 mg three times daily
over the following week (table). After 1 week of treatment
she was more optimistic and after 2 weeks reported being
almost free of symptoms.
A 27-year-old teacher (case 2) had no history of
psychiatric illness and a stable family situation. After her first
delivery 3 years ago she felt tired but not depressed. 2 weeks
after her second childbirth she began to feel depressed,
anxious, and had broken sleep. Her symptoms progressed
until 5 months after delivery when she felt unable to take
care of the children and herself. Routine laboratory tests
including thyroid function were within the normal range,
apart from serum oestradiol which was 23 pmol/L. With
informed consent, sublingual 17-p oestradiol was given 1 mg
four times daily (table). After 2 weeks she was happy and
reported to be without symptoms.
Week













MADRS 39 17 1 0
Oestradioi 23 240 810
,=not measured.
MADRS total scores and oestradiol concentration (pmol/L)
during treatment
Our method is based on measuring the serurr
concentration of oestradiol and replacing the deficiency with
physiological oestradiol, while monitoring oestradiol tc
ensure adequate dosage. The sublingual route has several
advantages: it avoids first-pass metabolism and the non¬
compliance' associated with transdermal oestrogen therapy.
Furthermore, it offers rapid but short duration of action,
thus mimicking the natural pulsatile ovarian function. These
findings and the connection between oestrogen and
serotonin' may have aetiological relevance to postnatal
depression.
1 Cox JL, Murray D, Chapman G. A controlled study of the onset,
duration and prevalence of postnatal depression. BrJ Psychiatry 1993;
163: 27-31.
2 Murray D. Oestrogen and postnatal depression. Lancet 1996; 347:
918-19.
3 Gregoire AJP, Kumar R, Everitt B, et al. Transdermal oestrogen for
treatment of severe postnatal depression. Lancet 1996; 347: 939-33.
4 Hail G, Spector T. The use of oestrogen replacement as an adjunct
therapy in rheumatoid arthritis. In: Berg G, HammatM, eds. Modern
management ofmenopause. London: Parthenon Publishing Group,
1994: 369-75.
5 Fink G, Summer BEH. Oestrogen and mental state. Nature 1996;
383: 306.
Department of Psychiatry, University of Hellsinki, Fin-00260 Helsinki,
Finland (A J Ahokas); and Adnex Research Centre of Gynaecology,
Helsinki
Thalamic deep-brain stimulation for
movement disorders due to multiple
sclerosis
Ian R Whittle. Julie Hooper. Brian Pentland
Since 1980 when deep-brain stimulation (DBS) was first
described for movement disorders,' there have been
substantial technical advances in DBS hardware and brain
imaging. Thalamic DBS is an established treatment for
Parkinson's disease^ but its value in movement disorders due
to multiple sclerosis (MS) is uncertain, although one study
suggested good results in 69% of patients.' We are
prospectively evaluating thalamic DBS in MS patients and
report our preliminary results.
17 MS patients with disabling upper-'iimb-movement
disorders underwent extensive clinical, movement disordei
(with videorecording), neuroradiological (magnetic resonance
imaging [MRI]), and neuropsychological assessments
Patients were deemed not suitable for DBS implant because o:
predominant postural axial tremor (n=4), severe associatec
neurological dysfunction (4), or minimum associatec
disability (1). Eight patients underwent stereotactic
exploration of the ventrolateral thalamus, with computed
tomographic guidance and the Brown-Robert-Well;
stereotactic system. Only five of these patients had a thalamic
quadripolar DBS electrode (Medtronic, Minneapolis, MN
USA) and programmable pulse generator (Itrel-II, Medtronic
implanted since in the other patients no thalamic target poin
that produced suppression of the movement disorder could be
identified, despite extensive intraoperative physiologica
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testing. One patient who showed no tremor suppression
intraoperatively had a dramatic and sustained (6 months)
improvement postoperatively, presumably because of a
microthalatomoty effect. Our initial follow-up shows that the
stimulus parameters for the DBS need regular adjustment to
maintain optimum limb function.
These preliminary results have highlighted some difficulties.
First, on clinical and neuroradiological grounds, it is
impossible to predict which patients will benefit from this
treatment. The movement disorders in all these patients were
complex with ataxic, dysmetric, and tremorigenic components
that affected the trunk and limbs. All the MRI scans showed
diffuse hemispheric and brain-stem plaques with distortion of
the thalami and widening of the third ventricle. Second, in five
of these patients the neurophysiological responses usually
elicited during stereotactic thalamocapsular stimulation were
absent, despite preserved contralateral limb function.
However, the responses to rostral midbrain stimulation
(induced eye movement and pupillary changes) were
preserved. Under these circumstances we have elected not to
insert an electrode purely on anatomical localisation. Third,
a comprehensive rehabilitation programme is required
to support DBS insertion since the stimulators need
programming adjustments and the patients need intensive
physiotherapy and occupational therapy to relearn use of the
limb. Fourth, mood disturbances occur after surgery either
because it has failed or the result is not considered the
expected panacea. This difficulty has occurred despite an
extremely cautious approach to this therapy adopted by the
research team. Further prospective evaluation of this
treatment is essential to determine the long-term efficacy of
thalamic DBS, its potential advantages compared with
stereotactic thalamotomy," and to avoid inappropriate
application, unnecessary morbidity, and wastage of funds.
This study was supported by the Multiple Sclerosis Society of Great Britain
and Northern Ireland.
1 Brice J, McLellan L. Suppression of intention tremor by contingent
deep-brain stimulation. Lancet 1980; 315: 1221-22.
2 Benabid AL, Pollack P, Gao D, et al. Chronic electrical stimulation of
the ventralis intermedius nucleus of the thalamus as a treatment of
movement disorder. J Neurosurg 1996; 84: 203-14.
3 Geny C, Nguyen J-P, Pollin B, et al. Improvement of severe postural
cerebellar tremor in multiple sclerosis by chronic thalamic stimulation.
Mov Disord 1996; 11: 489-94.
4 Haddow LJ, Mumford C, Whittle IR. Stereotactic treatment of tremor
due to multiple sclerosis. Neurosurg Quart 1997; 7: 23-34.
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Transfemoral angiography of a 22-year-old renal transplant
A: the left arteria iliaca externa and arteria femoralis. The arteria
circumflexa femoris profunda is feeding capsular arteries of the renal
transplant. The arteria circumflexa femoris profunda shows a high-
grade proximal stenosis (on the opposite side indicated by -»). The
closed main renal artery is indicated by*.
B: parenchyma phase of the perfusion of the renal transplant.
C: percutaneous transluminal angioplasty of the stenosis of the
arteria circumflexa femoris profunda, before angioplasty.
D; percutaneous transluminal angioplasty of the stenosis of the
arteria circumflexa femoris profunda, during angioplasty.
E: percutaneous transluminal angioplasty of the stenosis of the
arteria circumflexa femoris profunda, after successful angioplasty.
Severe hypertension 22 years after
renal transplantation
Martin Tepel, Ulf Laufer, Dieter Hermann, Walter Zidek
A 49-year-old woman was admitted to our department
because of hypertensive urgency and increasing serum
concentrations ' of creatinine. 22 years earlier she had
received a cadaveric renal transplant for renal failure due to
chronic pyelonephritis. She had been dialysed for 14
months, during which time she underwent bilateral
nephrectomy; tissue from the latter procedure showed end-
stage renal disease consistent with chronic pyelonephritis.
The cadaveric renal transplant had a cold ischaemic time
of 17 h and showed a splicing of the renal artery into two
small vessels. During the transplantation, a thrombosis of
the main renal artery was observed and a second ana¬
stomosis of the renal artery had to be made. An acute
rejection episode occurred 3 weeks after transplantation,
but was treated successfully with prednisolone 1 g for 3
days and radiation of the transplant. She was treated with
azathioprine 100 mg daily and prednisone 20 mg daily, as a
maintenance regimen; within 1 year, the prednisone dose
was reduced to 10 mg daily. Her allograft functioned wel
for several years; her serum concentration of creatinine
ranged from 88 pmol/L to 106 gmol/L. 12 years later, hei
serum creatinine concentration rose to 159 |xmol/L, and :
renal-graft biopsy showed chronic tubulointerstitia
rejection and focal scarring with changes indicative o
chronic vascular rejection. Cyclosporin A was administerec
for 12 months but was discontinued because of side-
effects. Because she developed severe hypertension, th<
patient was treated with several antihypertensive drugs
including furosemide, metoprolol, dihydralazin, anc
clonidine.
On physical examination, the patient was an alert
cooperative woman; her systolic/diastolic blood pressuri
was 200/120 mm Hg, pulse 80 beats per min and regular
and she was afebrile. Abdominal examination revealed :
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Rater Reliability of Fahn's Tremor Rating Scale in Patients
With Multiple Sclerosis
Julie Hooper, BSc, Robert Taylor, PhD, Brian Pentland, MD, Ian R. Whittle, MD
ABSTRACT. Hooper J, Taylor R, Pentland B, Whittle IR.
Rater reliability of Fahn's Tremor Rating Scale in patients with
multiple sclerosis. Arch Phys Med Rehabil 1998;79:1076-9.
Objective: Assessment of movement disorders in patients
with multiple sclerosis (MS) is difficult because of the complex
nature of the movement disorders. The aim of this study was to
determine the reliability of Fahn's Tremor Rating Scale (FTRS)
in assessing movement disorders in patients with MS.
Method: Videos were made of 10 patients with MS showing
their rest, postural, action/intention, and goal-related movement
disorders as well as their performance of spirometry, a volumet¬
ric task, and timed functional tasks. Ratings of tremor were
carried out by one rater on two occasions 3 months apart and by
8 raters on one occasion using FTRS.
Results: Intrarater reliability was generally very good, with
no significant "drift" in ratings over time. Interrater reliability
was generally good, with some variation in interpretation of
scoring criteria that may reflect raters' backgrounds.
Conclusion: The FTRS is a reliable and potentially useful
tool with which to assess movement disorders in patients with
MS.
© 1998 by the American Congress of Rehabilitation Medi¬
cine and the American Academy of Physical Medicine and
Rehabilitation
TREMOR AND OTHER movement disorders are recog¬nized features of multiple sclerosis (MS) and can be both
distressing and disabling. In their series of 656 patients, Kraft
and colleagues1 reported tremor in 27%, in half ofwhom it was
associated with difficulties in performing activities of daily
living. Various treatments for tremor have been described,
including oral medication, the use of weights applied to the
wrists, and stereotactic surgery.1-3 Descriptions of such thera¬
pies have used a range of ad hoc scales to measure tremor
response, but at present no validated scale is available.3 This
partly is in contrast to experience with both essential and
Parkinsonian tremor, for which standardized scales exist,4"7 and
reflects the complexity of-the movement disorders associated
with MS. As part of a prospective study of thalamic deep brain
stimulation as a treatment for movement disorders in MS, we
decided to use a modification of the Fahn Tremor Rating Scale
(FTRS) as a measure of the tremor. To evaluate the applicability
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of the FTRS in this cohort, studies of both the intrarater ai
interrater reliability of the FTRS in patients with moveme
disorders due to MS were undertaken.
PATIENTS AND METHODS
Patients. Ten patients who fulfilled the criteria for defini
MS8 participated in the study. The mean duration of disease w;
11 years (range, 6 to 19 years). There were 3 men and 7 womt
with a mean age of 40 years (range, 31 to 56). All we;
right-handed. Seven were wheelchair-bound and the remainir
three could walk short distances but had significantly impaire
mobility. All 10 patients underwent a full neurologic examin;
tion from which the expanded disability status scale scon
(EDSS) was obtained. The mean EDSS was 6.5 (range, 4.5
8.5). All patients had severe postural and intentional tremors.
Vtdeorecording. Videorecordings of the patients being a
sessed were made according to a standardized protocol. T1
videorecording included the following components: (1) "
rest" in supported sitting and/or supine lying; (2) performir
specific purposeful movements such as voluntary movemen
of the head, drinking from a cup (held by both the examin
and, when possible, the patient), maintaining the upper limbs :
certain positions and performing intentional movements and tl
finger/nose test; (3) attempting to sit unsupported for t
seconds, standing unsupported for 10 seconds, and walking 1
meters; (4) performing-spirometry; (5) performing a volumetr
test; (6) performing hand writing and card turning from tl
Jebsen Test of Hand Function. 1<rA-composite and edited vide
of the patients performing these tasks was compiled ar
distributed to each rater who used the following scales.
The FTRS. The FTRS comprises three parts^A, B and (
Part C assesses functional disability as scored by the patient at
consequently was not included in this reliability study. 'Mini
modifications were made to the FTRS from its original descri
tion in 1988. Goal-related tremor was assessed separately rath
than being grouped with action/intention tremor, and the lii
drawing tests were omitted because of the severity of disabili
in the patient group.
PartA of the FTRS included subjective rating of the severi
of tremor for the head, trunk, right upper extremity, and If
upperextremity for rest tremor, postural tremor elicited with t
arms maintained in an extended position and a flexed positic
action/intention tremor, and goal:related-tremor. In total, tl
part of the assessment required 18 separate scores (table 1). F
each of these subtests or observations the tremor was defin
as: 0 = none; 1 = slight, may be intermittent; 2 = moden
amplitude, may be intermittent; 3 = marked amplitude; and 4
severe amplitude.
Part B of the FTRS included subjective rating of tas
performed with each hand. These included drawing of Arcl
medss' spirals (spirometry) and pouring water from one cup
another (volumetric test). The quantification of spirometry v.
based on the crossing of the lines in the figure: 0 = normal; 1
slightly tremulous; 2 - moderately tremulous or crosses lir
frequently; 3 = accomplishes task with great difficulty, ma
errors; and 4 = unable to complete drawing. There was 1<
space between the iines in the smaller of the two spirals, maki
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Table 1: Statistical Values for Intrarater and Interrater Reliability








Spearman Ranks Spearman* Friedman
Rating of Correlation Test Correlation ANOVA
Tremor Coefficient (p Value) Coefficient (p Value)
Head tremor
1. Rest Not computed 1 .28 .002
2. Postural .92 .56 .87 .004
3. Action/
intention .97 .32 .82 .001
4. Goal .85 .41 .77 .002
Trunk tremor
5. Rest Not computed 1 .01 .02
6. Postural .64 1 .84 .166
7. Action/
intention .93 .16 .76 .001
8. Goal .72 .68 .72 .008
Right upperlimb
9. Rest Not computed 1 .22 .001
10. Postural a .99 .16 .87 .009
11. Postural b .99 .32 .86 .489
12. Action/
intention .92 1 .87 .001
13. Goal .94 .16 .84 .009
Left upper limb
14. Rest Not computed 1 .19 .001
15. Postural a .94 1 .86 .001
16. Postural b .99 .32 .9 .005
17. Action/
intention .93 1 .73 .001
18. Goal .81 .66 .69 .003
Upper limb tasks
19. Large spiral-
right 1 1 .93 .005
20. Large spiral-
left .99 .32 .81 .232
21. Small spiral-
right 1 1 .93 .292
22. Small spiral-
left .87 .16 .92 .912
23. Pouring-
right 1 1 .97 .195
24. Pouring—left .99 1 .99 .333
Correlations above 0.7 are considered highi and above 0.9 ar
considered very high,
•Derived from Kendall's coefficient of concordance.
the task more difficult. Pouring water from one cup to another
was also quantified. Cup size and amount of water used in the
test were specified to ensure consistency between assessments.
The amount ofwater spilled is the basis for the severity grading:
0 = normal function; 1 - more careful than a person without
tremor, but no water is spilled; 2 = spills a small amount of
water (up to 10% of total amount); 3 = spills a considerable
amount of water (>10% to 50%); 4 = unable to pour water
without spilling most of the water. This part of the FTRS
involved assessment of 6 separate tasks (table 1). In total, 24
separate scores were obtained for each patient.
Assessment of the patients. For the intrarater assessmen
one rater (JH) rated the 10 patients on each of the 24 tests oi
two separate occasions 3 months apart. For the interrate
assessment 8 raters (3 medical practitioners and 5 physiothera
pists) were asked to study the scoring guidelines and instruc
tions for using the FTRS scale. They then watched th
videotape of the 10 patients and rated each patient's tremor o:
each of the 24 tests. Six raters worked in the clinical neurosci
ences in different units within Edinburgh and two of the rater
were physiotherapy lecturers involved in teaching neurology a
undergraduate and postgraduate levels. None of the raters hai
any experience using the FIRS before the study. All rating
were performed independently.
Statistical analysis. Nonparametric statistics were usei
throughout. Intrarater or test-retest reliability data were ana
lysed using Spearman correlations andWilcoxon matched-pair
signed ranks tests. Interrater reliability data were analyse
using Kendall's coefficient of concordance (from which avei
age interrater Spearman correlations can be derived) am
Friedman analysis of variance (ANOVA). The data wer
analyzed using SPSS for Windows.3
RESULTS
All raters completed the requisite assessments and did nc
comment upon any particular difficulties. Once raters familiar
ized themselves with the scale, it was easy to use and tremo
was rapidly assessable.
Intrarater Reliability
The intrarater reliability coefficients (Spearman correlatio
coefficient [r]) are shown in table 1; and range from .85 to .9
for the different categories of head tremor, .64 to .93 for trun
tremor, .92 to .99 for the right upper limb tremor, .81 to .99 fo
the left upper limb tremor, and .87 to 1 for the tremor evideri
when performing upper limb tasks (spirometry and volumetri
test). Levels of reliability are high except when certain catego
ties of tremor in the trunk are being assessed (postural tremc
r = .64 and goal related r = .72).
Correlations could not be computed for rest tremor of any c
the four body parts because nearly all patients received identic:
ratings of 0, indicating no rest tremor in these MS patients.
The Wilcoxon matched pairs signed ranks tests showed n
significant differences (all p values >.05) between the level c
ratings of tremor on any of the 24 measures when rated by th
same rater on two different occasions 3 months apart, indicatin
that there was no "drift" to more stringent or more leniei
rating (table 1).
Interrater Reliability
The average value of the Spearman correlations between a
possible pairs of raters was calculated via Kendall's coefficiei
of concordance to determine the overall agreement for eac
measure among the eight raters' sets of scores. The interrati
reliability coefficients range from .69 to .99. The scores for re
tremor, where nearly all ratings on these measures were ze:
ranged from .01 to .28, confirming the absence of rest tremor
this patient sample.
Friedman ANOVA was used to establish whether some rate
scored patients more strictly or more leniently than other ratei
Results (table 1) showed several significant differences in tl
rating levels (those withp values <.05) indicating that althou;
there was good agreement among raters on ranking of trem
severity in different patients, raters varied in their interpretatii
of the severity of tremor required for allocation to given poir
on the 0-to-4 scale. Subsequent analysis showed that the tv
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non-medically qualified academic raters, who are not in regular
clinical practice, tended to rate tremor as more severe than did
the medical staff and the physiotherapists, who tended to differ
little among themselves.
DISCUSSION
The aim of this study was to determine the reliability of a
slightly modified FTRS when rating the severity of tremor in
various parts of the body in patients with movement disorders
due to MS. Raters found the FTRS simple to use when
evaluating an edited video of the patients performing ad hoc
tasks. In general, the results demonstrate very good intrarater
and good interrater reliability, although there were variations in
rater scores of tremor in different body regions. Assessment of
tremor in the trunk showed a lower intrarater and interrater
reliability, although it still showed a satisfactory level of
agreement This difficulty in scoring truncal tremor may be
because there is less emphasis in the guidelines on how to
assess tremor in the trunk. In contrast scores for tremor on the
upper limb tasks showed good reliability-(correlation coeffi¬
cients were all >0.8). In particular, spirometry provides a
convenient measure of the disability caused by a movement
disorder that is also consistently graded. Furthermore, spirom¬
etry is a quick and practical way of assessing and reassessing
patients in the clinic or by postal survey, especially as the spiral
drawings in FTRS have been standardized.
The extent of rater agreement in this study is a result not only
of the inherent qualities of the assessment scale but also of
features of the setting and characteristics of the individual
raters. Standardized testing is essential to permit comparison
between measurements. In this study the patients were assessed
using a standardized assessment protocol, a specified scoring
procedure, under the same environmental conditions, with
consistent directions. The video tape could be rerun as neces¬
sary to help assessment and assist the raters to reach a
judgement on the severity of a patient's tremor. When making
this judgement, raters are influenced by their own experiences,
expertise, knowledge, and personal bias. This contributes to the
differences in rating levels found among raters and suggests that
in clinical studies it is advisable for either the same person or
members of the same occupational group to perform the ratings
of tremor. Because of the diffuse nature of the disease, MS
patients will often have other associated neurologic symptoms
that may influence the assessment. For example, it is difficult to
assess postural tremor of the trunk if the patient is unable to sit
unsupported because of truncal weakness. It is also difficult to
assess action/intention and. goal-related tremor in the trunk if
there is no active, intentional movement. The cohort of patients
in this study was determined by the severity of their movement
disorders, as only patients with moderate to severe movement
disorders caused by MS were referred for thalamic deep brain
stimulation.
The variability in results reflects some of the practical
difficulties of assessing movement disorders in MS where
movement disorders are complex manifestations of cerebellar,
brain stem, diencephalic, and subcortical white matter disease.
Classification of tremor in MS is not straightforward for
clinicians." Currently, clinicians favor the classification of
tremor into rest and action categories, the latter being subdi¬
vided into postural, action, intention, and goal-related types, or
according to the etiology of the underlying diseases with which
a particular tremor is associated. Although these approaches
have been widely adopted, in practice clinicians experience
difficulties in distinguishing the intention and action compo¬
nents of tremor, particularly if a postural component is also
present. This is complicated further in patients with MS who
may also have an associated cerebellar syndrome.
It is difficult clinically to define the boundaries of action,
intention, and goal-related tremor and to differentiate between
these types of tremor and dysmetria. What different clinicians
mean by intention tremor is also questionable; recently, four
neurologists with a special interest in movement disorders were
asked to classify the upper limb tremors of 20 videotaped
patients. Before the assessments, the four agreed on the
definitions of action and intention tremors. The results for
interrater reliability showed that there was very poor agreement
among the assessors concerning which of the patients had
action or intention tremor and even less agreement on the
severity of these two components of tremor.12 In clinical
practice it may be better not to attempt to distinguish between
action and intention tremor. Intention tremor, also known as
terminal tremor, is the pronounced exacerbation of action
tremor (tremor evident during movement) towards the end of a
goal-directed movement. For this study we found it was easier
to assess action tremor along with intention tremor by asking
the patient to perform the widely used finger/nose test. Goal-
related tremor occurs to any significant extent during the
performance of a functional task. We assessed goal-related
tremor by observing the patient performing spirometry, pour¬
ing, and the subtests of the Jebsen Test of Hand Function.
There are guidelines for using the FTRS scale but the
emphasis is on assessing tremor in the upper limbs. Patients
with MS frequently present with a cerebellar syndrome thai
usually affects the proximal more than distal muscles and the
head and trunk may also be involved. In the past this type oi
tremor was frequently termed "rubral tremor" and characteris¬
tically results in movements being wild and flailing. Hallet1
recommends abandoning the term because of the inaccurate
pathophysiology that it implies and refers to this type of tremoi
as severe postural cerebellar tremor. Many MS patients have
severe postural cerebellar tremor and Hallet has observed tha
this type of tremor "persists"or worsens with goal directec
movement and it is associated with dysmetria." For this reason
in this study we scored goal-related tremor separately fron
action/intention tremor. Expansion of the guidelines and clarifi
cation of assessment instructions, particularly as regards th<
head and trunk, may improve ease of use and reliability
Assessments of rest tremor in different areas of the body are nc
appropriate tests for this group of patients since it is rare ii
patients with MS and therefore could be omitted from the scale
Itmight, however, be useful to keep this test in the assessment i
the scale is to be used with other patient samples.
Standardized assessment is essential to permit comparison
between raters and between studies. A training video showin
patients with varying severity of tremor being assessed usin
FTRS would help to calibrate the judgement of raters an
provide appropriate training. Adequate-reliability is a prerequ
site but obviously not a guarantee of adequate validity. Th
FTRS evidently has high reliability but further work shoul
elaborate upon the other aspects of validity.
CONCLUSIONS
A composite of the FTRS provides a simple, concise 24-ite:
scale for evaluating movement disorders in MS. Interrater ai
intrarater reliability scores obtained in this study show that
can be used with confidence in a clinical setting and that it m<
have important clinical utility. Raters, however, should 1
familiar with the guidelines for using the scale and preferab
should have experience in the field of clinical neurology. It
preferable for research purposes that one rater performs tl
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assessments, because intrarater reliability was higher than
interrater reliability.
The potential utility and reliability of the scale is evidently
high, but more work is needed to establish its validity further
and to expand the definitions and guidelines so that it relates
specifically to evaluating the complex movement disorders seen
in patients with MS. Treatment for disabling tremor in MS
patients cannot be properly evaluated without reliable and valid
measures of tremor.
Acknowledgments: We are grateful to our colleagues who rated
the videos of the patients.
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